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Abstract 
 The aim of this project was to investigate nutrient acquisition by glucose 
transporter null mutant Leishmania mexicana, to understand how genetic 
ablation of glucose transporter genes in these protozoan parasites affects their 
phenotype. It has previously been demonstrated that glucose transporter null 
mutant Leishmania (ΔLmGT) promastigotes have lost the capacity to transport 
glucose as well other hexoses. Glucose is a potential carbon source for 
promastigotes, which are typically maintained in glucose-rich media and which 
encounter high levels of glucose in the sandfly midgut. Despite inability to 
transport glucose, the null mutant parasite is able to survive and grow, although 
at a reduced rate in media that contains non-carbohydrate potential carbon 
sources. This finding suggesting that the null mutant may utilise other carbon 
sources. In this project, a variety of approaches have been applied to investigate 
the nature of these alternative carbon source and the mechanisms by which they 
are acquired and metabolised.  
 Amino acid uptake assays revealed that glucose transporter null mutant 
promastigotes take up several key amino acids at a significantly enhanced rate, 
compared with wild type promastigotes. A comparative metabolomic analysis 
was applied for more comprehensive comparison between the wild type and 
glucose transporter null mutant. Though the uptake assay and metabolomic 
analysis showed distinct changes in nutrient uptake and metabolisms between 
the two cell lines, these results does not tell whether the changes are due to 
changes in transporter activity or expression, nor does it inform on the enzymes 
involved in these processess. Thus, a proteomic approach was applied. Since 
membrane transporter were a focus of interest, but are known to be highly 
hydrophobic and of relatively low abundance, it was necessary to develop 
protocols for membrane protein enrichment and fractionation in Leishmania 
mexicana.  
 A previous comparative proteomic analysis, which did not represent 
membrane proteins, had highlighted changes in the abundance of a major 
component of the paraflagellar rod. This unexpected result was further 
investigated, by Western blotting, electron microscopy and taxis assay. The 
results point to changes in flagellar structure of function in glucose transporter 
null mutant Leishmania.  
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 It is no doubt the experiments carried out in this project have shown 
interesting changes in glucose transporter null mutant Leishmania, in terms of 
nutrient acquisition and phenotypic characteristics. The data provide a new set 
of ideas as to how Leishmania thrive in a condition where glucose is scarce. 
These data may have relevance to leishmaniasis in mammals, as it is likely that 
glucose is constitutively scarce in the intracellular environment inhabited by the 
amastigote. However, due to time constraints, it was not possible to extend 
these investigations to the amastigote stage of Leishmania. 
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Chapter 1 
General Introduction 
1.1 The Kinetoplastida 
 
 Kinetoplastida are a group of eukaryotes that have a unique structure 
called the kinetoplast, which is  the mitochondrial DNA of trypanosomatid 
protozoa (Shapiro & Englund 1995) and it is the structure located near the basal 
body of flagellum and is the genome of the mitochondrion. 
 Another unique feature of this genus is the flagella structure and, 
depending on the groups, kinetoplastids may exist as uniflagelatte 
(Trypanosomatids) or biflagellate (Bodonids). The flagellum facilitates the 
motility and may play a role in biosensing (Ginger et al. 2008). Kinetoplastids 
can be divided into two sub-groups; free living and parasitic. However, the most 
important group in the order is the trypanosomatidae, particularly Trypanosoma 
brucei, Trypanosoma cruzi and Leishmania spp. (Simpson et al. 2006), all of 
which cause serious infectious diseases in humans and domestic animals. Genetic 
sequencing of some of the species showed that trypanosomes and Leishmania 
share many similarities in their genome, although each different species has 
different manifestations upon infection of animals or humans (Stuart et al. 
2008). 
 Other parasitic protozoans in the group are Phytomonas spp.(plant 
parasite) and Crithidia fasciculata (insect parasite) (Shapiro & Englund 1995). 
 
1.2 Leishmania 
1.2.1 Life Cycle 
Leishmania spp. exists in two stages; the aflagellate amastigote 
mammalian stage and flagellated promastigote sandfly stage. The different 
developmental forms can be differentiated by their different habitat 
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requirement and morphology (Besteiro et al. 2007). The transmission of the 
parasite occurs when the sandfly, injects promastigotes into the skin of a 
mammal during a bloodmeal. These promastigotes will be taken up by 
macrophages and transform into amastigotes before start to multiply. The 
multiplication continues until the macrophage bursts and releases the 
amastigotes which then will infect neighbouring cells.  
 When a sandfly takes a bloodmeal from an infected mammal, the infected 
macrophages may be ingested into the sandlfy midgut and transform into 
promastigotes and start to divide. The promastigotes will move to the proboscis 
area of the midgut, ready to be transmitted to another mammalian host when 
the sandfly takes another bloodmeal.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1-1 Digenetic life cycle of Leishmania. Diagram has been removed due to copyright 
restrictions.  
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1.2.2 Life cycle forms 
Leishmania exists in two forms depending on the environment they are 
residing. The cycle alternates between two main morphological forms i.e. 
intracellular amastigotes which reside in mammalian hosts and motile 
promastigotes that reside in the sandfly vector.  
There are several forms of the sandfly phase of promastigotes that have 
been described and the metacyclic form which is the mammalian-infective stage 
that are best known for the promastigotes form (Gossage et al., 2003). A study 
on Leishmania (Leishmania) mexicana and Leishmania (Leishmania) infantum 
(syn. chagasi) demonstrated that there are two distinct, sequential  growth 
cycles during development in the sandfly vector, Lutzomyia longipalpis involving 
four separate life cycle stages (Gossage et. al. 2003). The growth cycles begun 
by procyclic promastigote (short and ovoid promastigotes), which reside in the 
abdominal midgut that contains the bloodmeal. Subsequently, the cells 
transform to non-dividing forms called the nectomonad promastigotes (long and 
slender promastigotes) and this is the form of the cells when the anterior 
migration occurs. Later, the transformation from the nectomonad into 
leptomonad forms (short and broad promastigotes) occurs, indicating the start of 
the second growth cycle in the anterior midgut. Subsequently the differentiation 
of leptomonad promastigotes into non-dividing metacyclic promastigotes arises, 
preparing the to be transmitted into a mammalian host (Gossage et al. 2003).  
However there are two morphological forms that are known to exist but 
regarded to be ‘unresolved issues’ i.e. haptomonad promastigotes and 
paramastigotes (Gossage et al. 2003). As described by Killick Kendrick, 
haptomonad  has two populations where both have the same small, broad 
electron-lucid forms but can be found either as free living in the gut lumen or 
attached to the cuticular surfaces of the gut (Killick-Kendrick et al. 1974). On 
the other hand, paramastigotes which  are both free-living and attached, have 
been described as infective stages. The form arising from haptomonad 
promastigotes or degenerate forms are found in the foregut in later stages of 
infection (Gossage et al. 2003). However, both haptomonad and  paramastigotes 
are comparatively a minor subpopulation and their role in the life cycle is 
uncertain (Gossage et al. 2003). 
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Figure 1-2 The image has been removed due to copyright restrictions. 
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1.2.3  Intracellular Organelles 
 
Figure 1-3 The image has been removed due to copyright restrictions. 
 
One of the unique features of the Trypanosomatidae organism is the 
existance of an organelle called kinetoplast DNA. The kinetoplast DNA represents 
a complex associate composed of a network of thousands of minicircles and a 
few dozen maxicircles. While maxicircles molecules occupy 5% of total DNA, 
minicircles exist in 5-50 thousands molecules per cell (reviewed in (Yurchenko & 
Kolesnikov 2000)). Maxicircles are analoug to other mitochondrial DNAs as they 
encode for mitochondrial rRNA and mitochondrial protein (Shapiro 1993). In 
minicircles, there is a variable region on the structure that carries information  
or so-called “guide RNAs” (gRNA) which participate in the posttranscriptional 
modification of mRNA known as “uridylate editing” (reviewed in (Yurchenko & 
Kolesnikov 2000). 
 
Whereas glycolisis in most all organisms occurs in cytosol, in 
tyrpanosomatids, the major part of the pathway, occur in compartmentalised  
organelle called glycosome; a microbody related to a higher eukaryote 
organelle, called peroxisome (reviewed in (Moyersoen et al. 2004)). Just like 
other peroxisome-like organelles in other oraganisms, glycosomes are bounded 
by a single phospholipid bilayer membrane, have an electron-dense 
proteinaceous matrix and do not have DNA (reviewed in (Moyersoen et al. 
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2004)). Other metabolisms may occur in glycosome (or at least in part). A study 
on Leishmania mexicana have shown that the enzymes from the first three steps 
in ether lipid biosynthesis are glycosomal (reviewed in Parsons et. al 2001). 
Ether lipids in trypanosomatids have vital roles in the association of major 
surface molecules with the plasma membrane through 
glycosylphosphatadylinositol (GPI) anchors. In addition, the GPI anchor of 
Leishmania promastigotes lipophosphoglycan (LPG) also has a unique ether lipid 
i.e. 1-0-alkyl-phosphatidylinositol or lyso-1-0-alkyl-phosphotidylinositol 
suggesting that it is likely that ether lipids have an important function in 
Leishmania (reviewed in (Parsons et al. 2001). Trypanosomatids are unable to 
synthesise purine, thus they rely on purine salvage from the host. Unlike several 
purine salvage enzymes in eukaryotes that are cytosolic, those enzymes i.e. 
hypoxanthine:guanine phosphoribosyl transferase, adenine phosphoribosyl 
transferase and xanthine phosphoribosyl transferase  are exclusively localised in 
glycosome (reviewed in (Parsons et al. 2001).  A study has showed that that 
compartmentalisation of glycolysis in glycosome is vital in trypanosomatid 
protozoans. Expression of the glycosomal enzyme phosphoglycerate kinase 
(PGK), which convert 1,3-bis phosphoglygerate  to 3-phosphoglycerate, in the 
cytosol proven to be toxic to the protozoan(reviewed in (Parsons et al. 2001)). 
Other functions of the glycosomal compartmentalisation in the trypanosomatid 
include avoiding osmotic effects when the glucose is high, recovery from 
starvation i.e.  the closed glycosomal system avoid the usage of ATP, thus allow 
the glycolysis to restart only when substrates are available (reviewed in (Parsons 
et al. 2001)).  
 
  
As they cycle between the vertebrate and invertebrate hosts vector, the 
protozoan parasite Leishmania undergo various developmental changes in their 
growth rates andnutritional requirements which include vivid changes in their 
morphology and function in organells involved in the secretory and endocytic 
pathway (Waller & McConville 2002). Flagellar pocket has been suggested to be 
the sole exocytosis and encytosis site as several organelles involved in secretory 
pathway and endocytosis pathway, residie around this area in the cell (Waller & 
McConville 2002). The secretory function in the parasite is played by the 
endoplasmic reticulum (ER) and Golgi apparatus and these two major organelles 
in the secretory pathway are morphologically well developed in dividing 
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promastigotes(Waller & McConville 2002). However, endocytic and lysosomal 
compartments in the promastigotes stage are still relatively poorly characterised 
(Waller & McConville 2002). In Leishmania, it has been identified that endocytic 
pathway involve three compartments that are morphologically different i.e. 
1)endosomes localised near the flagella pocket, 2)multi-vescular bodies (MVB) 
found at the anterior end of the protozoan promastigotes and 3)multi-vescular 
tubule-lysosome that runs along the anterior-posterior axis of the cell 
body(Waller & McConville 2002).  
 
MVT-lysosome is the terminal compartment in the promastigote endocytic 
pathway and was first recognised in Leishmania mexicana promastigote 
(reviewed in (Waller & Mcconville 2002)). Despite being the terminal lysosome 
compartment in promastigotes, this structure has a low pH level and low lytic 
capacity (reviewed in (Waller & Mcconville 2002)). Interestingly, promastigotes 
that are incubated in acidic media showed an increasing rate of degradation of 
chimera. This observation demonstrates that MVT-lysosome’s lytic capacity may 
be regulated by the acidity of the environment rather than the level of proteases 
expression (reviewed in (Waller & Mcconville 2002)). The MVT-lysosome’s 
structure and morphology has been suggested to be maintained by microtubules 
and this is supported by the finding that the MVT-lysosome rapidly 
depolymerised into one or two large vesicles if promastigotes are treated with 
microtubule disrupting agents like thioridazine (reviewed in (Waller & Mcconville 
2002)). 
 
MVBs that are located near the flagellar pocket have been suggested to be 
candidate intermediates that mediate transport from the Golgi apparatus or 
endosomes to the MVT-lysosomes (reviewed in (Waller & Mcconville 2002)).These 
MVBs could diffuse through the cytosol compartment or be transportered along 
the cytoplasmic microtubules by motor proteins as they have also been found in 
other trypanosomatids (reviewed in (Waller & Mcconville 2002)). 
 
Endocytic orgenalles mentioned above i.e. MVT-lysosome (multi-vescular 
tubule), endosomes and multi-vescular bodies(MVB) are different from 
acidocalcisomes (reviewed in (Waller & Mcconville 2002)). Acidocalcalcisomes 
are organelles that can be found in a diverse range of organisms and were first 
Dhilia U Lamasudin  Chapter 1, 8 
  
 
defined in trypanosomes (Docampo et al. 1995; Vercesi, Moreno, and Docompo 
1994). They are known as acidic organelles with a high concentration of 
phosphorus and exist in forms of pyrophosphate (PPi) and polyphosphate (poly 
P), and these phosphorus are complexed with calcium and other cations. The 
membrane of acidocalcisomes contain a number of pumps (Ca2+-ATPase, V-H+-
ATPase, H+-PPase), exchangers (Na+/H+, Ca2+/H+) and channels (aquaporins) 
(reviewed in (Moreno & Docompo, 2009)). 
 
In protists, acidocalcisomes are the compartments  used for the major 
storage of phosphorus e.g. Pi, PPi and poly P. PPi is a byproduct of the 
biosynthesis of nucleic acids, coenzymes and proteins, activation of fatty acids 
and biosynthesis of isoprenoids. But the information on how PPi is transported 
across acidocalcisomes and why it is stored is not really known. Unlike PPi, the 
functions of poly P in trypanosomatids are recognised and the changing 
concentrations of long and short chains of poly P in Trypanosoma cruzi during 
life cycle and when encountered with hyposmotic and hyperosmotic 
environments suggest that acidocalcisomes are involved in stress response to 
environmental changes (reviewed in (Moreno & Docompo, 2009)). As 
acidocalcisomes are the main storage compartments for poly P and calciums and 
other cations, this suggest that acidocalcisomes could be involved in energy 
sources and signaling processes respectively (Moreno & Docompo 2009, Lopez-
Martin et al 2008). In addition, acidocalcisomes may also be involved in pH 
homeostasis as poly P could be involved in intracellular pH regulation through 
the H+ produced from its hydrolysis. Acidocalcisomes are also suggested to be 
involved in osmoregulation as acidocalcisomes react to osmotic stress by altering 
the content of sodium and chloride (Moreno & Docompo 2009, Lopez-Martin et al 
2008,LeFurgey et al. 2001). 
 
Transition from the promastigote to amastigote stage is accompanied by 
changes in the intracellular organelles morphology. In lesion-derived 
amastigotes, the ER and Golgi apparatus appeard to be discreet and it has been 
reported that the latter has been shown in a majority of cases to be 
disseminated and hard to find (reviewed in (Waller & Mcconville 2002)). In 
amastigotes, the lysysome system is expanded and it is most obvious for 
members in the Leishmania mexicana complex, where the large lysosomal 
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vacuoles termed as megasomes exist (reviewed in (Waller & Mcconville 2002)). 
The term megasome reflect the large lysosomal organelles found in Leishmania 
mexicana complex amastigotes and the term was introduced by Alexander and 
Vickerman in 1975 (reviewed in (de Souza 2010)). Megasomes, which take up to 
15% of the cell volume in Leishmania mexicana complex amastigotes correlates 
with a great increase of cysteine proteases (reviewed in (de Souza 2010,Waller & 
Mcconville 2002)). However the size of megasomes is different between species 
(the size of megasomes in Leishmania chagasi amastigotes are only 5% of the cell 
volume) and it is also suggested that megasomes are a characteristic of the 
Leishmania mexicana complex (reviewed in (de Souza 2010)). It has been 
suggested that megasomes and their constituents may be important in the 
infectivity and virulence of Leishmania species (reviewed in (de Souza 2010).  
 
Autophagosome is a structure that is formed by a membranous structure 
that engulfs the cytoplasm/organelles that are to be degraded (reviewed in 
(Besteiro et al. 2006)). Autophagosome transports the internalised materials to 
the lysosomal compartment to be degraded and it is suggested that 
autophagosome needs to have strong interactions with the endosomal 
compartments to achieve its full degradative potential (reviewed in (Besteiro et 
al. 2006). Autophagosome also believed to be involved in the architectural 
modifications that occur during the development and differentiation processes 
(reviewed in (Besteiro et al. 2006)). 
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1.2.4 Cytoskeleton of Leishmania 
Trypanosomatids like Trypanosoma and Leishmania’s cell shapes are 
defined by their internal cytoskeletons (Gull 1999). The plasma membranes in 
most eukaryotic cells are well-known to be intimately connected with the 
cytoskeleton (Dagger et al. 1989, De Souza 1984). Cytoskeletons are made up of 
parallel rows of microtubules that run under the pellicle, and this assembly 
pattern by microtubules form a unique and complex structure i.e. subpellicular 
microtubule and like any other organisms, α/β tubulin heterodimers, are the 
major proteins constituents of subpellicular microtubules (De Souza 2010). These 
subpellicular microtubules in Trypanosomatids are cross-linked to each other and 
to the plasma membrane (Gull 1999).  
Subpellicular microtubules exist throughout the cell body but not at the 
flagella pocket area. Instead, at one point, the microtubule corset is substituted 
by a filamentous structure called the Flagellum Attachment Zone (FAZ) (De 
Souza 2010). FAZ is linked with microtubules that are closely associated with the 
cisternae of endoplasmic reticulum and is derived near to the basal bodies (De 
Souza 2010).  
The primary function of subpellicular microtubules is maintaining the cell 
shape and it is clear that experiments involving treatments that hamper the 
microtubules organisation, led to the changes in cell asymmetry (De Souza 
2010). In addition to cell shape maintainance, the microtubules’s function also 
involves the maintainance of the plasma membrane’s rigidity. Therefore, the 
assembly of endocytic vesicles and fusion of cytoplasmic vesicles with the 
membrane could be avoided (De Souza 2010). A few studies have demonstrated 
that endocytic and exocytic activities occur in the area that is not associated 
with the subpellicular membrane i.e. flagellar pocket (De Souza 2010, Field & 
Carrington 2004, Overath & Englster 2004).    
Glycosomes are the microbodies of the kinetoplastida and are related to 
peroxisomes and there is no evidence indicating that they have a nucleus. 
Studies on biogenesis of glycosomes in trypanosomatids are extensive and 
regarded as important as it is a potential candidate for drug targets (reviewed in 
(de Souza 2010)).  
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1.3  Leishmaniasis 
 Leishmania spp. (order, Kinetoplastidae; family, Trypanosomatidae), a 
protozoan parasite of mammals, is the causative agent of the infectious disease 
named leishmaniasis. Depending on the species of the protozoan, the disease is 
characterised by the manifestations of either one of the 3 major categories of 
the clinical symptoms i.e. self-healing cutaneous  leishmaniasis (CL), 
mucocutaneous leishmaniasis (MCL) and  visceral leishmaniasis (VL) (Lynn & 
McMaster 2008). While cutaneous leishmaniasis can be debilitating and 
disfiguring, and can lead to serious secondary bacterial infection, visceral 
leishmaniasis is always fatal without treatment. 
 Apart from the clinical symptoms, Leishmania spp. can be categorised 
according to the geographical distribution. The term “Old world” refers to 
species endemic to Asia, Middle East and Africa, e.g. Leishmania major , 
Leishmania infantum and Leishmania tropica whereas  the term “New World” 
refers to species endemic to  Southern and Central America,e.g. Leishmania 
mexicana, Leishmania (Vianna) braziliensis and Leishmania panamensis (David & 
Craft 2009)   
 It is estimated 1.5-2 million people acquire leishmaniasis every year, with 
350 million population are at risk (David & Craft 2009). It is possible that the 
figures will increase because of global warming and changes in human 
ecology(Bailey & Lockwood 2007;Desjeux 2001). 
 Factors that are believed to facilitate the spread of leishmaniasis are 
urbanization, immigration and deforestation. It also has been reported that 
soldiers who have served in Iraq have contracted the disease, as have tourists 
who have visited regions where leishmaniasis is endemic (Bailey & Lockwood 
2007;Harms et al. 2003;Weina et al. 2004). 
 Aas the disease is affecting mostly the poorest countries, efforts to 
combat leishmaniasis seem to be never-ending and the resources for diagnostics, 
treatment and control are costly. Many infected individuals reside in remote 
areas from where it is hard to access medical assistance.  
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 Despite extensive research over several decades, the aim to find the most 
accurate, high-sensitivity, affordable, less invasive, low toxicity drugs, 
treatments and diagnostic of the disease has yet been successful. Hence, 
research on various aspects of the parasite must be not neglected as it provides 
better insight into mechanisms of infection and pathology and will speed up our 
mission to contain the spread of the disease. 
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1.4  Diagnosis and Treatment 
Clinical features of fatal visceral leishmaniasis are fever, often associated 
with rigor and chills, splenomegaly, pancytopenia, weight loss and if leave 
untreated will lead to fatality (Sundar et al 2011). Some of the symptoms of CL 
are similar to other diseases (e.g. leprosy, skin cancers, tuberculosis, cutaneous 
mycoses, bacterial or fungal infections), which make the diagnosis difficult and 
misleading. In addition, delayed diagnosis could lead to mucosal infection (Blum 
& Hatz 2009a;Reithinger et al. 2007) . While cutaneous leishmaniasis is non-
fatal and self-healing, the infection can cause multiple lesions leading to 
mutilating scars, which in turn will cause   aesthetic stigma to the patient 
(Desjeux 2004). The aim in the treatment of cutanueous leishmaniasis is to 
speed up the healing process and so to lessen the scarring especially in cosmetic 
sites and to prevent spreading of the parasite (i.e. mucosal leishmaniasis) or 
relapse (Herwaldt 1999;Reithinger et al. 2007) 
 
1.4.1 Diagnosis 
Diagnosis of the disease is important to detect and confirm the organisms 
causing the infection. A rapid, accurate and non-risks methods are ideal criterias 
in diagnosing the disease.  
Traditionally, for VL , the method of testing on serologic specimen  and as 
well by demonstration of the parasite through microscopic examination and in 
vitro isolation have been accepted as the diagnosis procedure (Sundar & Rai 
2002, Antinori et al. 2007). Sera obtained from patients are tested with Indirect 
Flourescent Antibody Test (IFAT) and Enzyme-Linked- ImmunoSorbent Assay 
(ELISA), culture and Geimsa-stained paper (Sakru et al. 2011). For CL, the 
parasite presence can be tested by direct microscopy, a typical histology, 
positive culture and some indirect skin test like Montenegro skin test, positive 
serology or the presence of leishmanial DNA (Vega-Lopez 2003). However, 
molecular diagnosis by the polymerase chain reaction (PCR) has been accepted 
for leishmaniasis diagnosis (Vega-Lopez 2003, Antinori et al. 2007).  
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However, serologic specimens has a few undesireable criteria that make it 
less favourable as it has  less sensitivity i.e. in patients with severe 
immunosuppression, unable to discriminate between active or past-infections 
and unable to monitor the response of the parasite to specific theraphy (Sundar 
& Rai 2002, Antinori et al. 2007). Antinori (Antinori et al. 2007) has 
demonstrated that the PCR performed on whole blood samples produced more 
sensitive results as compared to PCR performed on serologic testing, in vitro 
culture and direct bone marrow specimen.  
Detection of Leishmania amastigotes in CL and ML mostly been performed 
using invasively obtained clinical specimens such as lesions aspirates, scrapings 
or biopsies (Veland et al 2011).However these techniques causing discomfort to  
patients as they are invasive procudures which posing risks of causing bleeding 
and infection (Veland et al. 2011). The procedures are difficult to perform 
especially to paediatric patients, in remote areas and areas with intercurrent 
bacterial or fungal infection (Veland et al. 20011). 
  
1.4.2   Treatment  
For decades, pentavalent antimonials (meglumine antimoniate, sodium 
stibogluconate) have remained the first line drugs to treat CL from the new 
world (Blum & Hatz 2009, Seifert 2011). Sodium stibogluconate (Pentostam) is 
where the pentavalent antimony is reacted with gluconic acid to generates a 
number of compounds where the structures are unknown and whereas 
meglumine antimoniate (Glucantime) is in which the pentavalent antimony is 
reacted with the sugar meglumine to form the same unknown compounds 
(Berman 1996). Response rate are over 95% in previously untreated VL patient 
but it has been reported of acquired resistance to pentavalent antimony in some 
areas that have high-prevalance and high-epidemic transmission. Not only that, 
the situation is aggravated by the fact that in some cases the drug has caused 
adverse side effect like cardiotoxixity (Seifert 2011). The drug also requires a 
long treatment duration which can take between 20-28 days and followed for 
one year (Markle & Makhoul 2004). 
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A polyene antibiotic or Amphotericin B which was extracted from 
Streptomyces nodosus is used as first line treatment in areas of high-rate of 
unresposiveness to pentavalent antimonials and second line elsewhere (reviewed 
in Seifert 2011). Treatment using amphotericin B deoxycholate has it drawbacks 
such as it need hospitalisation, regular supervision of patients, prolonged period 
of treatment and infusion-related side effects like fever, chills and 
trombophlebitis (reviewed in  Seifert 2011). Athough liposomal amphoterecin B 
is much safer and effective than amphoterecin B deoxycholate, the high cost for 
this drugs limits it comprehensive use in many endemic regions (reviewed in 
Seifert 2011).  
Miltefosine, which originally is a drug cancer, was the first oral anti-
Leishmanial treatment available to the market. It is a potential tool in 
elimination programme in some countries like India and Bangladesh and Nepal 
whereas in Colombia and Bolivia it is use as a second line treatment. However 
the drug has been reported to cause side effect i.e. gastrointestinal tract and 
also causing an elevation of hepatic enzymes (Seifert 2011). 
Other anti-Leishmanial drugs are paromomycin (injection for VL and topical 
treatment for CL), pentamidine (first line drugs for certain forms of CL and 
second line treatment for VL) and sitamaquine (Seifert 2011). 
However, mounting occurrence of resistance to these drugs and side 
effectes has becoming a problem for the current anti-leishmaniasis treatments, 
hence a development for a new drugs has been a focus for researchers.  
 
 
 
1.5  Environment Adaptation 
 As they move through their life cycle, Leishmania parasites adapt to 
survive in 2 different environments i.e. the parasitophorous vacuole in a 
macrophage that has low pH, with a temperature of 37°C and elevated CO2 
(Besteiro et al. 2007;Burchmore & Barrett 2001) whereas the sandfly midgut has 
neutral pH with a temperature that fluctuates with the environment of the 
insect. 
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 Both promastigotes and amastigotes have the ability to avoid the killing 
mechanisms of the macrophage by altering the macrophage signalling and 
functions (Abu-Dayyeh et al. 2010). For example, several studies have shown 
that both forms are capable of blocking the nitric oxide production that is fatal 
to many invading pathogens  (Forget et al. 2006;Proudfoot, O'Donnell, & Liew 
1995). The ability of the amastigote to thrive in these hostile conditions shows 
that it is an opportunistic organism which has evolved means for survival, has 
strategies to evade microbial activity and their components on their plasma 
membrane are compatible with the environment (Antoine et al. 1990).  
 
 
 
1.6  Metabolism in the life cycle of Leishmania 
 As the different stages of the parasite reside in two distinct environments, 
the parasite must adapt nutrient requirements and energy metabolism according 
to the surroundings. Proteins in the plasma membrane of the parasite are in the 
front line of this adaptation, both sensing changes in the environment and 
mediating the selective transfer of material from host to parasite. 
 Nutrient availability changes as Leishmania move through their life cycle. 
Between bloodmeals, sandflies feed on plant sugar, hence Leishmania 
promastigotes in this habitat encounter high sugar levels in the midgut and use 
this as source of energy and general nutrition (Schlein 1986).  Unlike 
promastigotes that constantly bathe in a sugar-rich environment, amastigotes 
reside in a macrophage parasitophorous vacuole (PV), which known to have a low 
level of free sugars  (Burchmore & Barrett 2001;McConville et al. 2007;Naderer & 
McConville 2008)  
 In a previous study, it was shown, in L.amazonensis-infected 
macrophages, that material was delivered to the parasitophorous vacuole 
(Rabinovitch et al. 1985), suggesting that amastigotes depend on the 
endocytosed materials from outside vacuole to gain nutrients. Russell and 
colleagues have described the findings of endocytosed material in the flagellar 
pocket and inside amastigotes, further confirming that parasite uptake of intra-
vacuolar substance (Russell et al. 1992). The expression of various plasma 
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membrane transporters in both amastigotes and promastigotes enable the 
parasites to exploit a range of molecules such as sugars, amino acids, polyamines  
and nucleoside metabolites available in sandfly midgut and macrophage 
phagolysosome (Burchmore & Barrett 2001). These endocytosis and lysosomal 
degradation provide extra means for the parasite to gain important nutrients 
(Waller & McConville 2002) essential for metabolism and survival of the parasites 
 
1.6.1  Energy Metabolism 
 Glucose is a primary source for energy metabolism for promastigotes and 
as promastigotes live in a high-sugar environment in the sandfly gut, glucose 
transporters play a pivotal role in maintaining the glucose supply. Glucose mostly 
metabolise via glycolysis and pentose phosphate pathway (Barrett 1997). Like 
any other trypanosomatids, the end products of glucose aerobic metabolism in 
Leishmania are mostly incompletely oxidised i.e succinate, L-alanine and 
acetate with traces of glycerol which 75% of the carbon comes from glucose 
(Maugeri et al. 2003).The remaining of the glucose may be oxidised in 
tricarboxilic acid cyle which generate CO2 (Cazzulo et al. 1988). 
 It is reported that the Leishmania amastigote has higher activities for 
enzymes that catalyse the β-oxidation  of fatty acids but low activities of 
glycolitic pathway enzymes (Coombs et al. 1982), suggesting that the 
amastigotes uses other carbon sources than glucose to support energy 
metabolism, probably because is glucose is scare in the parasitophorous vacuole  
(Burchmore & Barrett 2001). 
  Many metabolic pathways are essential for survival i.e. defence against 
oxidative stress, generation of molecules for nucleotides and nucleic acid 
synthesis, or generation of molecules essential for organism building block. To 
survive, the Leishmania must ensure that critical pathways remain provided, 
despite changes in the availability of key nutrients. The existence of essential 
catabolic, anabolic and anaplerotic pathways in the glycosomes of Leishmania 
provide them main targets for chemotheraphy (Hart & Opperdoes 1984).  
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1.6.1.1 Glycolysis  
 Glycolysis is a pathway that converts one molecule of glucose to two 
molecules of pyruvate which follow by the generation of two molecules of ATP. 
The breakdown of polysaccharides and molecules i.e glucose, related hexose 
sugars and sugar phosphates, generated from metabolism of oligosaccharide, 
make their way to the glycolysis pathway. In eukaryotic cells glycolysis take 
place in the cytosol and yielded pyruvate will continue further oxidation in 
mitochondria. However, trypanosomatidae parasites like Leishmania spp. carry 
the first seven reactions of glycolysis in an cytplasmic organelle called glycosome 
(Mathews et al. 2000). 
 Data for the occurrence of usual glycosomal enzyme distributions in 
promastigote life cycle of Leishmania major, Leishmania mexicana, Leishmania 
b. braziliensis and Leishmania donovani was published although little 
discrepancy has been noticed in enzymes composition between Leishmania spp. 
or with other members of the Trypanosomatidae (Hart & Opperdoes 1984).  
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Figure 1-4: Glycolysis pathway in Leishmania (The diagram was adapted from Saunders et 
al. 2010 and Hannaert et al. 2003). In contrast to the other organisms where the glycolytic 
enzymes are cytosolic, in Leishmania and other Trypanosomatids, the seven glycolytic 
enzymes converting glucose to 3-phosphoglycerate are restricted in peroxisome-like 
oganelles called glycosomes (Verlinde et al. 2001).  Enzymes  (1) Hexokinase : (2) glucose-6-
phoshate dehydrogenase: (3) phosphofructokinase : (4) aldolase : (5) triosephosphate 
isomerase : (6) glyceraldehyde-3-phosphate dehydrogenase : (7) posphoglycerate kinase : 
(8) phosphoglycerate mutase : (9) enolase : (10) pyruvate kinase. Abbreviations: G6P, 
glucose 6-phosphate ; F6P, fructose 6-phosphate ; FBP, fructose 1,6-bisphosphate ; DHAP, 
dihydroxyacetone ; G-3-P, glyceraldehyde 3-phosphate ; 1,3-BPGA, 1,3-
bisphosphoglycerate ; 3-PGA, 3-phosphoglycerate ; 2-PGA, 2-phosphoglycerate; PEP, 
phosphoenolpyruvate  ( Mottram& Coombs, 1985, Verlinde et al. 2001, Pabon et al. 2006, 
Quinones et al. 2007, Norwicki et al. 2009, Saunders et al. 2010) 
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1.6.1.2 Pentose Phosphate Pathway 
   
 Pentose phosphate pathway (PPP) is an anabolic pathway in cytosol. The 
primary function of PPP is to supply NADPH for reductive biosynthesis and ribose-
5-phosphate for nucleotide and nucleic acid biosynthesis (Mathews et al. 2000). 
 PPP has been less studied compared to glycolysis despite its importance in 
metabolism for many parasitic protozoa and in host-parasite relationship 
(Barrett 1997).  
  PPP supplies NADPH to organisms, which involves in oxidative stress. It 
was highlighted in previous published paper (Rodriguez-Contreras et al. 2007) 
that glucose transporter null mutant is sensitive to oxidative stress.  
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Figure 1-5: Glucose metabolism in pentose phosphate pathway. Glucose from the 
extracellular transported by the glucose transporter (green-coloured oval) converted to 
glucose-6-phosphate (G6P) which metabolise by the pentose phosphate pathway (PPP). 
PPP generates NADPH which is important for cellular redox (reduction of glutathione, 
trypanothione and thioredoxin; detoxification (cytochrome P450, glutathione-S-transferase); 
and reductive biosynthesis. Apart from NADPH generation, PPP generates important ribose- 
5-phosphate (for nucleotide biosynthesis) and intermediates for phosphorylated 
carbohydrates production. Abbreviations: G6P, glucose 6-phosphate: 6PGL, 6-
phosphogluconolactone: 6PG, 6-phosphogluconate: Ru5P, ribulose 5-phosphate: R5P, 
ribose 5-phosphate: Xu5P, xylulose 5-phosphate: S7P, sedoheptulose 7-phosphate: E4P, 
erythrose 4-phosphate: F6P, fructose-6-phosphate: GAP, glyceraldehyde-3-phosphate. 
Enzymes indicated by numbers: 1, hexokinase: 2, glucose-6-phosphate dehydrogenase: 3, 
6-phosphogluconolactonase: 4, 6-phosphogluconate dehydrogenase: 5, pentose phosphate 
isomerase: 6, ribulose-5-phosphate-3’-epimerase: 7, transketolase: 8, transaldolase. 
(Description and pathway image was adapted and amended from Barrett, 1997) 
 
 
 
 
 
 
 
 
 
 
Dhilia U Lamasudin  Chapter 1, 22 
  
 
1.7  Transporters 
 Nutrients and essential molecules for the survival of Leishmania need to 
be transported into the cell. Membrane transporters are critical in transporting 
molecules into the cell compartment where various metabolisms operate.  
 
1.7.1  Glucose transporters 
 As glucose is the primary source for energy metabolism in organism, the 
glucose transporter has been the major focus of researchers (Manolescu et al. 
2007). In Leishmania spp., the central role of glucose uptake has make it 
important to better understand the process at it molecular, cellular and genetic 
level to enhance our biochemistry and physiology knowledge of the parasite, 
therefore gives more information for researches to develop a novel therapeutics 
target that selectively impede the function of vital permeases of the parasites 
without affecting the host’s glucose transporter (Landfear 2010).  
 It is unclear of whether Leishmania glucose transporter is a facilitative 
transporter or concentrative proton symporters although it is reported that 
glucose uptake in parasite is inhibited by protonophores and sodium azide 
(respiratory inhibitors) (Burchmore & Hart 1995;Zilberstein & Dwyer 
1984;Zilberstein & Dwyer 1985), indicating the existence of proton symport 
(Landfear 2010). 
 The big number(40%) of metacyclic-like cultures in stationary phase 
culture and increasing expression of glucose transporter in Leishmania mexicana 
cultured under surrounding that induced metacyclogenesis suggesting 
metacyclogenesis process is coupled with increased glucose uptake and 
utilisation (Bates & Tetley 1993;Burchmore & Hart 1995).  
 The genome of Leishmania mexicana contains  a cluster of 3 genes named 
LmGT1, LmGT2 and LmGT3 (Burchmore & Landfear 1998) which are link to each 
other. These gene encode glucose tansporter proteins and these proteins are 
related in sequence and predicted secondary structure  to mammalian 
facilitative  glucose transporters, contain 12 transmembrane domains although   
only approximately 20% of the sequence reported to be similar to the closest 
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homologue, human glucose transporter GLUT1 (reviewed in (Landfear 2010)). 
These 3 L.mexicana’s glucose transporter proteins are isoforms that similar but  
differ to each other over the region containing transmembrane domains and 
connecting loops. However, these exhibited to be significantly diverge in 
sequence in the hydrophilic domains at the NH2 and COOH termini (Burchmore & 
Landfera 1998). 
 Each isoform has been expressed in xenopus oocytes  and glucose 
transporter Leishmania mexicana and from these experiments it showed that 
these proteins transported hexose sugars i.e. glucose, fructose, mannose and 
galactose (Burchmore & Landfear 1998, Rodriguez-Contreras et al. 2007). 
 Pro-1 protein, which is a glucose transporter in Leishmania enriettii exists 
in two isoforms i.e. isoform 1 and isoform 2 (Piper et al. 1995) and the protein is 
encoded by a sigle family of tandemly clustered genes which contain 8 copies of 
3.6 kilobaserepeat unit (Stein et al. 1990). Isoform 2 has been reported to be 
closely related to LmGT2 of the Leishmania mexicana (Burchmore & Landfear 
1998). Glucose transporters in parasitic parasites i.e. Leishmania,Trypanosoma 
and Plasmodium are related in sequence and structure to mammalian facilitative 
glucose transporters of the SLC family althoughthey are quite divergent in 
sequence (reviewed in (Landfear 2010)).   
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Figure 1-6 Structure of the LmGT gene locus in L.mexicana. (Upper) A Southern blot 
analysis showing genomic DNA restriction fragments separation in the electrophoresis , 
transferred to a nylon membrane  and hybridised with a protein-coding region of L.enrietti 
Pro-1 glucose transporter gene. Lane 1, BglII; lane 2, NotI; lane 3, EcoRI; lane 4, HindIII; lane 
5, BamHI; lane 6, EcoRV. The analysis revealed the single hybridising bands in EcoRI, 
HindIII, EcoRV and BamHI digests, suggesting that most or all of the LmGT locus  was 
contained within the ~14 kb EcoRI. (Lower) A picture showing the restriction map of  ~14 kb 
EcoRI genomic clone. Southern blot analysis showed that glucose transporter homologs 
mapped to three fragments in a KpnI-EcoRI digest of this genomic clone. The three 
fragments that were subcloned and partially sequenced are an EcoRI-KpnI (~5.2 kb), a KpnI 
(~3.8kb) and a KpnI-EcoRI (~2.7 kb). The solid boxes in the picture indicates protein coding 
regions and were deduced and revealed that the single L.mexicana glucose transporter 
locus comprises 3 clustered genes that encode 3 glucose transporter isoforms i.e. LmGT1, 
LmGT2 and LmGT3. Coding and 3’-UTR sequences downstream of the ~14 kb EcoRI 
fragment were acquired from cDNA using primers at locations designated by the small 
arrows marked 1, 2 and 3. R, EcoRI; K, KpnI; S, ScaI; B, BglII; P, PstI; C, ClaI. Restriction 
fragments for BglII/ClaI (BC) and PstI (P) are indicate by the solid lines below the map. 
Image from Burchmore & Landfear 1998). 
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Figure 1-7 The predicted amino acids sequences alignment for L.mexicana’s glucose 
transporters LmGT1, LmGT2 and LmGT3. The white backgrounds indicate the non-identical 
regions in all three proteins, while regions that are identical in two out 3 sequences are 
showed by a gray background. The positions for amino acids in each sequence show by the 
the numbers on the left, whereas the total number of constituent amino acids indicated by 
the numbers at the end of each sequence. Spaces presented to optimize the alignment are 
demonstrated by a period.  The roman numbered bars above the aligned sequences indicate 
the predicted transmembrane domains. Image from Burchmore & Landfear 1998. 
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Figure 1-8 The image has been removed due to copyright restrictions. 
 
 
 
 
 
 
 
 
 
Dhilia U Lamasudin  Chapter 1, 27 
  
 
1.7.2 Amino acid transporter 
Refer to Chapter 2.  
  
1.7.3  Myo-inositol transporter 
 The plasma membrane of Leishmania generally composed of inositol 
containing phospholipids or glycoproteins which attach to the membrane by an 
anchor called glycosylphosphotidyinositol anchors  (McConville & Ferguson 1993). 
Lipophosphoglycan , which is the main glycolipid found in  promastigotes(Turco 
& Descoteaux 1992), is structurally modified of inositol-phospholipid. Both 
lipophosphoglycan and glycoprotein of the parasites are thought to facilitate the 
attachment of the parasite to the epithelium of the sandfly midgut and as well 
as serving as a protection to the parasites as the parasite able to survive and 
replicate in a known hostile condition. From the biosyenthetic pathway of 
lipophosphoglycan (Turco & Descoteaux 1992) and glycosylphosphotidylinositol 
anchors (McConville & Ferguson 1993), it has been  found to be essential as 
their building block.  Drew et al. have shown that myo-inositol, i.e. the 
biosynthetic precursor for abundant glycolipids, is transported across the plasma 
membrane of Leishmania donovani promastigotes by a specific transporter and 
this transporter exhibits a structural associate to mammalian facilitative glucose 
transporters (Drew et al. 1995). The study using tow-electrode voltage clamp 
experiments have demonstrated that the transporter  is a symporter that utilises 
a proton gradient to accumulate myo-inositol within the cell. In addition, 
immunolocalisation experiments from the same paper (Drew et al. 1995) 
revealed the presence of this protein in the Leishmania donovani’s plasma 
membrane. The gene that encodes for this transporter was named D1 (or also 
known as MIT (myo-inositol/proton co-transporter)) and it was cloned and 
sequenced from L.donovani  (Langford et. al 1992). This gene sequence is shown 
to be related to ITR1 and ITR2 genes i.e.genes encode for inositol transporters 
from the yeast,  Sachharomyces cerevisiae(Drew et al. 1995) and it is reported 
to have a number of  conserved residues and motifs from the sugar transporter 
superfamily and these residues are important for the function of inositol uptake 
(Seyfang et al. 1997 & Seyfang & Landfear 2000). 
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Figure 1-9 The image has been removed due to copyright restrictions.  
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1.7.4   Nucleoside transporter 
 Unlike the mammalian cells that possess the ability to synthesised purines 
de novo, Leishmania spp. and other protozoan parasites depend on the various 
kinds of nucleoside transporters to salvage these compounds from their hosts. 
This lack of de novo purine synthesis is in concurrence with the parasite 
surroundings that plentiful   with pre-formed purine (Lafon et al. 1982). 
However, contrary to purine metabolism, L.mexicana has the capacity for 
pyrimidine biosynthesis (Galbraith 1991;Marr 1983).   The reason of huge interest 
of scientist to study these transporters in Leishmania is also because that they 
mediate the uptake of a variety of cytotoxic drugs (Landfear et al. 2004).  
  Genetic and biochemical studies done by Iovannisci et al. showed that 
Leishmania donovani promastigotes have 2 nucleoside transport activities with 
different substrate specificities (Iovannisci et al. 1984).The first is a transport 
activity of adenosine and pyrimidine nucleoside and as well as a cytotoxic analog 
of adenosine i.e. tubercidin, while the other is a transport activity for 
guanosine, inosine and the cytotoxic inosine isomer, formycin B (Aronow et al. 
1987).   Mutant cell lines from Leishmania donovani promastigotes i.e. TUBA5 
(tubercidin-resistant) and FBD5 (formycin B resistant) have been used to clone 
the respective nucleoside transporter genes by functional complementation 
(Vasudevan et al. 1998 & Carter et al. 2000). The genetic locus of LdNT1 
encompasses 2 closely related genes i.e. LdNT1.1 and LdNT1.2 (Vasudevan et al. 
1998).  It has been shown that these nucleoside transporter proteins, LdNT1.1 
and LdNT1.2 are related to mammalian equilibrative transporters but have 
higher substrate specificity for adenosine and pyrimidine nucleosides (Aronow et 
al. 1987) compared to mammalian equilibrative transporters which have broad 
substrate specificities which transport all of the nucleosides (Yao et al. 1997)). 
LdNT1.1 and LdNT1.2 proteins are predicted to have 11 transmembrane domains 
(Vasudevan et al. 1998). When TUBA5 Leishmanias were transfected with a 
cosmix library containing the LdNT1.1 and LdNT1.2 genes, the cells showed 
restoration of sensitivity to the cytotoxic adenosine analog tubercidin and ability 
to transport [3H] adenosine and [3H]uridine.  In addition, expression of LdNT1.2 
ORF in Xenopus oocytes enhanced the uptake of [3H]adenosine, hence these 
findings  confirm that the LdNT1.1 and LdNT1.2 proteins are functional 
nucleoside transporters (Vasudevan et al. 1998). 
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 Gene LdNT2 encodes a polypeptide comprising 499 amino acids which also 
exhibit significance homology with other members of the equilibrative 
nucleoside transporters family (Carter et al. 2000). Molecular analysis done on 
Leishmania donovani genome has demostrated that LdNT2 gene exists as a single 
copy gene which encodes a single transcript of 3 kilobase pairs (Carter et al. 
2000). Expression of LdNT2 in nucleoside transport null mutant L.donovani and in 
Xenopus laevis oocytes had proved that LdNT2 is an inosine-guanosine 
transporter with high affinity with a singular predicted membrane topology 
(Carter et al. 2000). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1-10 The image has been removed due to copyright restrictions. 
 
 
 
 
 
 
Dhilia U Lamasudin  Chapter 1, 31 
  
 
 
 
 
 
 
 
 
Figure 1-11 The image has been removed due to copyright restrictions. 
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1.8  Glucose transporter null Leishmania mexicana 
 Leishmania mexicana  has  a cluster of  family of  3 related single copy 
glucose transporter genes and they encode for proteins LmGT1, LmGT2 and 
LmGT3 (Burchmore & Landfear 1998) . The proteins are similar isoforms but 
different from each other at the transmembrane domains and connecting loops 
and significantly diverge at the amino and carboxy-hydrophylic 
domains(Burchmore & Landfear 1998) . Although LmGT2 mRNA is reported to be 
more highly expressed in promastigotes compared to amastigotes, the LmGT1 
and LmGT3 mRNAs expression in both development stages are the same 
(Landfear 2000).The phenotype of these transporters genes were analysed by 
reverse genetics.  Targeted gene replacement technique was employed by 
knockout  LmGT1, LmGT2 and LmGT3 genes residing on both homologs 
chromosomes and replace them with drug resistance marker and this glucose 
transporters genes deletion was generated at promastigote stage (Burchmore et 
al. 2003). The study showed that glucose transporter null mutant Leishmania 
(ΔLmGT) lost the ability to uptake  hexoses sugar i.e. glucose, fructose, mannose 
and galactose and the uptake of all 4 sugars  is restored by the complementation  
of the null mutant with each open reading frame on an episomal expression 
vector (Rodriguez-Contreras et al. 2007). Apart from the lost capacity of the 
hexoses uptake, the growth of ΔLmGT promastigotes is slower and to a lower 
density compared to the wild type. However by complementation of all 3 LmGT 
open reading frame the growth rate are restored to almost to the same level of 
the wild type (Landfear 2010). 
 In the studies involving murine primary macrophages,  ΔLmGT 
promastigotes able to infect macrophages (Burchmore et al. 2003). While the 
wild type Leishmania mexicana amastigote replicate,   ΔLmGT  was unable to 
replicate  and died over the course 6 days later(Landfear 2010). Nevertheless, 
the growth of ΔLmGT amastigotes in macrophages is partially restored by 
complementation with LmGT2 or LmGT3. Furthermore,  ΔLmGT promastigotes 
were unable to transform into axenic culture form  amastigotes , and wild type 
axenic amastigotes were unable to survive with withdrawal of glucose from 
growth medium (Burchmore et al. 2003). These findings show that, although 
down-regulation of glucose transport(Burchmore & Hart 1995) and metabolism 
(Hart & Coombs 1982;Rainey & MacKenzie 1991) are observed in Leishmania 
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amastigotes, glucose transporter expression is important for amastigotes survival 
(Landfear 2010).A study on Leishmania mexicana showed that glucose 
transporter LmGT2 and LmGT3, can mediate ribose uptake(Naula et al. 2010). 
LmGT2 has the higher affinity for the  pentose sugar D-ribose (Naula et al. 2010). 
Leishmania has the capacity to transport (Maugeri et al. 2003;Pastakia & Dwyer 
1987) and metabolise ribose (Berens, Deutsch-King, & Marr 1980). Amastigote 
may use ribose as an energy source (Burchmore & Barrett 2001). These 
observations support the suggestion that glucose transport is essential for the 
survival of both Leishmania life cycle stages as it is has high affinity for other 
molecules than glucose thus Leishmania can thrive in a condition with scarce 
glucose supply.   
 However, Feng has demonstrated that these null mutants have suppressed 
the avirulent phenotype and found the amplification of the gene called LmGT4, 
a gene that encodes an alternative hexose transpoter, LmGT4. The suppressors 
null mutant display an increased expression of LmGT4 mRNA and protein (Feng 
et al. 2009). Other phenotypes exhibited by the suppressor null mutants  recover 
the capability of transporting hexose sugar, boost its resistance to stress; 
oxidative stress, heat shock and starvation for nutrients, and enhance their 
carbohydrate β-mannan storage, as well as increasing the cell size compared to 
the unsuppressed null mutants.In addition, the growth as a  promastigote stage 
is increased compared to the unsuppressed null mutants (Feng et al. 2009).  
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Figure 1-12 Construction of glucose transporter null mutant.  The mutant was generated by 
targeted gene replacement strategy. (Upper) To target homologous recombination of the 
gene disruption constructs, the LmGTgene locus including the three ORFs (open reading 
rectangles  marked GT1, GT2 and GT3), the 10kb SmaI and 14 kb EcoRI restcition fragments, 
and the location of the upstream (US) and downstream (DS) segments were used in the 
strategy. The example of one of the disruption constructs structure is showed  immediately 
below the LmGT locus. The construct includes the US and DS segments, the ORF for the 
PAC selectable marker , the EcoRV and BgIII terminal polylinker restriction sites, and the 
internal EcoRI and SmaI restriction sites.  The sites for the homologous integration 
indicated by the thin arrows. (Lower)  Below the thick arrow shows the event of the targeted 
gene replacement, showing the structure of the resulting chromosomal locus and the 
predicted 2 kb EcoRI and 7 kb SmaI restriction fragments that are diagnostic of the correct 
homologous integration event. The restriction fragments are indicated by the symbols : RI, 
EcoRI; S, SmaI; RV, EcoRV; Bg, BgIII. As required, a null mutant need a second targeted 
gene replacement using similar gene disruption cassette containing a SAT marker. 
(Burchmore et al, 2003). 
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1.9  Proteomics 
 Why is there still a need to measure protein level when there are  many 
other methods e.g. DNA chip arrays, can accurately measure mRNA levels?  
 The truth is, the level of mRNA does not reflect the actual amount of 
protein present in the cell (Conn 2003). Several studies have showed poor 
correlation  between  transcriptome and proteome in yeast (Gygi et al. 
1999) and human liver (Anderson & Seilhamer 1997).  Furthermore, the 
phenotype expressed somehow is influenced by the surroundings, thus, study on 
mRNA or protein profile expressed must be done under strictly controlled 
conditions (Burchmore et al. 2001).  
 Unlike genome which the content is static, proteome may change as it 
goes through post-translational modification(PTM) like proteolysis, glycosylation, 
acetylation, deamination, palmitoylation, sulfation,phosphorylation and so on, 
or formation of large protein complexes (Cho 2007;Conn 2003). Ultimately, a 
single gene may encode as many as 50 different proteins type. Thus, genome 
content does not predict the active of protein and RNA quantitation does not 
represent the protein levels (Cho 2007). 
 Proteomic studies have reported higher percentage in predicting the 
proteome compared to transcriptomic studies as stage-specific protein are 
specifically regulated at translational and post-translational level (Bente et al. 
2003;Cohen-Freue et al. 2007;Leifso et al. 2007;McNicoll et al. 2006;Rosenzweig 
et al. 2008). 
 However, proteomics studies can be less conclusive in elucidating 
phenotype or diversity of pathology.  For example in a drug resistance study 
(Drummelsmith et al. 2003;Drummelsmith et al. 2004;El Fadili et al. 
2009;Sharma et al. 2009;Singh et al. 2008;Vergnes et al. 2007) and species 
diversity study(Brobey et al. 2006), a number of differently expressed proteins 
lacking annotated functions were listed and this may make the process of 
identifying of how different proteins in the biological systems of organisms 
relate to each other and hence, may raise many other new questions(Scheltema 
et al. 2010).  
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1.9.1 Proteomics & challenges for membrane protein 
  The central proteomic technology is mass spectrometry but in order 
to achieve significant invention and findings other technologies, resources and 
expertise are needed (Brewis & Brennan 2010). Prior to the identification of 
proteins (or peptides) by MS, there are certain procedures that a sample protein 
needs to go through. A choice of separation, fractionation and identification 
techniques needs to be considered carefully in order to get the most valuable 
results.   
 There are major challenges imposed upon the study of membrane 
proteomes. Firstly, membrane proteins are mostly present at low levels in 
biological membranes and it is thus difficult to isolate proteins of interest in 
sufficient quantities for further analysis or identification. This can be solved by 
enriching membrane proteins using biochemical approaches. Secondly, the high 
hydrophobicity characteristic of membrane proteins makes them less soluble in 
an aqueous environment. Alternative methods for membrane protein 
solubilisation are thus required (Seddon et al. 2004). 
 Challenges are also present at the downstream protocol of the 
experiment. As membrane protein is highly hydrophobic, it needs to be 
solubilised in a suitable detergent. Unfortunately this detergent may interfere 
with separation particularly those with LC and produce noise in analytical 
analysis i.e in ESI-MS, so detergents need to be carefully removed before being  
further analysis(Blonder et al. 2002) analysis steps.  
 
1.9.2 Protein Enrichment 
 Enrichment is the first key steps in my proteomic experiment and this 
step, which defines the plasma membrane starting material, is undoubtedly the 
most important (Sprenger & Jensen 2010). Unlike DNA, protein unable to be 
amplified within minutes using PCR. Depends on the working hypotheses, nature 
or target of the experiment, the commonly used enrichment strategies are 
selective precipitation and/or subcellular fractionantion of proteins or organelles 
by density gradient centrifugation and two-phase partitioning, cationic colloidal 
silica fractionation, immunoisolation and affinity enrichment plasma membrane 
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proteins by using cell-surface biotinylation chemistries or by using lectins 
(Cordwell & Thingholm 2010;Josic & Clifton 2007;Sprenger & Jensen 2010). 
 
1.9.3 Protein Separation 
 Enriched protein samples contain numerous of complex protein and 
peptides. In order to optimise the characterisation of each protein/peptide, one 
has to choose the most suitable separation technique hence easier to identify 
each molecule.  
 The most used separation techniques in proteomic experiments are liquid 
chromatography or gel electrophoresis, either one-dimensional (1-DE) or two- 
dimensional (2-DE). 2DE, which was first described in 1975 (O’Farrell, 1975) 
relies on separating proteins based on 1) pI, isoelectric focusing, (first 
dimension) and 2) molecular weight (second dimension) and stained for 
visualisation using Coomassie blue and silver staining. Liquid chromatography 
although offering a wide choice of matrices for protein separation and the 
potential for automation and direct feed into MS, also has disadvantage that 
made this less attractive. The direct feeding of samples into MS limit the time to 
analyse each fraction individually as each fraction is a moving target (Minden 
2007). 
 As 2-DE separate proteins in gel, this permits more time to spend on 
analysing each fraction individually i.e. predict the molecular weight by looking 
at the position of the fraction in the gel and more than one samples can be run 
simultaneously unlike column chromatography which is limited to one sample per 
apparatus which may take longer time for analysis and is not suitable for 
comparative proteomics. 
 However, 2-DE has been proven be incompatible for membrane proteins 
separation as it poorly resolve basic and hydrophobic protein (McDonough & 
Marban 2005) and has low sensitivity in detecting protein with low abundance 
(Ning et al. 2008).  
 To overcome these problems, one approach is combination of gel based 
fractionation, particularly 1-dimensional polyacrylamide sodium dodecyle 
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sulphate gel electrophoresis (1D-SDS PAGE) with isoelectric focusing (IEF) 
fractionation in solution.  
 
1.9.4 Comparative proteomic challenges 
 Comparative study in biological science can be interpreted as 
experimentation where 2 or more samples are being compared against their 
biological states i.e. the biochemistry or physiological processes, molecular 
content/level etc of their cells, tissues or organs depending on the hypotheses 
and aims of the experiment. 
 It is widely used in biomedical studies and has shed some light on 
understanding the pathology of diseases. Proteomic approaches have been 
incorporated in comparative studies as it is considered to be a highly powerful 
technology to investigate the differences of proteome in cells, tissues or organs 
which facilitates addressing the issues in biomedical research.  
 Comparative studies in Leishmania have been widely used in 
understanding several important issues i.e. how one of the stages of the life 
cycle can be pathogenic to humans whereas the other stage does not, 
investigating the mechanism of survival of the intracellular form and 
simultaneously pinpointing therapeutic targets (Walker et al. 2006) and, how one 
stage of the life cycles can strive in harsh conditions and be more infective to 
mammals compared to the another (Bente et al. 2003;Nugent et al. 2004). 
 However, before one wants to start a comparative proteomics study, 
some challenges need to be considered as if these challenges are not taken 
seriously, it could influence the experimental outcome. Such challenges are: 
 
  
1. How to resolve complex proteins and identify the few proteins that differs 
between the samples being compared (Minden 2007).  
 The chemical complexity of the proteome is far greater than is 
encountered in genomic and transcriptomic profiling. These complexities are 
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contributed by the protein mass, protein isoelectric points (pI) and protein 
abundance where the mass can range from 1000-1,000,000 Da, the pI ranges 
between 3-10 and abundance ranges from 1000-10,000,000 copies per cell. To 
find proteins with small amounts that are different between samples and sifted 
through these highly complex proteins, one will need to design a fractionation 
method that reduces the complexity without modifying the chemical nature of 
the proteins although the detection method nowadays has advanced in 
identifying proteins rapidly. 
2. Dynamic range 
 The Dynamic range of proteome poses another challenge to comparative 
study. One can have hypotheses to search for proteins that might be as high 
1x106 molecules per cell to as low as 50 molecules per cell (Ghaemmaghami et 
al. 2003).  Tubulin is known to have high-abundance in kinetoplastida and due 
through their extensive modification and processing together with the existence 
of numerous isoforms, detection of low abundance proteins is difficult and could 
lead to underrepresentation of low copy number proteins (Foucher et al. 2006).  
 
 
 
1.9.5 Membrane Protein 
 The plasma membrane serves as the cell boundary and contains a 
numerous number of transporters and other proteins that are important for the 
survival, growth and virulence of parasites. Membrane protein which exist as a 
lipid bilayer, play various important roles in cellular processes i.e. signal 
transduction, cell adhesion, metabolite and ion transport, endocytosis etc. 
Comparative proteomic analyses, which have demonstrable value in 
understanding parasite phenotypes, tend to be biased against the plasma 
membrane proteome because these proteins are often of low abundance and has 
poor solubility. The importance of membrane protein to organisms is further 
supported by the fact that the membrane protein represents around 30% of total 
proteins (Wallin & von Heijne 1998). 
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 Extensive researches on membrane proteins have been ongoing for several 
decades and yet it remains as difficult tasks for membrane protein experiments 
because of its contents/building blocks, which requires a balanced hydrophilic 
and lipophilic surrounding, which optimises the differences among different 
proteins (Sprenger & Jensen 2010).  
 Membrane consists primarily of protein and lipid. Protein can comprise 
greater than 50% by mass of membrane and carries out most of the tasks of the 
membrane.   Depending on the type of the cell, the ratio of the weight of 
membrane-associated proteins to lipids may range from 1.0 for blood cells to 3.0 
for mitochondrial membranes except for myelin where it is only 0.23 as it 
function as an insulator unlike other cell types that serve as ‘conductors’ (Singer 
2004). 
 
1.10  Metabolomics 
 Metabolomics aim to understand biology by studying the metabolic 
profiling of subject under study. As none of the post genomic technologies i.e 
genomics, transcriptomics, proteomics can stand alone in studying the 
phenotypic characterisation of organisms, metabolomic investigations may 
needed in order to complement more conventional –omic studies. By using the 
L.major genome sequence, two different studies (Chavali et al. 2008;Doyle et al. 
2009;Scheltema et al. 2010) have predicted around 1000 metabolites that 
comprise central metabolism and related with enzyme-catalysed reactions. 
However this number may reduce to 600 as cell-based metabolomics covers 
varies cellular sections, so the same metabolites may exist in more than one 
cellular compartment (Scheltema et al. 2010). Transcription and protein events, 
which are intermediate processes in the information flow from genotype to 
phenotype, are much more complex than the metabolome, but the chemical 
diversity of the metabolome is far greater than for the nucleic acid or protein. 
While proteins are the primary effectors molecules in cells, the metabolites are 
the substrates and products that are processed to drive living processes. 
 Nevertheless, it is impossible to predict metabolite levels by looking at 
the protein and transcript levels as metabolic levels or metabolome profile may 
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influenced by non-local control structure of metabolic network i.e enzyme 
inhibitors operating at the remote points in metabolic system as showed by 
metabolic control investigation (Kell & Westerhoff 1986).  
 Metabolomic analysis has potential to reveal important processes that may 
be specific to Leishmania and that may consequently present excellent drug 
targets. Indeed most drugs act as metabolite mimics. Metabolomic approaches 
were exploited in this project to complement proteomic analyses, with the 
assumption that cells unable to acquire a key metabolite like glucose would 
display significant changes at the metabolomic level.    
 
1.11 Mass spectrometry 
Over the years scientists have paid their attention to the sequential 
isolation, structural characterisation and functional assay of proteins. These 
studies are no doubt have been giving invaluable insights to understand the 
functional biochemisty of proteins. However these approaches do not suitable 
for studying ‘global’ biological studies (Ferguson & Smith 2003) where a complex 
mixture of proteins are studied at once rather than targeting a particular protein 
of interest.  Mass spectrometry has been used widely in proteomic studies as it 
has enabled rapid protein identification and characterisation, owing to its speed, 
specificity and sensitivity (Reid & McLuckey 2002). 
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Figure 1-13 Mass spectrometry consists of three components. As a sample of study 
subjected to mass spectrometry , it is first ionised into a gas phase by the ionisation 
technique e.g. electrospray ionisation (ESI) and matrix laser desorption ionisation (MALDI) 
etc. The gas phase comprises ionised molecules and ions are pass through an anlyser 
which can be only one kind e.g. time-of-flight (TOF), quadrupole and ion trap etc or a 
combination of 2 more of the mentioned analyser. The analyser will sort out the ions and 
separate them according to their mass and charge ratio (m/z).  Finally, the separated ions 
are detected and measured. 
 
 Basically the samples, either mixtures of proteins or peptides originated 
from whole cell lysate or tissue homogenate, are initially separated in 
microcapillary format liquid chromatography or electrophoresis before being 
transformed to gas phase by electron ionisation followed by mass analysis by the 
mass analyser.  
 In the current project, ESI-QTOF MS (Electrospray ionisation-quadrupole 
time-of-flight mass spectrometry) was used. It has an ESI source, hybrid mass 
analysers (quadrupole and time of flight) and a multichannel plate detector. In 
the studies, experiments were operated in both MS and tandem MS modes. MS 
mode uses the TOF to measure peptide ion mass, then MS/MS mode uses the 
quadrupole to isolate and fragments specific peptie ions and the TOF to measure 
their mass.  
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1.11.1 Ionisation 
Ionisation techniques and instruments to be used depends on the samples 
and what kind of analysis is to be conducted. The most common ionisation 
techniques used in biological studies are electrospray ionisation (ESI) and matrix 
assisted laser desorption ionisation (MALDI). 
 
1.11.1.1 Electrospray Ionisation (ESI) 
       The history of ESI began with the work of Malcolm Dole, who described 
it in the studies of ions from syntheticpolymers in 1968 (Zhou & Veenstra 
2008). However, only in the late 1980’s ESI has made an impact in 
biochemical studies when John Bennett Fenn showed that it is possible to 
analyse high molecular weight proteins (Zhou & Veenstra 2008). ESI 
generates intact ions in vacuum from large and complex species and makes 
it applicable for analysis that involve fragile polar molecules which may 
have important roles in biological systems (Fenn et al. 1989).  
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Figure 1-14 This image has been removed due to copyright restrictions. 
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1.11.2 Analyser 
An alternative approach is using the tandem mass spectrometry (MS/MS) 
(Ferguson & Smith 2003). Usually, this is done using triple quadrupole (TQ), 
quadrupole ion trap (QIT), Fourier transform ion-cyclotron resonance (FTICR) or 
the hybrid that was used in this project (Ferguson & Smith 2003) i.e. quadrupole 
time-of-flight (QTOF) mass spectrometers.  
1.11.2.1 Quadrupole 
 
 
 
 
 
 
 
Figure 1-15 This image has been removed due copyright restrictions. 
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1.11.2.2 Time-of-Flight (TOF) 
Time-of-flight is based on the simple principle of mass separation. The 
velocites of ions are related to their mass to charge ratio (m/z). If ionised 
species were at the same initial position, when they were accelerated by a 
constant homogenous electric field, the ions will move and the time taken to 
reach reach to the destination directly indicate their masses.  
1.12  Project Aims  
1. Look for changes in nutrient acquisition by glucose transpoter null 
Leishmania. 
2. Further investigate proteomic changes seen in a previously performed whole 
proteome comparative analysis. 
3. Develop a plasma membrane protein enrichment strategy for Leishmania. 
4. Apply this to look for differences in the plasma membrane proteome between 
wild type and glucose transporter null Leishmania. 
5. Comparative metabolomic study. 
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Chapter 2 
 
Nutrient Uptake in Glucose transporter null mutant 
Leishmania 
  
 
2.1 Introduction  
 The sand fly vector of Leishmania feeds primarily on plant material, 
which is rich in carbohydrates but relatively poor in other carbon sources 
(Burchmore et al. 2003;Young et al. 1980). Sugars are thus the major energy 
source available to the promastigote stage as it multiplies in the sand fly gut. 
Consistent with this, genetic ablation of glucose transporters in Leishmania gives 
rise to cells that cannot acquire glucose and that are poorly able to survive in 
the sand fly host (Burchmore et al. 2003). However, glucose-transport-null 
Leishmania promastigotes are viable in rich media, indicating that this stage has 
the ability to acquire other carbon sources from the environment. The major 
carbon sources that are presented to Leishmania in standard promastigote 
growth media (Appendix) are glucose and a variety of amino acids. To 
investigate the amino acid uptake capacity of Leishmania promastigotes, and to 
compare amino acid transport in wild type and glucose transport-null 
Leishmania, a series of transport assays were performed, together with a 
comparative metabolomic analysis of these lines.  
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Table 2-1 The table has been removed due copyright restrictions. 
 
 
 
 
 
 
 
 
(Refer to Table 2-1) The cells were left to starve up to 3 hours to measure 
the amino acid in starvation experiments. Some amino acids were found to be 
enhanced during the experiment including isoleucine, phenylalanine and arginine 
and this accumulation maybe because of continued protein breakdown, as slowly 
metabolised compounds or as catabolic products of other cellular components 
(Simon et al. 1983). However, other amino acids that were found to be 
decreased during starvation are proline, valine, methionine, aspartic acid , 
threonine and serine and this fall in concentration may be due to continued 
catabolism or the inability of the cells to synthesise  during starvation (Simon et 
al. 1983). As proline has been shown to have special physiological importance in 
Leishmania sp., (Krassner & Flory 1969 and Krassner & Flory 1972) Simon et al. 
decided to look for effects in the amino acid pool (Simon et al 1983). Following 
the 3 hours of incubation of the cells with 5 mM proline, the amino acids that 
have been elevated are glutamic acid, serine, glucine, arginine, tyrosine and 
lysine. The observation of theeffect of proline on the amino acids pool  may be 
associated with the proline’s suitability as a precursor of other amino acids 
(Simon et al. 1983). Furthermore, the chromatography of cell extracts after 
incubation with [14C]proline generates a number of label amino acids, hence, 
signifying that proline is  a precursor of other amino acids (Simon et al. 1983). 
The use of sodium fluoride (metabolic inhibitor) in the study (Simon et al 1983) 
is in view that metabolic inhibitors are demonstrated to  increase proteolysis in 
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L.tropica (Simon & Mukkada 1983). Following prolonged intoxication with sodium 
fluoride, several of the amino acids were reduced in concentration i.e. 
threonine, serine, glutamic acid, methionine, aspartic acid, histidine, proline 
and alanine. Nevertheless, the majority of the amino acids have increased in 
concentration during the first 30 minutes of incubation (data not shown in the 
paper Simon et al 1983), hence this finding is well-matched with the previous 
observation (Simon & Mukkada 1983) of increased proteolysis which is  caused by 
metabolic inhibitor i.e. in this experiment, sodium fluoride (Simon et al. 1983). 
The experiments in Table 2-1, show changes in the concentrations of 
amino acid pool and these changes may be a sign  that these components are on 
demand in Leishmania to support their physiological metabolism (Simon et al. 
1983). Serine , threonine, glycine, alanine were identified to be amongst  the 
major components in the amino acid pool in Leishmania tropica promastigotes 
and these can be converted to intermediates in glycolysis or Krebs cycle. It is 
proposed that amino acids that came from proteolysis could be oxidised through 
Krebs cycle (Simon et. 1983). The identification of several enzymes that are 
involved in amino acids-carbohydrate transformations further strenghten the 
possibility of the usage of amino acids as readily feasible sources for carbon and 
energy metabolisms (Simon et al. 1983). The important links between proline 
and carbohydrate metabolism were provided by the reversible transamination 
for the formation of aspartic and glutamic acids from corresponding keto acids 
(Simon et al. 1983).  
The amino acids that were shown to be reduced during both starvation 
and treatment with the metabolism inhibitor (Table 2-1) i.e. proline, serine, 
aspartic acid and methionine, highlight their importance as this observation 
signify the usage of these amino acids to support carbon and energy sources for 
survival during critical conditions. (Further explaination of serine and proline 
(including arginine and glutamine) are available in the discussion section in this 
chapter). 
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2.1.1 Amino acid Transport in Leishmania 
 Several amino acid transporters have been identified in Leishmania. In 
eukaryotes amino acids play essential biological functions such as osmolytes, 
precursor for protein biosynthesis or other biosynthetic pathways.  Leishmania 
and other eukaryotes have the ability to synthesise a subset of amino acids 
whereas others need to be taken up from the host environment. However, there 
may be permeases (transporters) for amino acids that are unable to be 
synthesised by a cell in order to supplement the supply provided by biosynthesis 
(Landfear 2011). Several amino acid transporters have been characterised in 
Leishmania. Although the transport of glutamate and methionine are found to 
exist in Leishmania, the transporters for these amino acids have not been cloned 
in Leishmania spp. 
Arginine transport: An arginine transporter, LdAAP3, was the first Leishmania 
amino acid permease to be cloned and functionally characterized, in Leishmania 
donovani (Shaked-Mishan et al. 2006). The transpoter is make up by 480 amino 
acids and predicted to have 11 membrane spanning domain (Shaked-Mishan et al 
2006). Saccharomyces cerevisiae mutant transfected with the gene LdAAP3  
showed that the encode for high-affinity arginine transporter with Km recorded 
to be at 14μM (Shaked-Mishan et al. 2006). LdAAP3 gene exists in two copies 
which located next to the other in chromosome 31 and these copies are only 
different in their 3’UTR (Shaked-Mishan et al. 2006). Arginine transports in 
trypanosomatidae and mammals are probably to be fundamentally different as 
they are belong to two different family (LdAAP3 closely related family of AAP 
which is exclusive to members in the family trypanosomatidae  and arginine 
transpoters of the mammals like CAT1-3  belong to amino acid-polyamine-
organocation (APC) family) (Reviewed in (Shaked-Mishan et al. 2006).  
Arginine is an important amino acid in Leishmania and must be obtained 
from the host(Opperdoes & Coombs 2007). The amino acid is used for protein 
synthesis and serves as precursor in polyamine synthesis (Roberts et al. 2004). 
The uptake of arginine is regulated by the internal arginine levels as starvation 
of this amino acid for 4 hours leads to a ~5 fold increase of the arginine uptake 
and increased expression of LdAAP3 protein and mRNA (Darlyuk et al. 2009).  
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Lysine transport: Unlike mammals, in which the same permease transports both 
arginine and lysine, trypanosomatid protozoa appear to have separate transport 
systems for both (Inbar et al. 2010). Trypanosomatids do not have the key 
enzyme essential for lysine synthesis that can be found in plants, thus they 
depend on the import of lysine from outside of the cell (Opperdoes & Coombs 
2007). A transporter for lysine has been  identified and characterised in 
Leishmania donovani (Inbar et al. 2010). In L. donovani, the gene LdAAP7 
encodes a lysine transporter. Attempts made to delete LdAAP7 in Leishmania 
donovani have failed because of gene duplication (Inbar et al 2010). Analysis on 
the gene’s sequence revealed that L.donovani ISR chromosome 32 that contains 
LdAAP7 gene is present at only 2 alleles (Reviewed in (Inbar et al. 2010)). 
Therefore, it has been concluded that the LdAAP7 duplication in the knockout 
experiments may suggest that the gene is important for the survival of the 
parasite and the only lysine transporter in the promastigote stage (Inbar et al. 
2010). 
The LdAAP7 protein belongs to the large amino acid/auxin permease 
(Inbar et al, 2010). While overexpression of this transporter in T.cruzi increased 
lysine uptake, this was not the case in L.donovani. This maybe because 
Leishmania regulate the intracellular lysine accumulation strictly (Inbar et 
al,2010) in accordance with the observation that the concentration remain 
stable during starvation (Darlyuk et al, 2009). Lysine transport decreases during 
growth in culture and stationary phase cultures, which also transport less 
arginine and proline than cultures in logarithmic growth, transport almost no 
lysine (Inbar et al. 2010). Lysine is used solely for protein biosynthesis, unlike 
proline and arginine (Darlyuk et al, 2009) which are utilised in other anabolic 
and catabolic processes. Given the toxic effect of lysine to many organisms 
(Inbar et al, 2010) , reduced transport in non-dividing stationary phase parasites 
may be an adaptive mechanism to avoid the accumulation of lysine (Inbar et al, 
2010).  
Glutamate Transport:  Enzymes responsible for glutamate metabolism, such as 
glutamate dehydrogenase, have been shown to exist in  several species of 
Leishmania (Martin et al. 1976). The transport of glutamate has been reported in 
Leishmania (Leishmania) amazonensis (Paes et al. 2008). The transport of the 
amino acid has been characterised by Paes et al as an active transport, shown to 
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be partially inhibited by analogues such as glutamine, aspartate, α-ketoglutarate 
and oxaloacetate, methionine and alanine.  
Methionine transport :   Methionine uptake in Leishmania tropica promastigotes 
was characterised by Mukkada et al (Mukkada & Simon 1977) and shown to occur  
against a concentration  gradient and via a saturable system which requires 
metabolic energy and was sensitive to temperature.  Influx of methionine is 
inhibited by increased levels of methionine in the intracellular pools (feedback 
inhibition) and increased levels of other amino acids, including some that have 
no affinity for the methionine carrier (i.e. lysine and tyrosine) can also inhibit 
methionine uptake, through an incompletely understood phenomenon described 
as transinhibition (Simon & Mukkada 1977).  
Proline transport: Geraldo et al  have shown that the putative proline 
transporter  La-PAT1 gene in Leishmania amazonensis is up-regulated in 
amastigotes and, it was suggested that two distinct transporters that are 
developmentally regulated exist for proline uptake in amastigotes and 
promastigotes (Geraldo et al. 2005). The single copy gene is upregulated in 
amastigote stage and it encodes a putative amino acid transporter that belongs 
to the amino acid/auxin permease family, a group of H(+)/amino acid 
symporters (Geraldo et al. 2005). 
 Leishmania promastigotes and amastigotes exhibit different kinetic 
properties and pH sensitivity for proline transport(Glaser & Mukkada 
1992;Krassner & Flory 1972). Uptake of proline in both life stages is by active 
transport, driven by proton motive force, and this is might be important to 
maintain the acidic intravacuolar environment (Geraldo et al. 2005).  
Serine transport: Serine uptake has been characterised in both promastigote 
and amastigote stages of Leishmania (Leishmania) amazonensis (dos Santos et 
al. 2009). The serine uptake is characterised to be a saturable transport system 
and the uptake increased linearly with temperature in the range of 20°C to 
45°C.  The uptake is pH dependent and optimum transport of the amino acid is 
at pH 7.5.  
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2.2 Materials and Methods 
Homem (Invitrogen), Foetal bovine serum (PAA), L-[3,4-3H (N)]- glutamine, L-
[2,3,4-3H]-monohydrochloride arginine, L-[2,3-3H]-proline, L-[3H(G)]-serine (all 
radioactive amino acids are from Perkin Elmer), chloroform (Fishcer Scientific), 
methanol (Sigma), L-serine, L-proline, L-arginine, L-glutamine (all from Sigma), 
PBS (Sigma), mineral oil (Sigma), formaldehyde (Sigma), dibutyl phthalate 
(Sigma) 
 
2.2.1 Culturing Leishmania mexicana 
  L. mexicana WT MNYC/BZ/62/M379 promastigotes, and a glucose 
transporter null line derived from this parent (Burchmore et al, 2003) were 
grown in modified Eagle’s minimal essential medium, HOMEM, with 10% (v/v) 
heat-inactivated foetal calf serum (FBS) and maintained at 25°C. 
 
2.2.2  Amino Acid Uptake Assay 
 Cells were grown up to the density of 1 X 107 cells/ml, counted and 
washed twice in cold PBS at 1200 x g for 10 minutes at 4°C. The cells were 
resuspended at a density of 5 x 108/ml in PBS and were preincubated in a 25°C 
water bath for 5-10 minutes. Uptake assays were performed in triplicate. 1.7 ml 
Eppendorf tubes, with caps removed, were prepared with 200μl dibutyl 
phthalate/mineral oil. Then, 100μl of labelled substrate, prepared in PBS at 2x 
the desired final concentration, was added and the tubes were centrifuged at 
13000 x g for 1 minute.  
 The substrates were labelled with either of these 4 amino acids i.e. L-
[3,4-3H (N)]- glutamine, L-[2,3,4-3H]-monohydrochloride arginine, L-[2,3-3H]-
proline, L-[3H(G)]-serine (Perkin Elmer) 
 To initiate the assay, 100μl of cell suspension was added into the aqueous 
layer of the substrate and timed from the instant of addition 
(5X108/1ml(concentration) X 100μl = 5X107cells). The uptake was stopped by 
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centrifugation at 13,000 x g for 1 minute. Tubes containing pelleted cells were 
immediately transferred into liquid nitrogen to snap freeze the cell pellets. The 
base of each frozen tube was then clipped off, with the cell pellet intact, into 
scintillation vials. To estimate the specific activity of the labelled substrate 
stock, 10μl aliquots of the 2x substrate were transferred to scintillation vials. 
200μl of 2% SDS was added to each scintillation vial and these were incubated 
for ~30minutes with occasional agitation before addition of 3 ml of scintillation 
fluid. Vials were sealed, agitated, and incubated o/n in the dark at room 
temperature before scintillation counting (Perkin Elmer, 1450 Microbeta Wallac 
Trilux Liquid Scintillation & Luminescence counter).   
 An aliquot of each cell suspension was fixed by 100-fold dilution into 1% 
formaldehyde and accurate cell count was performed to determine the number 
of cells in each assay. As a control for non-specific binding, extracellular 
substrate trapping etc, identical assays were performed with cells that had been 
pre-incubated for 10minutes with 1% formaldehyde. 
 
 
2.2.3   Metabolomics  
2.2.3.1 Cell Preparation 
 Promastigote cultures of Leishmania mexicana were grown as described in 
2.2.1 but merely grown up to 2x104 cells/ml and only used 20ml per sample. 
2.2.3.2 Metabolomic sample preparation 
 Cells were quenched by submersion of tube in dry ice/ethanol bath until 
culture temperature reached 4°C. This may take approximately 1 minute. For 
subsequent steps, all were performed at 0-4°C. Cells were centrifuged for 
10minutes at 100g and supernatant was removed to approximately 500μl. For 
analysis of spent medium, 5μl of supernatant was kept. Pellets were 
resuspended and transferred to 1.5ml eppendorf tube. Centrifuged for 
10minutes at 1000g and supernatant was removed completely. 
 The pellet was suspended in 200 μl of chloroform/methanol/water (1:3:1) 
and vigorously mixed on a cooled shaker for 1 hour. Cells were centrifuged for 3 
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minutes at 13,000g. Supernatant was taken and stored at -80°C until analysis by 
LCMS.  
 Medium sample (5 μl) was extracted with solvent according to the same 
protocol for samples extraction, prior to LCMS analysis. This is to allow removal 
of medium contaminants at the data-analysis stage.  
2.2.3.3 Mass Spectrometry 
The analysis of samples using mass spectrometry were done by Dr Karl 
Burgess and Dr Darren Creek (Creek et al. 2012). The experiments were only 
repetead technically hence the results are preliminary data.  
The protocol begins with the samples being analysed on an Exactive 
Orbitrap mass spectrometer (Thermo Fischer) in both positive and negative 
modes (rapid switching), coupled to a U3000 RSLC HPLC (Dionex) with a ZIC-
HILIC column (Sequant) (Vincent et al. 2010 and Vincent et al. 2012). All samples 
from each experiment were analysed in the same analytical batch (Vincent et al. 
2012. Analysis of quality control samples, internal standards and total ion 
chromatograms were done to test the quality of the chromatography and signal 
reproducibility. Samples that showed undesirable analytical variation (retention 
time drift) were taken out from the analysis (Vincent et al. 2012). To facilitate 
metabolite identification, a standard mix comprising approximately 200 
metabolites runs from the start of the experiment (Vincent et al. 2012. 
Raw files generated by the mass spectrometer were converted into 
mzXML files by ReAdW converter. These mzXML files were split into positive and 
negative ions and subsequently processed in with XCMS 
(http://www.scripps.edu) to detect peaks.  MzMatch 
(http://mzmatch.sourceforge.net/) was used to convert the files into peakML 
files, combine data from all samples and annotate related peaks. Further 
processing was conducted using in-house Excel VBA scripts to identify 
metabolites by looking at the combination of mass and retention times. A 
filtering process was then applied to remove related and duplicated peaks.  
 Dhilia U Lamasudin                                                                                                      Chapter 2,    
  
56 
All putatively identified metabolites abundance were compared between 
wild type, glucose transporter null mutant, HOMEM media and spent HOMEM 
media from wild type and glucose transporter null mutant culture. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 Dhilia U Lamasudin                                                                                                      Chapter 2,    
  
57 
2.3 Results 
2.3.1  Amino Acid Uptake Assays 
 To determine relative levels of amino acid uptake in wild type and 
glucose transporter null Leishmania, uptake of radiolabelled [3H]- serine, [3H]-
arginine, [3H]-proline and [3H]-glutamine was determined at 4 time points i.e 30 
seconds, 60 seconds, 90 seconds and 120seconds. These four amino acids were 
chosen as they are amongst the most abundant in the HOMEM media (Appendix) 
that was used to maintain the cells in culture. The activity of the labelled amino 
acids are 1mCi (37MBq)/1ml for 3HL-proline and 250μCi (9.25MBq)/250μl for 3HL-
arginine, 3HL-glutamine and 3HL-serine. 
 
 
 
Table 2-2: Uptake of amino acids in wild type (WT) and glucose transporter null mutant 
(ΔGT). Timetable summarised experiments that were done 2 times for each amino acid 
(each experiment was run in triplicate). Graphs for uptake for individual amino acid are 
shown in the next page. Mean±SEM, n=6. 
Amino Acid Uptake (pmoles/107 cells) 
Proline Serine Arginine Glutamine 
Time 
(Seconds) 
WT ΔGT WT ΔGT WT ΔGT WT ΔGT 
30 5.47 
±2.60 
13.76 
±1.86 
3.91 
±0.99 
222.98 
±30.54 
26.55 
±3.481 
17.39 
±3.73 
1.77 
±0.28 
28.01 
±6.01 
60 6.49 
±2.25 
17.69 
±3.10 
9.79 
±3.36 
222.09 
±17.20 
55.66 
±6.50 
29.32 
±4.47 
3.44 
±0.47 
27.62 
±2.78 
90 10.14 
±4.27 
44.34 
±6.26 
18.11 
±6.12 
340.54 
±44.26 
97.37 
±8.84 
61.88 
±13.82 
5.47 
±0.97 
53.26 
±4.99 
120 29.66 
±11.47 
55.81 
±6.33 
30.51 
±10.14 
198.28 
±24.86 
109.86 
±19.79 
68.74 
±12.05 
9.14 
±0.56 
54.43 
±6.50 
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2.3.1.1        Serine Uptake Assay 
 Serine uptake was assayed at 30μM in wild type and glucose transporter 
null mutant promastigotes. We found that uptake of serine was significantly 
higher in glucose transporter null Leishmania.  The initial rate of serine uptake 
(i.e. the first 30 seconds of the assay) in the glucose transporter null mutant was 
222.98 pmoles per 1X107 cells whereas the initial rate of uptake in wild type 
cells, assayed in parallel over the same period, was 3.91 pmoles per 1X107 cells. 
The initial rate of serine uptake in glucose transporter null Leishmania was 57 
times higher than in wild type Leishmania. However, over the uptake assay time 
course (120 sec), glucose transporter null Leishmania did not continue to 
accumulate labelled serine while wild type Leishmania accumulated serine at a 
linear rate. 
 
 
 
 
 
 
Figure 2-1: Serine uptake assay by glucose transporter null mutant and wild type 
Leishmania promastigotes. Experiments were done twice in triplicate with all triplicates 
were run in parallel. Each point represents the mean of 6 replicates. GT null mutant: glucose 
transporter null mutant Leishmania.Cell numbers used, (5X108cells/1ml(concentration) X 
100μl = 5X107cells). 
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2.3.1.2        Arginine Uptake Assay 
 Uptake of arginine by glucose transporter null mutant and Leishmania WT 
was investigated over 120 seconds with exposure to 30 μM. The uptake showed 
that wild type has a slightly higher uptake compared to the null mutant. At 30 
seconds, the wild type accumulates arginine at 26.55 pmoles per 1x107  cells 
whereas the null mutant accumulates arginine 1.5 times lower than the wild 
type i.e. 17.39 pmoles per 1x107 cells. At 60 seconds, wild type accumulates 
1.9x more arginine compared to the null mutant i.e. 55.66 pmoles per 1x107 cells 
and 29.32 pmoles per 1x107 cells respectively. At 90 seconds, the wild type and 
null mutant continue to accumulate arginine at 97.37pmoles per 1X107 cells and 
61.88 pmoles per 1X107 cells respectively. The uptake of the amino acids 
continues at 120 seconds with wild type accumulate 109.86 pmoles per 1X107 
cells and 68.73 pmoles per 1X107 cells for null mutant.  
 
 
Figure 2-2:  Arginine uptake assay by glucose transporter null mutant and wild type 
Leishmania promastigotes. Experiments were done twice in triplicate with all triplicates 
were run in parallel. Each point represents the mean of 6replicates. GT null mutant: glucose 
transporter null mutant Leishmania. Cell numbers used, (5X108cells/1ml(concentration) X 
100μl = 5X107cells). 
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2.3.1.3         Proline Uptake Assay 
 Measurement of proline transport along a time course was done with 
proline concentration of 30 μM. The accumulation of proline at the first time 
point is significantly higher in the null mutant compared to the wild type i.e. 
2.4X  higher in the null mutant compared to the wild type which is 5.47 pmoles 
per 1x107 cells in wild type and 13.76 pmoles per 1x107 cells in null mutant. At 
60 seconds, the accumulation continues with the uptake in wild was recorded at 
6.49 pmoles per 1X107 cells and 17.69 pmoles per 1X107 cells in null mutant.  
The uptake of proline in the null mutant at 90 seconds was 44.34 pmoles per 
1x107 cells whereas the wild type uptake for proline at this point was 10.14 
pmoles per 1x107 cells i.e 4.4X difference between the cell lines. At 120 
seconds, null mutant accumulates 55.81 pmoles per 1X107 cells of proline 
whereas the wild type accumulates 29.66 pmoles per 1X107 cells of proline.  
 
Figure 2-3: Proline uptake assay by glucose transporter null mutant and wild type 
Leishmania promastigotes. Experiments were done twice in triplicate with all triplicates 
were run in parallel. Each point represents the mean of 6 replicates. GT null mutant: glucose 
transporter null mutant Leishmania. Cell numbers used, (5X108cells/1ml(concentration) X 
100μl = 5X107cells). 
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2.3.1.4         Glutamine Uptake Assay 
 Glutamine uptake for both wild type and null mutant was analysed and 
the concentration of 3H-glutamine is set at 30 μM and the uptake is observed 
over 120seconds. At the first time point, null mutant accumulate 28.01 pmoles 
of glutamine per 1x107 per cells, 15.8X higher compared to wild type i.e 1.77 
pmoles per 1x107 cells. Both cell lines continue the uptake for glutamine after 
120seconds and null mutant remained to transport glutamine higher compared to 
wild type with the final time’s record for the uptake was 9.14  pmoles per 1x107 
cells for the wild type and 54.43 pmoles per 1x107 cells for null mutant.  
 
 
Figure 2-4: Glutamine uptake assay by glucose transporter null mutant and wild type 
Leishmania promastigotes. Experiments were done twice in triplicate with all triplicates 
were run in parallel. Each point  represents the mean of 6 replicates. GT null mutant: 
glucose transporter null mutant Leishmania. Cell numbers used, 
(5X108cells/1ml(concentration) X 100μl = 5X107cells). 
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2.3.2     Metabolomics 
The analysis of samples using mass spectrometry was done by Dr Karl 
Burgess and Dr Darren Creek (Creek et al. 2012). The experiments were only 
repetead technically hence the results are preliminary data.  
 The Identification Macro programme (http://mzmatch.sourceforge.net/) 
has identified 803 metabolites in all samples analysed based on putative 
identification. The metabolite levels are expressed as mean peak heights, 
relative to the wild type cells. However, only 71 metabolites (refer to Table 2-2 
to Table 2-7) have the confidence level of 10 which is the highest confidence 
level in the analysis process. The metabolites that have confidence levels below 
5 were excluded from the analysis.  The confidence level of the metabolites is 
based on several factors including:  
1) Retention times (RT) from the HPLC chromatography. The software has a 
record of RT for a number of known metabolites and this is called standard RT. 
The metabolites that match this standard RT scored the confidence level of 10, 
while metabolites that do not have a standard RT in the database are assigned a 
confidence level of 8 if the predicted retention time is within a predicted RT 
window.  
2) The existence of the metabolites in Leishmania metabolism. This is done by 
referring to the database called LeishCyc 
(http://leishcyc.bio21.unimelb.edu.au/), which is a database of metabolic 
pathways for Leishmania. Confidence levels for putative identifications not 
present in LeishCyc were reduced by 1.  
3) Related peaks were assigned by the mzMatch software to indicate possible MS 
artefacts. Putative metabolites assigned as related peaks were given lower 
confidence levels (-2).  
The mass spectrometry procedure was done by Dr Daren Creek and Dr Karl 
Burgess. This metabolomic study is a preliminary data as it the the experiment 
was only technically repeat instead of biologically repeat. 
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Amino Acid Metabolism 
Name Formula Isomers Homem WT-C WT-H ΔGT-C ΔGT-H 
L-Aspartate C4H7NO4 4 0.36 1 0.08 0.6 0.09 
L-Cysteine C3H7NO2S 2 0 1 0.003 0.42 0  
L-Glutamate C5H9NO4 14 0.26 1 0.12 0.74 0.09 
L-Valine C5H11NO2 16 0.22 1 0.27 1.46 0.25 
L-Isoleucine C6H13NO2 11 0.3 1 0.32 0.94 0.22 
L-Leucine C6H13NO2 11 0.42 1 0.34 1.17 0.32 
5'-Methylthioadenosine C11H15N5O3S 2 0 1 0 1.96 0.22 
S-Adenosyl-L-Methionine C15H23N6O5S 1 0 1 0 0.83 0  
Putrescine C4H12N2 1 0.03 1 0.02 1.5 0.04 
4-Aminobutanoate C4H9NO2 14 0.27 1 0.29 0.9 0.32 
Spermidine C7H19N3 1 0.08 1 0.12 0.85 0.11 
L-Ornithine C5H12N2O2 6 0.12 1 0.11 0.4 0.11 
L-Arginine C6H14N4O2 3 0.34 1 0.25 0.5 0.29 
L-Tyrosine C9H11NO3 11 0.35 1 0.37 0.9 0.37 
L-Tryptophan C11H12N2O2 6 0.43 1 0.39 0.77 0.39 
L-Kynurenine C10H12N2O3 2 0.38 1 0.43 0.57 0.44 
3-(2-Aminoethyl)-1H-indol-5-ol C10H12N2O 4 0.17 1 0.28 0.55 0.26 
L-Glutamine C5H10N2O3 6 0.2 1 0.14 1.13 0.1 
L-Phenylalanine C9H11NO2 7 0.32 1 0.34 0.93 0.35 
Phenylacetylglycine C10H11NO3 8 0.33 1 0.38 0.57 0.43 
L-Methionine C5H11NO2S 5 0.42 1 0.33 1.56 0.32 
N6,N6,N6-Trimethyl-L-lysine C9H20N2O2 2 0.91 1 0.38 2.23 0.65 
L-Carnithine C7H15NO3 2 1.71 1 0.7 1.62 1.4 
Trimethylammoniobutanoate C7H15NO2 6 0.63 1 0.49 0.75 0.6 
L-Lysine C6H14N2O2 7 0.29 1 0.33 0.61 0.3 
L-Histidine C6H9N3O2 4 0.34 1 0.32 0.88 0.32 
L-Threonine C4H9NO3 11 0.24 1 0.25 0.43 0.13 
L-Serine C3H7NO3 3 0.57 1 0.24 0.16 0.06 
L-Cystathionine C7H14N2O4S 4 0 1 0 0.56 0.03 
Choline C5H14NO 1 0.4 1 0.35 0.82 0.4 
Trypanothione disulfide C27H47N9O10S2 1 0 1 0 1.26 0 
Glutathione C10H17N3O6S 3 0 1 0 0.38 0  
L-Cystine C6H12N2O4S2 2 0.66 1 0.7 0.22 0.39 
S-glutathionyl-L-cysteine C13H22N4O8S2 2 0 1 0 0.13 0  
Glycine C2H5NO2 3 0.28 1 0.2 2.02 0.3 
Pantothenate C9H17NO5 1 0.27 1 0.25 0.44 0.31 
L-Proline C5H9NO2 4 0.02 1 0.03 0.04 0 
L-Asparagine C4H8N2O3 6 0.26 1 0.21 0.21 0.04 
L-Alanine C3H7NO2 9 0.03 1 0.06 0.1 0.01 
O-Acetylcarnitine C9H18NO4 1 1.89 1 0.59 1.26 1.69 
Table 2-3: Metabolites from amino acid metabolism. The metabolite levels are expressed as 
mean peak heights, relative to the wild type cells (WT-C). Homem is mean peaks from neat 
Homem, WT-C is mean peaks from wild type cells, WT-H is the mean peak for spent Homem 
in wild type culture, ΔGT-C is mean peak from glucose transporter null mutant cells and 
ΔGT-H is mean peaks from Homem used for glucose tranporter null mutant culture. Isomers 
refer to the number of alternative isomers that exist within the Scotmet metabolite database.  
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Carbohydrate Metabolism 
Name Formula Isomers Homem WT-C WT-H ΔGT-C ΔGT-H 
Succinate C4H6O4 7 0.02 1 0.29 0.07 0.02 
2-Oxoglutarate C5H6O5 7 0 1 0.16 0.21 0.14 
Fumarate C4H4O4 3 0.1 1 0.1 0.45 0.2 
Pyruvate C3H4O3 3 0.47 1 0.43 0.6 0.45 
D-Glucose 6-phosphate C6H13O9P 46 0 1 0 0.29 0  
D-Glucose C6H12O6 57 0.33 1 0.41 0.71 0.45 
Sucrose C12H22O11 42 0.78 1 0.64 0.11 0.08 
Glycerol C3H8O3 1 2.72 1 1.21 2.18 2.64 
(s)-Malate C4H6O5 4 0.03 1 0.08 0.26 0.07 
Table 2-4: Metabolites from carbohydrate metabolism. The metabolite levels are expressed 
as mean peak heights, relative to the wild type cells (WT-C). Homem is mean peaks from 
neat Homem, WT-C is mean peaks from wild type cells, WT-H is the mean peak for spent 
Homem in wild type culture, ΔGT-C is mean peak from glucose transporter null mutant cells 
and ΔGT-H is mean peaks from Homem used for glucose tranporter null mutant culture. 
Isomers refer to the number of alternative isomers that exist within the Scotmet metabolite 
database.  
 
 
Metabolism of Cofactors and Vitamins 
Name Formula Isomers Homem WT-C WT-H ΔGT-C ΔGT-H 
Pyridoxal C8H9NO3 9 0.89 1 0.77 1.35 0.89 
Thiamin C12H17N4OS 1 0.37 1 0.43 0.77 0.39 
Riboflavin C17H20N4O6 2 0.44 1 0.44 0.68 0.42 
Folate C19H19N7O6 1 0.37 1 0.41 0.59 0.36 
Nicotinamide C6H6N2O 4 1.33 1 0.63 0.77 1.07 
Table 2-5: Metabolites from metabolism of cofactors and vitamins. The metabolite levels are 
expressed as mean peak heights, relative to the wild type cells (WT-C). Homem is mean 
peaks from neat Homem, WT-C is mean peaks from wild type cells, WT-H is the mean peak 
for spent Homem in wild type culture, ΔGT-C is mean peak from glucose transporter null 
mutant cells and ΔGT-H is mean peaks from Homem used for glucose tranporter null mutant 
culture. Isomers refer to the number of alternative isomers that exist within the Scotmet 
metabolite database.  
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Nucleotide Metabolism 
Name Formula Isomers Homem WT-C WT-H ΔGT-C ΔGT-H 
UMP C9H13N2O9P 4 0.01 1 0 1.48 0.01 
AMP C10H14N5O7P 7 0.08 1 0.03 1.57 0.09 
Xanthine C5H4N4O2 3 0.35 1 0.03 0.59 0.07 
Hypoxanthine C5H4N4O 3 0.16 1 0.06 0.31 0.08 
Guanine C5H5N5O 3 0.09 1 0.05 0.35 0.09 
Inosine C10H12N4O5 3 4.09 1 0 0.48 0  
IMP C10H13N4O8P 3 0 1 0 0.91  0 
Adenosine C10H13N5O4 3 0.31 1 0.13 1.07 0.26 
Allantoin C4H6N4O3 3 0.59 1 0.43 0.75 0.59 
Table 2-6: Metabolites from nucleotide metabolism. The metabolite levels are expressed as 
mean peak heights, relative to the wild type cells (WT-C). Homem is mean peaks from neat 
Homem, WT-C is mean peaks from wild type cells, WT-H is the mean peak for spent Homem 
in wild type culture, ΔGT-C is mean peak from glucose transporter null mutant cells and 
ΔGT-H is mean peaks from Homem used for glucose tranporter null mutant culture. Isomers 
refer to the number of alternative isomers that exist within the Scotmet metabolite database.  
 
 
Energy Metabolism 
Name Formula Isomers Homem WT-C WT-H ΔGT-C ΔGT-H 
Orthophosphate H3O4P 1 0.51 1 0.57 0.89 0.56 
NAD+ C21H28N7O14P2 1 0.84 1  0 1.77 0.74 
Table 2-7: Metabolites from energy metabolism. The metabolite levels are expressed as 
mean peak heights, relative to the wild type cells (WT-C). Homem is mean peaks from neat 
Homem, WT-C is mean peaks from wild type cells, WT-H is the mean peak for spent Homem 
in wild type culture, ΔGT-C is mean peak from glucose transporter null mutant cells and 
ΔGT-H is mean peaks from Homem used for glucose tranporter null mutant culture. Isomers 
refer to the number of alternative isomers that exist within the Scotmet metabolite database.  
 
 
Lipid Metabolism 
Name Formula Isomers Homem WT-C WT-H ΔGT-C ΔGT-H 
Choline phosphate C5H15NO4P 1 0 1 0 3.1 0 
sn-glycero-3-Phosphocoline C8H21NO6P 1 0.41 1 0.05 1.04 0.13 
sn-Glycerol 3-phosphate C3H9O6P 3 0.01 1 0.01 0.15 0.02 
Table 2-8: Metabolites from lipid metabolism. The metabolite levels are expressed as mean 
peak heights, relative to the wild type cells (WT-C). Homem is mean peaks from neat 
Homem, WT-C is mean peaks from wild type cells, WT-H is the mean peak for spent Homem 
in wild type culture, ΔGT-C is mean peak from glucose transporter null mutant cells and 
ΔGT-H is mean peaks from Homem used for glucose tranporter null mutant culture. Isomers 
refer to the number of alternative isomers that exist within the Scotmet metabolite database.  
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Generally, the metabolomic data shows that there are differences in the 
accumulation of amino acids between the glucose transport null mutant 
Leishmania and wild type Leishmania. The observation on serine accumulation in 
neat Homem and cells (refer to Table 2-3 which compares amino acid contents 
in neat Homem and cells labelled as C-WT and C-ΔGT) are showing that there is 
a probability of increased reliance on this amino acid metabolism as a carbon 
and energy source as the serine’s content was recorded to be very low in null 
mutants (metabolomic data, Table 2-3) but high in uptake(Figure 2-1), and the 
serine’s concentration in neat HOMEM is high (Table 2-3). These observations 
indicate that serine may be have been utilised heavily in the null mutant.  
The levels of metabolites associated with carbohydrate metabolism are 
uniformly lower in glucose transport null mutant Leishmania, as would be 
expected for cells that cannot acquire exogenous glucose. Interestingly, the 
level of glycerol is higher in glucose transport null mutant Leishmania. Glycerol, 
which can be directed to carbohydrate production or for energy generation, may 
derive from increased lipid metabolism.  
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Figure 2-5: Bubble plot of metabolites of wild type and glucose transporter null mutant’s 
cells from metabolomic analysis. Wild type is represented by the blue circles and glucose 
transporter null mutant is represented by the red circles. The radius of each circle is 
proportionate to the mean peak of the respective metabolite. This plot includes displays of 
the 71 metabolites that have a confidence score of 10 found in both cell lines.  
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 Bubble Number Metabolites 
1 NAD+ 
2 Sucrose 
3 Glutathione 
4 D-Glucose-D-phosphate 
5 Pantothenate 
6 Choline Phosphate 
7 N6,N6,N6-Trimethyl-L-Lysine 
8 MOPS 
9 5'-Methylthioadenosine 
10 Inosine 
11 sn-Glycerol-3-phosphate 
12 L-Serine 
13 Glycine 
14 Glycerol 
15 Fumarate 
16 Succinate 
17 L-Ornithine 
18 S-Glutathione 
19 L-Asparagine 
20 Hypoxanthine 
21 (S)-Malate 
22 L-Alanine 
23 L-Methionine 
24 L-Arginine 
25 Putrescine 
26 Spermidine 
27 L-Cystine 
28 Trypanothione disulfide 
29 Thiamine 
30 S-Adenosyl-L-Methionine 
 
Table 2-9: The table shows the name of metabolites of the numbered bubbles from the 
bubble plot (Figure 2-5).  
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Figure 2-6: Volcano plot of wild type and glucose transporter null mutant from metabolomic 
analysis. It plots significance or T-test or p-value (y-axis) versus magnitude of change (x-
axis). Metabolites that have low P-value (P<0.05) are regarded as highly significant and 
appear towards the top of the plot. Values that appear on the left denotes the 
downregulation of the metabolites in null mutant compared to wild type and values on the 
right denotes the upregulation of the metabolites in null mutant compared to wild type. The 
dotted blue line denotes the border of P<0.05. The metabolites names of the numbered red 
dots are listed in Table 2- 10(refer to next page).  
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Numbering Metabolites down-regulated in Glucose transporter null mutant Numbering 
Metabolites up-regulated in Glucose 
transporter null mutant 
1 Sn-glycerol 3 phosphate 1 Choline phosphate 
2 L-Ornithine 2 N6,N6,N6-Trimethyl-L-lysine 
3 L-Proline 3 5'-methylthioadenosine 
4 Succinate 4 NAD+ 
5 L-alanine 5 L-Methionine 
6 L-Asparagine 6 Putrescine 
7 (S)-malate 7 L-Valine 
8 L-Serine 8 L-Carnitine 
9 L-Cystine 9 Glycine 
10 D-glucose-6-phosphate 10 UMP 
11 L-Aspartate 11 Trypanothione disulfide 
12 L-Arginine   
13 Glutathione   
14 L-Cystathionine   
15 Fumarate   
16 L-Cysteine   
17 2-Oxoglutarate   
18 Hypoxanthine   
19 Guanine   
20 L-Threonine   
21 L-Lysine   
22 S-gluthathionyl-L-lysine   
23 Riboflavin   
24 Pyruvate   
25 Pantothenate   
26 Sucrose   
27 Inosine   
28 3-(2-aminoethyl)-1H-indol-5-ol   
29 Xanthine   
30 L-Kynurenine   
31 Folate   
32 L-Glutamate   
Table 2-10: Table listing labelled metabolites from volcano plot (Figure 2-6). 
 
 The bubble plot (Figure 2-5) helps in identifying metabolites that differ in 
expression level between wild type and null mutant. The difference of 
metabolite expression in each cell type is easy to see as the diameter of the 
bubble is proportionate to the mean level of the metabolite. Although the 
bubble plot displays all 71 metabolites that have a confidence level of 10, Table 
2-9 list down all the ‘most’ easiest bubbles to be characterised in the plot. Some 
of them were not listed as the bubbles from different metabolites were piling on 
top of each other hence were difficult to be identified individually.   
 The volcano plot (Figure 2-6) displays the metabolites from null mutant in 
comparison to wild type. The comparison was based in terms of the metabolites 
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significance (p-value,t-Test) in it occurrence in the results (y-axis) and level of 
the metabolites abundance in the null mutant in comparison to the wild type (x-
axis). The red dots (represent metabolites from the null mutant) in the plot, 
which appear at the left side (x<1) of the plot are metabolites found to be 
down-regulated in the null mutant but higher in the wild type cells. While the 
red dots that appear on the right side (x>1) of the plot are metabolites that have 
been found to be up-regulated in the null mutant but lower in the wild type 
cells. Metabolites that have P-value lower than 0.05 (P<0.05) are regarded to be 
highly significant and these metabolites appear towards the top of the plot. The 
t-test assesses whether the mean peaks of metabolites derived from null mutant 
cells and wild type cells are statistically different from each other.   
 The volcano plot shows that amongst metabolites that were down-
regulated in the null mutant are intermediates from citric acid cycle and 
glycolysis i.e. succinate, (S)-malate, fumarate, D-glucose-6-phosphate and 
pyruvate. However, NAD+, the ‘electron acceptor’ that highly used in glycolysis 
and citric acid cycle was upregulated in the null mutant. Other than those 
metabolites, amino acids were among metabolites being down-regulated ( L-
proline, L-alanine, L-serine, L-aspartate, L-arginine, L-cysteine, L-threonine, L-
lysine and L-glutamate) and upregulated (L-methionine and L-valine)  in the null 
mutant cells. Other metabolites of interest that appeared on the volcano plot 
are sucrose, L-ornithine,L-cystine and L-kynurenine (all down-regulated in null 
mutant) and putrescine (upregulated in null mutant). 
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2.4 Discussion 
2.4.1 Amino Acid in Organisms 
 Amino acid intake generally exceeds the basic requirement for essential 
protein synthesis and other biosynthesis. The nitrogen from protein usually 
degraded whereas the carbon skeleton will be metabolised in the citric acid 
cycle. Therefore, protein can contribute significantly as a source of energy. The 
processes of amino acid degradation start with the removal of the α-amino group 
to generate the corresponding α-keto acid. Subsequently, the carbon skeleton 
will proceed either to oxidation in the citric acid cycle or for biosynthesis of 
carbohydrate, depending on the physiological state of the organism. Pyruvate 
and oxaloacetate are generated by carbon skeletons  coming from alanine and 
aspartate  and subsequently converted to carbohydrate via gluconeogenesis 
whereas amino acids are metabolised in ketogenesis leading to acetyl-CoA and 
acetoacetyl-CoA (Mathews et al. 2000). 
 My experiments to investigate nutrient uptake by glucose transporter null 
mutant Leishmania show that this mutant takes up significantly more amino 
acids than the wild type. These mutants grow at a slower rate than wild type 
Leishmania promastigotes. This observation and facts about organism 
dependence on amino acids or proteins help us to understand the physiological 
importance of amino acids whenever the glucose availability is scarce i.e in the 
parasitophorous vacuole.  
 It has been suggested that an intracellular amino acid pool is one way that 
Leishmania may use to keep a storage of metabolic intermediates that are 
capable of providing energy and facilitate the maintenance of ionic balance 
(Simon et al.1983). From our metabolomic data, it appeared that the wild type 
contains significant amount of alanine and serine and this supports the 
observation of Simon et al in their experiment with Leishmania tropica 
promastigotes, which showed that serine and alanine were amongst the amino 
acids in the protozoan’s intracellular amino acid pool.  
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Figure 2-7: The diagram has been removed due to copyright restrictions.   
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2.4.2     Serine 
 In the serine uptake assay, the null mutant showed a very high 
uptake of serine. This high initial uptake of serine was also demonstrated  
by promastigotes and amastigotes of Leishmania amazonensis (dos Santos 
et al. 2009), which the amastigotes had higher uptake compared to 
promastigotes.However the uptake in null mutant is decreasing at  
90seconds. This may be because that the null mutant cells are saturated 
with serine or (more interestingly) one could speculate that the null cells 
are utilising serine as an energy source, and are thus releasing 
radiolabelled products into the media. The metabolomic data (Table 2-3) 
support the serine uptake result. The level of L-serine in null mutant cell 
is significantly lower compared to the level in the wild type cell i.e serine 
was 6.25X  (refer to Table 2-3)lower in null mutant than in wild type and 
clearly the spent media from the null mutant indicated to have 4X lower 
serine compared to the wild type’s spent media. This demonstrated that 
not only the uptake of serine was higher in null mutant but the usage of 
serine was also higher in the null mutant compared to the wild type. 
These findings were not surprising as previous published papers have 
indicated the importance of serine in Leishmania and the extra increases 
of serine uptake and usage indicates that in an environment where 
glucose is scarce and where the capability of glucose uptake is lacking in 
the parasite, serine is probably one of the amino acids used as an energy 
source. Serine is one of the amino acids that is essential for Leishmania 
and may be captured from the surroundings (Hanada 2003). Serine is a 
substrate for the synthesis of sphingolipids and phosphatidylserine (dos 
Santos et al. 2009). Phosphatidylserine can be found ubiquitously in 
eukaryotic and prokaryotic cells as a membrane phospholipid(Vance & 
Steenbergen 2005).  In Leishmania promastigotes, serine is required for 
de novo synthesis of ethanolamine which is essential for the 
metacyclogenesis of Leishmania. A mutant deficient in ethanolamine 
synthesis shows enhances cell deaths as it enters stationary phase, 
despite normal growth during the log phase(Zhang et al. 2007). Evidence 
shows that serine is essential for the differentiation and metacyclogenesis 
processes of the parasites. The condensation of L-serine and palmitoyl-
CoA into 3-ketosphingosine (3-ketodihydrosphingosine or 3-KDS) leads to 
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the de novo synthesis of sphingolipids and this process is catalysed by the 
enzyme serine palmitoyltransferase(Zhang et al. 2003). Parasites that lack 
the catalytic subunit of this enzyme showed high frequencies of cell shape 
abnormality and, upon entry into the stationary phase,  showed poor 
infectivity in macrophage and animal infections, and reduced viability as 
amastigotes(Zhang et al. 2003).  
  Simon et al have demonstrated that serine and ethanolamine ,in 
 addition to alanine, glycine, threonine, α-aminobutyric acids, were the 
 principal constituents of the free amino acids in Leishmania tropica 
 promastigotes (Simon et al. 1983).  
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Figure 2-8: The diagram has been removed due to copyright restrictions.   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2-9: This figure has been removed due to copyright restrictions. 
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2.4.3      Arginine                                                                                                                                                
 In this study, arginine uptake (Figure 2-2) was demonstrated to be slightly 
higher in the wild type. This observation was supported by results from the 
metabolomic comparison of wild type and glucose transporter null mutant lines. 
Unlike serine uptake, both the wild type and null mutant showed that the 
arginine uptake still continue even after 90seconds.  
 Arginine is essential for Leishmania as it has been demonstrated that 
Leishmania promastigotes are unable to survive in a L-arginine-free medium 
(Krassner & Flory 1971). This suggests that mechanisms for transport and 
utilisation of arginine exist in Leishmania promastigotes (Wanasen & Soong 
2008). L-arginine is involved in the activation of macrophage function and, 
depending on the extracellular stimuli, L-arginine can be catabolised by an 
enzyme called inducible nitric oxide synthase (iNOS) to produce nitric oxide or 
an enzyme called arginase for polyamine synthesis. The upregulation of iNOS in 
macrophages after expose to stimuli such as Th1 cytokines leads to nitric oxide 
production which promotes parasite killing. On the contrary, stimulation by Th2 
cytokines induce L-arginine that leads to the production of polyamines (Iniesta 
et al. 2002). In addition, stimulation of Th2 triggers the expression and activity 
of arginase that is involved in conversion of arginine to L-ornithine, which is 
subsequently converted to putrescine by ornithine decarboxylase (ODC) (Raina & 
Janne 1968). Activities of iNOS and arginase are suggesting to be influenced by  
L-arginine (Wanasen & Soong 2008) as it has been shown that counter-regulatory 
mechanisms exist between iNOS and arginase. It has been documented that an 
intermediate product of the iNOS pathway, N-omega-hydroxy-L-arginine (LOHA) 
inhibits arginase function (Iniesta et al. 2001) and by competing for L-arginine, 
an arginase can decrease the iNOS activity (Gotoh & Mori 1999).  
 LdAAP3 has been identified as an arginine transporter in Leishmania 
donovani (Shaked-Mishan et al. 2006). It is an amino acid permease that 
comprises 480 amino acids with 11 predicted trans-membrane domains. LdAAP3 
is highly specific for arginine, as it was not inhibited by other amino acids or 
arginine-related compounds.  
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 As previous papers have shown that arginine is important in Leishmania 
(Wanasen & Soong 2008), the small reduction in arginine uptake in the glucose 
transporter null mutant in the current experiment could be due to impairment of 
the arginine uptake system. Another explanation is that arginine may not be  
needed in high amount in promastigotes. Arginine can be used to generate nitric 
oxide and polyamines, as well as urea and ammonia. Urea and ammonia were 
found to be abundant in late log and stationary phase cultures of L. mexicana 
(Hart & Coombs 1982), which may suggest that arginine is important for the 
metacyclogenesis process. The experiments reported here were conducted in 
promastigotes, where arginine utilisation is likely less critical to the parasite. 
Moreover, as arginine is important as a defence mechanisms, the slightly 
reduced rate of arginine uptake in the null mutant may be the reason for null 
mutant amastigotes are unable to survive in macrophages (Burchmore  et al. 
2003;Rodriguez-Contreras et al. 2007).  
 
  
2.4.4  Proline   
 The result from proline uptake (Figure 2-3) showed that the null mutant 
transports higher level of proline compared to wild type. The metabolomic result 
showed that in the null mutant the level of proline is 25X lower compared to the 
wild type. This may be explained by rapid incorporation of proline, such that the 
radiolabel is accumulated but the proline is only transiently present within cells. 
Previous reports suggest that proline has an important role in amino acid 
metabolism (Krassner & Flory 1972). Thus, in conditions where glucose maybe 
scarce, proline plays an important part as an energy source for Leishmania. 
 In Leishmania donovani promastigotes , it was demonstrated that oxygen 
uptake was stimulated by L-proline and to a lesser extent by L-glutamate and L-
arginine (Krassner & Flory 1972). Moreover, L-proline is an energy source for L. 
tarentolae  and as such may be replaced by D-glucose(Krassner 1969) and it may 
play an important role in amino acid metabolism as its presence supports growth 
in the absence of any one of 5 amino acids i.e. L-methionine, L-alanine, L-
glutamic acid, L-isoleucine and L-aspartic acid.  All these 5 amino acids are 
essential in the absence of L-proline. Based on a study in L.donovani 
promastigotes, proline has been found to be oxidised at a high rate and to be 
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present in a huge amount in the hemolymph. Promastigote culture media is 
presumed to approximate the habitat ,encountered in the insect host and 
proline is thought to be a major substrate in insect metabolism (reviewed in 
(Krassner & Flory 1972)). Through that observation it may be reasonable to 
suggest that the insect form of hemoflagellates have access to an abundant 
energy source in the form of proline, a habitat that supports the development of 
a proline oxidase system (Krassner & Flory 1972). 
 
2.4.5  Glutamine 
 The uptake assay of glutamine showed very little transport of this amino 
acid in both glucose transporter null mutant and wild type, although uptake was 
slightly higher in the null mutant compared to the wild type. Consistent with 
this, in the metabolomics result, the accumulation of L-glutamine in the null 
mutant was slightly higher in null mutant. Unlike uptake of serine, arginine and 
proline, uptake of glutamine in both cell lines shows a linear uptake even after 
90seconds.  This may be because glutamine (together with asparagine) is formed 
directly from glutamate and aspartate (Mathews et al. 2000) and transport of 
glutamine from outside cells may not necessary.  
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2-10: This figure has been removed due to copyright restrictions. 
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 Glutamine can supply its amide nitrogen to be used in several reactions 
generating other amino sugars, purine and pyrimidine nucleotides, nicotinamide 
nucleotides and glycoproteins (Mathews et al. 2000). Carbamoyl phosphate 
synthetase is an enzyme that is involved in the pyrimidine biosynthesis pathway. 
The enzyme that uses glutamine as substrate is named carbamoyl phosphate 
synthetase II (CPSaseII) whereas CPSaseI, which localises in mitochondria uses 
ammonia as the substrate (Mathews et al. 2000;Tatibana & Shigesada 1972). 
 
 
 
2.4.6 Metabolomic Data 
 In general, the metabolomic results do support the results from the amino 
acid uptake assay. From the metabolomic data, L-arginine levels were lower in 
the null mutant, and, in uptake assays, arginine uptake in the null mutant was 
lower compared to the wild type. All 3 other amino acids tested i.e. serine, 
proline and glutamine, were shown to be transported into the null mutant at 
higher levels compared to the wild type. Metabolomic analysis for L-alanine 
showed that this amino acid is present in a significant amount in wild type cells. 
The level of L-alanine was significantly high in wild type and very low in null 
mutant. Alanine is one of the end products of glucose catabolism (Bringaud et al. 
2006;Hart & Coombs 1982;Saunders et al. 2011;Tielens & van Hellemond 2009) 
which supports the lack of glucose transport in null mutant hence reduced the 
secretion of alanine. Previous observations reported that alanine and serine 
(which is also significantly high in wild type promastigotes) are among the most 
abundant amino acids, that can be found in the pool of intracellular amino acids 
in Leishmania tropica promastigotes (Simon et al. 1983). It was postulated that 
aminotransferases were essential enzymes for the conversion of pyruvate to 
alanine (reviewed by (Krassner & Flory 1972)) thus contribute to the abundance 
of alanine in Leishmania. Thus, the high content of pyruvate and alanine in wild 
type compared to glucose transporter null mutant shown by metabolomic 
analysis further supports the incapability of the null mutant to use glucose as a 
carbon source for energy metabolism. Aminotransferases are enzymes that 
catalyse transamination reactions, a process whereby amino acids can  replenish 
citric acid cycle intermediates  (Mathews et al. 2000).  
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 NAD+ is consumed during glycolysis when two glyceraldehyde-3-
phosphates are converted by glyceraldehyde-3-phosphate dehydrogenase to two 
1,3-bisphosphoglycerates (Mathews et al. 2000). In a volcano plot (Fig 2-6), NAD+ 
was high in null mutant cell. This is not surprising as NAD+ consumption is exist 
in metabolism like glycolysis that uses glucose as the carbon source. 
 In Leishmania mexicana promastigotes it has been demonstrated that 
alanine and acetate are highly utilised under glucose replete -conditions 
(Saunders et al. 2011). In the current experiment, metabolomic results revealed 
that L-alanine was down-regulated in glucose transporter null mutant. Given the 
finding by Saunders, this is not surprising as wild type cells still utilised 
significant amount of alanine. Thus promastigotes that lack glucose transporter 
may use more alanine as they depend solely on carbon sources other than 
glucose to support energy metabolism and other important physiological and 
biochemical processes.   
 Saunders et al (Saunders et al. 2011) also suggest that the replenishment 
of citric acid cycle intermediates is essential to maintain the cataplerotic 
synthesis of glutamate and biosynthetically related amino acids like proline and 
glutamine. Both proline (96% lower in null mutant) and glutamate (26% lower in 
null mutant) in glucose transporter null mutant were down regulated in the 
current metabolomic experiment. This may show that the heavy utilisation on 
these amino acids by the null mutant to support various biochemical and 
physiological processes has caused the constant low level of the amino acids in 
the cell. 
 As the glucose transporter null mutant cannot acquire glucose as an 
energy source, glycolysis may be running at a reduced rate. The low uptake of 
glucose and low rate of glycolysis also reflects on the level of D-glucose-6-
phosphate which is one of the intermediates in glycolysis. In glycolysis, the 
phosphorylation of glucose by hexokinase generates D-glucose-6-phosphate, 
which in turn is converted to D-fructose-6-phosphate by the enzyme 
phosphoglucoisomerase (Mathews et al. 2000).  
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 Gluthathione was also down regulated by 62% in the null mutant while 
trypanothione disulfide level in the null mutant were just 21% higher than wild 
type. Trypanothione disulfide(T[S]2) plays a vital function in the defence against 
oxidative stress and is an unusual form of glutathione found in parasitic protozoa 
(Castro-Pinto et al. 2008).  In mammals and other eukaryotes, the thiol cofactor 
glutathione is the substrate for glyoxalase enzymes but in Leishmania, 
trypanothione is used for their activity(Padmanabhan et al. 2005;Vickers et al. 
2004). Glutathione is important as a defence mechanism against nitric oxide 
cytotoxicity of  macrophages  (Romao et al. 1999). Romao et al demonstrated 
that macrophages and L.major depleted of glutathione were more susceptible to 
cytotoxic effects of nitric oxide donors, S-nitroso-N-acetyl-D,L-penicillamine 
(SNAP). Therefore, the decrease of glutathione in the metabolomic results may 
explain why glucose transporter null mutant Leishmania mexicana promastigotes 
could not survive in macrophages (Rodriguez-Contreras et al. 2007). 
 Polyamines (PA) also appeared to give interesting results in the 
metabolomic analysis. Polyamines are important metabolites in eukaryotes as 
they participate in a variety of proliferative processes and in Leishmania and 
trypanosomes, PAs take part in additional functions in the synthesis of the thiol 
trypanothione (Colotti & Ilari 2011). PA metabolites that only showed increases 
in the null mutant were putrescine (33%higher in null mutant) and the rest PAs  
were down-regulated in the null mutant i.e L-arginine (50% lower), L-ornithine 
(60% lower), spermidine (15% lower) and s-Adenosyl-L-methionine or AdoMet 
(17% lower).  
Comparative metabolomic analysis reveals significant differences between 
wild type and glucose transporter null mutant promastigotes. In addition to 
increased amino acid transport the result generated from metabolomic results 
provides a proof of principle that metabolomic analysis can be utilised to 
investigate the mechanisms behind phenotypic changes in Leishmania.   
Nevertheless, the complex data generated by metabolimic analysis are 
challenging to analyse and the changes in the light of the specific lesion in 
glucose transport are difficult to interpret with the knowledge and current 
understanding of intermediary metabolism in Leishmania.  Furthermore, there is 
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no obvious correlation between metabolomic and proteomic datasets, suggesting 
that the current resolution of “global” omic analyses leaves much to be desired.  
 
2.5 Conclusion 
 
Figure 2-11: Amino acid uptake at 90secs by wild type and glucose transporter null mutant 
promastigotes (GT null mutant). 
 
 
 The uptake of 3 out of 4 amino acids tested in the assay were significantly 
higher in glucose transporter null Leishmania. This higher rate is consistent with 
utilisation of these amino acids as an energy source in glucose transporter null 
parasites, while the same substrates may have primarily anabolic fates in wild 
type cells, that are able to use glucose as a primary energy source. The 
metabolomic results indicate that levels of several metabolites were down 
regulated in the glucose transporter null mutant.  This may be because the 
utilisation of other metabolites in the null mutant is significantly high as 
‘dependence’ on glucose as the main energy source inevitably has to be shifted 
to other metabolites that are available to the null mutant. Hence, although the 
null mutant transports significantly high amounts of several amino acids (uptake 
assay) i.e. serine and proline, these amino acid were found to be low in the null 
mutant cell according to the metabolomic result. The metabolomic data also 
shows components of lipid metabolism are up regulated in the null mutant thus 
it could be that the null mutant relies on lipids as a source of energy beside 
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amino acids. In general it appears, perhaps not surprisingly, that glucose 
transporter null mutant Leishmania exhibit a different metabolic economy, as an 
adaptation to the loss of glucose as an exogenous carbon and energy source. 
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Chapter 3 
 Characterisation of the plasma membrane 
subproteome of Leishmania mexicana 
promastigotes 
3.1 Introduction 
3.1.1 Plasma membrane proteomics 
 The surface of Leishmania parasites is the interface with the environment 
and with the host. Surface proteins are tethered to the plasma membrane, 
either directly or indirectly by interaction with membrane proteins. The plasma 
membrane proteome is a defining feature of all eukaryotes but is of particular 
interest in Leishmania in the context of host: parasite interactions.  
 Recently, the Trypanosoma brucei bloodstream form plasma membrane 
proteome was characterised (Bridges et al. 2008). Although Leishmania and 
trypanosomes are phylogenetically related, methods that were developed to 
enrich T. brucei bloodstream form plasma membranes were not easily adapted 
to Leishmania promastigotes (R. Burchmore PhD thesis, 1993). A major goal of 
this PhD project was thus to develop efficient methods for the enrichment of a 
Leishmania promastigote plasma membrane fraction, and to exploit this to 
characterise the proteome of this fraction. 
 Integral membrane proteins (IMPs) have important functions in cell-cell 
interactions, molecular transport and signal transduction. However, analysing 
IMPs is a challenging task because of the relatively hydrophobic nature of 
proteins that are soluble in the phospholipid bilayer which comprises the plasma 
membrane. Hydrophobic proteins are difficult to solubilise in aqueous solvents, 
but this is a prerequisite for conventional proteomic analyses. Furthermore, 
most integral membrane proteins are of relatively low abundance, as they are 
constrained to the 2-dimensional space of the lipid bilayer (Speers & Wu 2007). 
 As a consequence of these features, membrane proteins are typically 
under-represented in proteomic analyses (Lu et al. 2008). 
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3.1.2  Enrichment of the membrane proteins, subcellular    
fractionation and removal of membrane-associated proteins 
 The generally low abundance of membrane proteins has been a major 
issue in large scale identification of integral membrane proteins (IMPs). Thus, 
the strategy of enriching IMPs plays a major part in sample preparation. A 
common strategy for membrane protein enrichment is differential 
ultracentrifugation to achieve subcellular fractionation. Cells are lysed and 
subcellular components are separated by a series of centrifugations at increasing 
speeds to recover fractions that have different densities. Following each 
centrifugation, the organelles that have sedimented to the bottom of the tube 
are recovered in the pellet. The supernatant is then recentrifuged at higher 
speed to sediment organelles or subcellular fractions with progressively lower 
densities.    
 We applied a salt-extraction protocol(Piper et al. 1995) to remove 
membrane associated proteins (Pedersen et al. 2003;Schluesener et al. 2005) 
with the aim of further enriching IMPs. As a result of their high hydrophobicity, 
IMPs and membrane associated proteins are poorly soluble in aqueous solvents 
and are mainly soluble in detergents or organic solvents. Alkaline sodium 
carbonate was used to remove the membrane-anchored protein by disrupting the 
electrostatic interactions between proteins. In principle, this strategy should 
result in the release of hydrophilic peripheral membrane proteins into the 
aqueous buffer, leaving hydrophobic IMPs in the lipid bilayer. Removal of the 
peripheral membrane-associated protein should reduce sample complexity and 
facilitate a focus on IMPs. 
 Extraction with sodium carbonate for IMP enrichment has been widely 
exploited in a variety of systems (Pedersen et al. 2003;Rahbar & Fenselau 
2005;Zhang et al. 2006), suggesting that a similar approach may be useful in the 
isolation and identification of  IMPs from Leishmania mexicana. 
 We also tried an extraction protocol using Triton X-114. The principle of 
this protocol is to exploit  the solubility of the membrane proteins in detergent 
to preferentially solubilise IMPs (Bordier 1981).  
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3.1.3 Protein Separation 
 
 We applied both 1 and 2 dimensional strategies for protein separation. 
Proteins were separated in one dimension using conventional SDS PAGE based on 
apparent molecular weight. To increase the resolution of the protein separation, 
we used solution-phase isoelectric focussing, to generate fractions of proteins 
separated by isoelectric point. These fractions were then separated by SDS-
PAGE. 
 Solution-phase isoelectric focussing was achieved using the Agilent 3100 
OFF-GEL fractionator, a new system for protein and peptide separation. This 
instrument generates a voltage potential and a pH gradient across a chamber 
that is divided into multiple (12 or 24) wells. This enables isoelectric 
fractionation of proteins in solution, to generate a fraction that can be further 
resolved by electrophoresis. 
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Picture 3-1: This picture has been removd due to copyright restrictions. 
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Picture 3-2: This picture has been removed due to copyright restrictions.  
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3.1.4     Monitoring plasma membrane enrichment 
 Subcellular fractionation can result in enrichment of specific subcellular 
compartments and organelles. It is important to identify markers that can be 
exploited to monitor recovery of subcellular components. Although some 
enzymatic markers have been identified for the Leishmania plasma membrane 
(Gottlieb & Dwyer 1981;Zilberstein & Dwyer 1988), I wished to use an integral 
membrane protein as a marker. Despite previous efforts in the Burchmore lab, it 
was not possible to obtain an antibody against native integral membrane 
proteins. Therefore, an epitope-tagged glucose transporter was generated for 
this purpose. 
 A myc-tagged glucose transporter as a marker for plasma membrane 
enrichment, to provide quality control for membrane fractionation. It is an 
epitope tag of the sequence 408-420 AEEQKLISEEDL of human c-myc 
(http://www.biocompare.com/). Dr Christina Naula had designed   and 
synthesised a plasmid construct (px63NEO) (Figure 3-2) containing this myc-
epitope within the coding sequence of the LmGT2 glucose transporter (LeBowitz  
et al 1990, Cruz et al 1991, Goyard & Beverley 2000). The heterologous epitope 
tag was inserted into a hydrophilic loop region of LmGT2 (Figure 3-1), at a 
location that has previously been shown to tolerate sequence change without 
affecting function (Snapp & Landfear 1997). This construct was transfected into 
glucose transporter knockout Leishmania (episome) and maintained in 50μg/ml 
of neomycin. Functional expression in the plasma membrane of the parasites was 
confirmed by glucose transport assay (Figure 3-3). Myc-glucose transporter was 
expressed from pX63 neo vector. Expression is driven by flanking regions from 
DHFR-TS (dihydrofolate reductase-thymidilate synthase). 
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Figure 3-1: myc-tagged glucose transporter. The glucose transporter has 12 integral 
membrane spanning helices. The myc tag is located in the first loop of the amino-terminus 
of the transporter. Picture from Dr Richard Burchmore, University of Glasgow. 
 
 
 
 
 
Figure 3-2: Plasmid construct encoding a myc-tagged glucose transporter. The construct 
was designed and synthesised by Dr Christina Naula. The glucose transporter is an integral 
component of the Leishmania plasma membrane. I performed western Blot analysis of 
Leishmania cells that express this construct, in order to monitor the recovery efficiency for 
plasma membrane proteins in differential subcellular fractionation. Picture from Dr. 
Richard Burchmore and Dr. Christina Naula. 
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3.2 Materials and Methods 
3.2.1 Materials 
G418 (Calbiochem), HOMEM (Invitrogen),Foetal Bovine Serum(PAA , The Cell 
Culture Company), G418 sulfate (Calbiochem),Tris-CL (Fischer Scientific), EDTA 
(SIGMA), Sarkosyl(PROMEGA), NaCl (Fishcer Scientific), ethanol (Fischer 
Scientific), Tween-20(Sigma), Phosphate buffer saline (PBS) (Sigma), leupeptin 
(Sigma), pefabloc(Sigma), pepstatin (Sigma), phenanthroline (Sigma),sucrose 
(Fischer Scientific), 3HGlucose (GE Healthcare),Glucose (Sigma), HEPES (Fischer 
Scientific), NaHCO3 (Fischer Scientific), sodium dodecyl sulphate (SDS)(Sigma), 
the E.coli positive control (Abcam), Tween (Sigma), powder milk (Marvel), 
CyDyes (GE Healthcare), Lysine (Sigma), acetonitrile (Sigma), ammonium 
carbonate (Sigma), formic acid (Fishcer), sequencing grade modified trypsin( 
Promega), DTT (Agilent), c-Myc antibody (Cell Signalling Technology), 
iodoacetamide (Sigma) ,anti-mouse secondary antibody HRP (Calbiochem), 
Prestained protein marker (New England Biolabs), SuperSignal®Substrate 
(Novagen), bromophenol blue (Sigma), glycerol (Sigma) 
 
3.2.2 Cell culture 
 Promastigotes from 3 cell lines (wild type Leishmania mexicana, glucose 
transporter null mutant Leishmania mexicana( ∆LmGT), myc-tagged glucose 
transporter Leishmania mexicana(myc-GT2) (drug selection of transfected cells –
G418 50μg/ml)) were used in the study. The cell lines were grown in modified 
Eagle’s minimal essential medium HOMEM with 10% (v/v) heat inactivated foetal 
bovine serum (FBS) and maintained at 25°C. 
 
3.2.3 Glucose uptake 
 The protocol is similar as for the amino acid uptake in Chapter 2. 
However, we used wild type and myc-tagged glucose transporter cell line. 
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3.2.4 Protein from whole cell lysate preparation 
 Promastigotes with the density of 1x107 cells/ml were pelleted at 1200xg 
for 10minutes at 4°C and pelleted again 2 times with cold 1x PBS using the 
original volume. The cells were resuspended to a density of 1x107cells/10μl or 
6x107cells/15μl of PBS containing protease inhibitors (the final concentration for 
each inhibitor, for example in 10ml PBS, must be as follows: leupeptin 
100μg/ml, pefabloc sc 50μg/ml, pepstatin 5μg/ml, phenanthroline 50μg/ml and 
1mM EDTA).  
 An equal amount of 2x Leammli buffer were added. The cells then were 
heated up at 65°C for 5 minutes, quick spin for 1 minute and stored in a freezer 
until needed. Prior to loading of samples on gel, the proteins were heated again 
at 65°C for 5 minutes. 
 
 
3.2.5 Salt-extracted membrane proteins  
 The protocol was amended from Piper et al (Piper et al. 1995). Cells with 
a concentration of 1x107cells/ml (with each cell line has a volume of 380ml) 
were pelleted at 1200xg for 10minutes at 4°C and rinsed twice in HES buffer 
containing 20mM Hepes, pH 7.5, 1mM EDTA, 255mM sucrose. Cells were 
resuspended in 5mls HES buffer on ice, and the cells were lysed using a sonicator 
(15 pulses with 3 seconds each pulse, in a cold room). The lysates were diluted 
with 15ml of NaHCO3, pH 10.6 to remove peripheral membrane proteins. Divided 
into 2 fractions i.e. whole cell lysate (add the Leamli buffer and kept in -20°C 
freezer immediately) and the remainder was spun in an ultracentrifuge (rotor 
,70Ti: Beckman Instruments, Inc., Fullerton, CA) for 1½  hour at 40,000 rpm at 
4°C.  
 Both supernatant and membrane preparation (the pellet) were added to 
Leamli buffer to make 3x1010 cells/ml and kept in -20°C freezer until further 
analysis. Before the samples were used for a western blot, 2μl of 2-β-
mercaptoethanol was added into 18μl (5.4x108cells) of each samples. I tried 
various cell counts and 5x107 cells showed the expression of myc-tagged glucose 
transporter. 
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3.2.6 Triton X-114 extraction 
 Protocol from Bordier et al (Bordier 1981) and Burchmore et al (PhD 
Thesis, 1993). Cells harvested from 200 ml at 5 X107 cells/ml by spinning at 2.4 k 
x g for 10 minutes at 4°C. Cells resuspended in 50ml of ice cold PBS and 
harvested by  repeating the spinning. Pellet resuspended in 5ml of ice-cold 1% 
Triton X-114 in PBS with a protease inhibitor cocktail (the final concentration for 
each inhibitor, for example in 10ml PBS, must be as follows: leupeptin 
100µg/ml, pefabloc sc 50µg/ml,pepstatin 5µg/ml, phenanthraline 50µg/ml and 
1mM EDTA). The pellet mix was stirred vigorously on ice for 90 minutes, then a 
500 μl aliquot was removed and frozen at -20°C (total lysis). The remainder was 
spun at 40,000 xg for 30 minutes at 4°C, supernatant removed and repeated 
again. The pellets were combined and frozen at -20°C (detergent insoluble 
fraction). The supernatant was incubated at 30°C for 10minutes, then spun at 
5000 xg for 20 minutes at 30°C without using the brake when the machine is 
decelerating. The upper (aqueous) phase is separated and both were placed on 
ice. Both portions were returned to a volume of 5 ml by adding ice-cold PBS to 
detergent phase and ice-cold 10% Triton X-114 in PBS to the aqueous phase. Both 
stirred vigorously on ice for 60 minutes. Both samples were incubated at 30°C 
for 10 minutes, then spun at 5000 xg for 20 minutes at 30°C. The aqueous wash 
was separated from the original detergent phase and the detergent phase from 
the original aqueous phase and discarded.  Samples were stored at -20°C until 
analysis by SDS-PAGE.  
 
3.2.7 1-SDS-Polyacrylamide Gel Electrophoresis 
 Sodium dodecyl sulphate-polyacrylamide gel electrophoresis was 
performed on Novex 4-20% Tris-glycine pre-cast gels (Invitrogen). Pre-stained 
protein marker, Broad Range (6-175kDa) (New England BioLabs) was used as 
molecular weight (Mw) marker. The proteins were separated by standard 
method. The E.coli positive control whole lysate expressing 11 different epitope 
tags (Abcam) was used. Gels that served as loading control were stained with 
Coomassie blue and gels that need for protein screening were proceed to 
Western Blot procedure.  Prior to loading, samples were incubated at 60°C for 5 
minutes.  
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3.2.8 Western Blot 
 Three different transfer buffers were tested, to identify the best 
conditions for blotting of integral membrane proteins: 
 1. 25mM Tris-Base, 192mM Glycine, 20% Methanol pH 8.3(standard  
  buffer) 
 2. 0.1% SDS in buffer 1. (Small et al. 1988) 
 3.  0.7M Glycine, 25mM Tris-Base pH 7.7 (Small et al. 1988) 
 Different time for blotting have been used for each buffer, between 
40minutes to 4hrs 30minutes. 2 different transfer voltages were also tested i.e. 
200volt and 0.10-0.15Ampere.  
 The proteins were electroblotted from the gel onto Hybond-ECL 
nitrocellulose membrane (Amersham Hyperfilm, GE Healthcare) using a mini 
transblot apparatus (Bio Rad Laboratories) according to the manufacturer’s 
instruction.  
 The blots were blocked with milk 5% (W/V) in PBS-Tween 0.1% for 1 hour 
at room temperature, washed 3 times with PBS-Tween 0.1% for 15 minutes for 
each wash, incubated 1 hour to overnight with anti-c-Myc mouse monoclonal 
antibody (9B11) with the concentrations used for each western blot were 
mentioned in Figure 3-6, Figure 3-7, Figure 3-8 and Figure 3-9 (Cell signaling 
Technology), repeat the same washing procedure and incubated with goat anti-
mouse IgG peroxidase conjugate (Calbiochem)(concentrations of secondary 
antibody used are mentioned in Figure 3-6, Figure 3-7, Figure 3-8 and Figure 3-
9). 
 The blot(s) was developed using SuperSignal ®Substrate (Novagen). 
Developed blots were exposed to high performance chemiluminescene film 
(Amersham Hyperfilm™ ECL, GE Healthcare Ltd. UK).  
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3.2.9 Labelling and separation of membrane proteins  
 In the protocol that used the incorporation of CyDye, CyDye labelling was 
performed prior to IEF fractionation, samples from the wild type and glucose 
transporter null mutant was suspended in 10 μl Lysis buffer (pH 9) prior to 
labelling. Then, protein samples were labelled with CyDyes (400 pmol of dye for 
each sample) named Cy3 and Cy5 respectively and incubated in the dark for 30 
minutes. The reaction was stopped by the addition of 1μl of 10mM lysine into 
each sample.  CyDye labelled samples were mixed together prior to the IEF 
fractionation. The mixture volume was 140μl.  
 The fractionation was conducted using an AGILENT 3100 Off-Gel 
fractionator according to the manufacturer’s instructions. First, OFFGEL stock 
solutions with a concentration of 1.25X, comprises thiourea (entire tube, 
AGILENT), DTT (entire tube, AGILENT), 6ml glycerol solution (AGILENT) and 
600μl OFFgel Buffer (AGILENT) were prepared by mixing all the solutions 
mentioned, and bring the total volume to the 50ml with dH2O.This mixture is for 
24 wells frame. As the sample (i.e. the mixture of dye-labelled WT and ∆LmGT) 
is only 140μl and it is in an OFFGEL compatible solution and the volume is less 
than 0.72ml, 0.58ml (0.72ml minus sample volume in ml) of dH2O was mixed in 
2.88ml 1.25X OFFGEL stock solution and mix. Then, the 140μl CyDye-labelled 
sample was added. Meanwhile, an IPG strip rehydration solution was prepared by 
mixing 0.48ml OFFGEL Stock Solution(1.25X). Following the manufacturer’s 
instruction, an IPG strip (pH 3-10) was placed in one of the lanes in the tray. 
After placing the frame onto the IPG strip, IPG strip was rehydrated by pipetting 
40μl of IPG Strip Rehydration Solution into each well. Following the rest of the 
instruction in the manual, after adding the sample (CyDye-labelled samples 
mixture in the OFFGEL solution mix) with equal amounts into each well,all 
protocols were followed. The current was applied on the fractionator, and the 
voltage ranged from as low as 200V to as high as 1500V.  
 The fractionation took approximately for 4 days (96hours) to complete. At 
the end of the fractionation, all samples in 24 wells were collected and kept at -
20°C until further analysis. 
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 Prior to SDS-PAGE analysis, the samples were heated at 65°C for 5 
minutes. 5µl of loading buffer was added to each samples and subsequently 
loaded into wells in precast gel, Novex ®4-12%  Tris –Glycine mini gel 
(Invitrogen). 
 
3.2.10 Bands Picking and Cutting 
 The SDS gels that contained protein samples that have been fractionated 
in AGILENT 3100, Scanned with Typhoon 9400 Variable Mode Imager (GE 
Healthcare) according to the manufacturer’s protocol. 
 Depending on the purpose of the experiment, each sample in their 
respective lane was sectioned into 30 equal-sized bands, or bands of interest. 
The cutting is done manually. Lanes that showed strong differences in expression 
were chosen and cut for analysis. Spots of interest were cut from the gel using a 
scalpel and kept in a fridge until in-gel trypsin digestion. 
 
3.2.11 In-gel Trypsin Digest for Coomassie-stained proteins 
 Gel pieces were washed in 500μl of 100mM ammonium bicarbonate for 1 
hour. The gel sections were then washed in 50% acetonitrile, 100mM ammonium 
bicarbonate for another 1 hour before being reduced by the addition of 150μl of 
100mM ammonium bicarbonate and 10μl of 45mM DTT and the pieces were then 
incubated for 30 minutes at 60°C. To alkalyte, the pieces were let to cool to 
room temperature and 10 μl of 100mM iodoacetamide and incubated in the dark 
for 30 minutes.  The solvent was then discarded and the gel pieces were washed 
again in 500 μl of 50% acetonitrile in 100 mM ammonium bicarbonate with 
shaking for 1 hour. Then 50 μl of acetonitrile was added to shrink the gel pieces 
and the solution was removed after 10 minutes and the gel pieces were dried in 
a vacuum centrifuge. Afterwards, a 0.2μg/μl sequencing grade modified Porcine 
Trypsin (Promega) in 25 mM ammonium bicarbonate was sufficiently added to 
rehydrate the shrank gel plugs. Add more the trypsin solution until gel bands 
were fully rehydrated.  Approximately 20 μl of 25mM ammonium bicarbonate 
was added and enough to cover the gel pieces and the gels were leave to digest 
overnight at 37°C. Acetonitrile was added to the digest to make approximately 
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50% acetonitrile in the digest and subsequently incubated for 20 minutes. The 
tubes containing the samples were briefly centrifuge to pellet the gel bands. All 
liquid was transferred to a clean tubes and care must be taken to make sure no 
gel was transferred together. Next, 1 % formic acid was added and sufficient to 
cover the gel pieces and centrifuge briefly to pellet the gel. All liquid was 
transferred to the same tubes used for the first extract and care was taken to 
avoid any transfer of the gel and this step was repeated for one more time. A 
sufficient amount of acetonitrile was added to cover the gel pieces and 
incubated for 10 minutes and transferred all liquid into the same tube for the 
first extract and avoid to transferred the gel pieces. This extract step is 
repeated again for one more time and subsequently, the combined extracts were 
completely dried in the Speedvac. The samples are now ready for mass 
spectrometry analysis.  
  
3.2.12 Mass Spectrometry 
 Tryptic peptides were solubilized in 0.5 % formic acid and fractionated on 
a nanoflow HPLC system (Famos / Switchos / Ultimate, LC Packings) before 
being analysed by electrospray ionisation (ESI) mass spectrometry on a Q-STAR® 
Pulsar i hybrid MS/MS System. Peptide separaration was performed on a Pepmap 
C18 reversed phase column (LC Packings), using a 5 - 85% v/v acetonitrile 
gradient (in 0.5% v/v formic acid) run over 45 min. The flow rate was maintained 
at 0.2 l / min. Mass spectrometric analysis was performed using a 3 second 
survey MS scan followed by up to four MS/MS analyses of the most abundant 
peptides (3 second per peak) in Information Dependent Acquisition (IDA) mode, 
choosing 2+ to 4+ ions above  threshold of 30 counts, with dynamic exclusion for 
120s. 
 Data generated from the Q-STAR® Pulsar i hybrid mass spectrometer was 
analysed using Applied Biosystems Analyst QS (v1.1) software and the automated 
Matrix Science Mascot Daemon server (v2.1.06). Protein identifications were 
assigned using the Mascot search engine, which gives each protein a probability 
based MOWSE score. In all cases variable methionine oxidation was allowed in 
searches and carbamidomethylation of cysteines was selected as a fixed 
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modification. An MS tolerance of 1.2 Da for MS and 0.4 Da for MS/MS analysis 
was used.  
 
 
3.2.13 Screening for integral membrane protein 
 The results from MS analysis that were analysed by MASCOT were further 
examined to search for integral membrane proteins (IMPs). The accession 
numbers of each protein identified in the samples were entered in the TriTrypDB 
website (tritrypdb.org/) to search the transmembrane domain (TMD) in the 
protein. The protein that showed the existence of TMD was concluded to be the 
membrane protein in IMPs group. Because IMPs may have a substantial fragment 
of their sequence embedded in the membrane, analysis of TMD peptides 
magnifies the chance of categorised IMPs (Speers & Wu 2007). 
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3.3 Results 
3.3.1 Expression of an epitope-tagged glucose transporter 
 
 
Figure 3-3: Glucose uptake of wild type, glucose transporter null mutant (GT-null mutant) 
and myc-tagged glucose transporter (Myc-tagged GT). The graph shows that the recovery of 
glucose uptake ability with the introduction of plasmid containing Myc-tagged glucose 
transporter. 
 
 An uptake assay was performed to see the functionality of the restored 
glucose transporter through transformation of plasmid into glucose transporter 
null mutant Leishmania. A graph line for wild type taken from a published paper 
from Burchmore et al (Burchmore et al. 2003) was extrapolated in the graph. 
Two clones of the myc-tagged glucose transporter Leishmania, Myc-tagged 
glucose transporter showed a very high uptake of glucose compared to the wild 
type whereas the null mutant line shows negligible glucose uptake. 
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3.3.2 Fractionation efficiency by western blot tracking for glucose 
transporter and proteomic analysis 
 
 
Figure 3-4: Flowchart shows the workflow of whole cell lysate and membrane fractionation. 
Both whole cell lysate and membrane prep samples were analyse for glucose transporter 
recovery. This is done to investigate the expression of myc tagged glucose transporter. The 
‘quality’ of the myc-tagged glucose transporter’s expression in western blot is an indicator 
for fractionation efficiency. Samples from membrane preparation were tested in 2 extraction 
protocols i.e. Salt-extraction and Triton X-114 membrane extraction. Based on the Western 
blot result, only whole cell lysate and membrane extraction from salt-extraction protocol 
were analyse for proteomic analysis. Samples from Triton X-114 were not giving satisfying 
result in western blot analysis and performing proteomic analysis on these samples thought 
to be not necessary.  SDS gel loaded with samples were used as a loading control.  
 
 
 
 
3.3.3 Detection of myc-tagged LmGT2 in Leishmania mexicana 
 In order to test the efficiency of membrane fractionation, 3 samples 
should be collected i.e. the whole cell lysate, the supernatant and membrane 
preparation. The efficiency of the preparation of the samples and the extraction 
are based on whether the myc-tagged glucose transporter is seen in 2 fractions 
of the cell i.e. the whole cell lysate and the membrane fraction. And this myc-
tagged glucose transporter should not be seen in the supernatant.  
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 Thus, in the experiment three fractions i.e. whole cell lysate, 
supernatant, membrane preparation from the sample preparation were collected 
from both the wild type and null mutant cells and immunoblotted to screen for 
the myc-tagged glucose transporter recovery. All three fractions must be 
collected from the same source i.e. from the same flask. It was necessary to test 
different cell counts of cells to see the expression of myc-tagged glucose 
transporter i.e 2.7x108 cells to 2.7x107 cells from the cell cultures that have 
been grown up to the cell density of 1X107cells/ml. It appeared that the lower 
the cell counts that I used, the better was the expression. Immunoblotting for 
integral membrane proteins can be difficult to achieve because these proteins 
are typically of low relative abundance. Furthermore, hydrophobic proteins blot 
less efficiently than more hydrophilic proteins (Small et al. 1988).  
  In addition, the higher level of 2-β-mercaptoethanol has shown to give a 
better expression of the band.  1-SDS gel (Figure 3-5) loaded with proteins from 
whole cell lysate, membrane protein fraction and supernatant from all 3 cell 
lines tested (wild type, glucose transporter null mutant and myc-tagged glucose 
transporter), serves as a loading control(Welinder & Ekblad 2011). Western blots 
were done for whole cell lysate (Figure 3-6), supernatant (Figure 3-7) and 
membrane fraction (Figure 3-8) to monitor the myc-tagged glucose transporter 
recovery and the approximate band size for myc-tagged glucose transporter is 
between 46-58kda. A band’s expression was seen in whole cell lysate (Figure 3-
6) and lane loaded with myc-tagged glucose transporter cell line in membrane 
fraction (lane 4, in Figure 3.8). But in Figure 3-8, i.e. membrane protein 
fractionation, although lane 4 and lane 5 loaded with the same myc-tagged-
glucose transporter cell lines, a band’s expression was stronger in lane (5) and 
mildly in lane (4) (lane 4 has higher protein content than lane 5). No expression 
was seen in supernatant fraction from all cell lines (Figure 3-7). However the 
molecular weight of these bands expressed in whole cell lysate and membrane 
fraction was slightly higher (in whole cell lysate, Figure 3-6) and slightly lower 
(in membrane fractionation, Figure 3-8) compared to glucose transporter 
molecular weight which is around 52kDa. This may caused by various reasons 
such as post-translatonal modification (for Figure 3-6 and Figure 3-8) or the 
protein may have been aggregated due to the chemical used in extraction thus  
the protein moved slower in the gel(in Figure 3-8). 
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Figure 3-5:  1-SDS gel stained with Coomassie blue for analysis of the salt-extraction 
protocol to monitor the recovery of membrane proteins where myc expression serves as the 
indicator. All 3 fractions i.e. whole cell lysate, membrane protein and supernatant were 
collected to screen for the myc expression. This gel serves as quality control to show that 
all proteins in all lanes were loaded into the respective well at equal amounts (Welinder & 
Ekblad 2011). (20μl samples were loaded for all lanes which in the membrane protein 
fraction’s lanes, may contain 6x108 cells per lane and this cell count is likely be less in the 
other lanes i.e. whole cell lysate and supernatant). 
 
 
 
Figure 3-6: Western blot of whole cell lysate from salt-extraction. Screening for glucose 
transporter expression probed with c-Myc Mouse mAB (1:200) and anti-mouse secondary 
antibody (1:50,000). 1: c-Myc positive control, 2: Wild type, 3: glucose transporter null 
mutant, 4: myc-tagged glucose transporter expressing cells. Blue arrow shows the 
approximate molecular weight for myc-tagged glucose transporter (52kDa) and the black 
arrow shows a band. 
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Figure 3-7: Western blot of supernatant fraction from salt-extraction. Screening for glucose 
transporter expression probed with c-Myc mouse mAB (1:200) and anti-mouse secondary 
antibody (1:50,000). 1: c-Myc positive control, 2: Wild type, 3: glucose transporter null 
mutant, 4: myc-tagged glucose transporter.  
 
 
 
 
 
 
Figure 3-8: Western blot of membrane preparation fraction from salt-extraction. Screening 
for glucose transporter expression probed with c-Myc Mouse mAB (1:200) and anti-mouse 
secondary antibody (1:10,000). 1: c-Myc positive control, 2: Wild-type, 3: glucose 
transporter null mutant, 4: myc-tagged glucose transporter (5.4x107 cells), 5: myc-tagged 
glucose transporter (2.7x107 cells). The arrow on the right-handside shows the approximate 
molecular weight for myc-tagged glucose transporter i.e. approximately 52kDa. 
 
 
 
 
 
 
 
 
 
 
Dhilia U Lamasudin                                                                                                       Chapter 3,   
  
105
3.3.4 Western blot for samples from Triton X-114 extraction. 
Recovery for myc-tagged glucose transporter Leishmania 
mexicana 
 Another membrane protein extraction protocol using Triton X-114 was 
tested. 20μg proteins were loaded in each well. Two fractions of the extraction 
i.e. detergent phase and aqueous phase from each cell line i.e. wild type, 
glucose transporter null mutant and myc-tagged glucose transporter, were 
collected  and the myc-tagged expression was monitored on a western blot 
(Figure 3-9). A band was detected in lane 7 which was loaded with myc-tagged 
glucose transporter cell line from detergent phase. However, the expressed band 
was not resolved by molecular weight but rather smeared. This is likely due to 
the formation of mixed micelles between Triton X-114 and SDS in the sample 
(Burchmore, R.J., PhD thesis, 1993). A strong band is seen between 31kDa-46kDa 
in all cell lines from the aqueous phase (lane 2, 3, 4). This could be some cross 
reaction with an unrelated protein as the wild type and glucose transporter null 
parasites were not transfected with a myc-tagged construct.  The positive 
control (lane 1) showed a very strong expression but the lower band is 
considered to be the positive control as the molecular weight for the positive 
control is 41kDa (from manufacturer’s instruction sheet).  
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Figure 3-9: Western blot of protein samples from Triton X-114 extraction. 1: myc positive 
control, lane 2,3 and 4 are aqueous phase and lane 5,6 and 7 are detergent phase . Lane 
2&5: Wild type, lane 3&6: glucose transporter null mutant, lane 4&7: myc-tagged glucose 
transporter. Positive control is a E.coli positive control (whole lysates) containing a 41kd 
recombinant protein expressing 11 tags, including C-Myc (Abcam).  
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3.3.5 Proteomics for Whole Cell Lysate 
A comparative analysis of whole proteome was carried out between wild 
type (WT) and glucose transporter null mutant (∆LmGT) to detect whole protein 
content expression differences. Figure 3-10 shows the 1-SDS gel used in the 
proteomic analysis. 35 equal-sized bands were cut out from both lanes i.e WT 
and ∆LmGT and bands were analysed by mass spectrometry. Results from the 
mass spectrometry analysis are summarised in Table 3-1 (Band 1-Band 35). 
 Based of the observation of hydrophobic predicted Transmembrane 
domains (TMD), several IMPs were identified in whole cell proteome in both 
cells. Some IMPs were exclusively identified in wild type i.e. MDR1-
glycoprotein(LmjF34.0990), ATP-dependent zinc metallopeptidase 
(LmjF18.0610), E1F3-interacting protein-like protein (LmjF36.0250) and protein 
transport protein sec 61 gamma subunit (LmjF25.1015). IMPs that were 
exclusively found in the null mutant whole cell proteome were calcium motive 
p-type ATPase (LmjF35.2080), fatty acid elongase (LmjF14.0650), hypothetical 
protein (LmjF23.0640) and Gim5A protein (LmjF35.3700).  
Integral protein that was found in both whole cell proteome from both 
cells analysed was only glucose regulated protein 78 (LmjF28.1200). 
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Figure 3-10: 1-SDS gel stained with Coomassie blue. This gel serves as loading control for 
whole cell lysate proteomic analysis. Each lane was loaded with 2x107 cells (Welinder & 
Ekblad 2011). 
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3.3.5.1 Whole Proteome Comparison 
Table 3-1: Results from mass spectrometry analysis for whole cell protein comparison 
between wild type (WT) and glucose transporter null mutant (∆LmGT) were summarised in 
the table below (Band 1-Band 35). 35 bands from each cell line were excised from the gel. 
TMD (transmembrane domain) was search in each found protein to confirm whether the 
protein was a membrane protein. (Mwt=molecular weight in kDa). Blue column= proteins 
(with TMD) found only in wild type, red columns= proteins (with TMD) found only in glucose 
transporter null mutant, yellow columns= proteins (with TMD) found both in wild type and 
glucose transporter null mutant. 
 
Band 1        
  
Accession 
Number Gene Annotation MWt 
Protein 
Score 
Sequence 
Coverage 
(%) 
Number 
of 
predicted 
TMD 
Queries 
Matched 
Wild Type LmjF19.1070 Hypothetical protein, conserved 103031 35 0 0 1 
  LmjF34.3330 Cytochrome p450-like protein 60567 30 1 0 1 
∆GT LmjF21.1860 Beta tubulin 50395 162 16 0 6 
  LmjF16.1460 Kinesin, putative 247359 60 0 0 1 
  LmjF17.0080 Elongation factor 1-alpha 49485 44 0 0 1 
  LmjF20.0160 Hypothetical protein, conserved 88683 39 0 0 1 
  LmjF25.2155 Hypothetical protein, conserved 27588 32 4 0 1 
        
Band 2        
  
Accession 
Number Gene Annotation MWt 
Protein 
Score 
Sequence 
Coverage 
(%) 
Number 
of 
predicted 
TMD 
Queries 
Matched 
Wild Type LmjF15.0440 Hypothetical protein 1527956 101 0 0 1 
  LmjF13.0280 Alpha tubulin 50526 74 3 0 1 
∆GT No significant hits to report           
        
Band 3        
  
Accession 
Number Gene Annotation MWt 
Protein 
Score 
Sequence 
Coverage 
(%) 
Number 
of 
predicted 
TMD 
Queries 
Matched 
Wild Type LmjF08.1230 Beta tubulin 50302 28 2 0 1 
∆GT LmjF15.0440 
Hypothetical protein, unknown 
function 1527956 92 0 0 1 
  LmjF27.0500 Calpain-like cysteine peptidase 702676 31 0 0 1 
        
Band 4        
  
Accession 
Number Gene Annotation MWt 
Protein 
Score 
Sequence 
Coverage 
(%) 
Number 
of 
predicted 
TMD 
Queries 
Matched 
Wild Type LmjF27.0500 
Calpain-like cysteine peptidase, 
putative 702676 28 0 0 1 
∆GT LmjF13.1650 Dynein heavy chain, putative 532336 42 0 0 1 
  LmjF25.0980 Dynein heavy chain, putative 538395 40 0 0 3 
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Band 5        
  
Accession 
Number Gene Annotation MWt 
Protein 
Score 
Sequence 
Coverage 
(%) 
Number 
of 
predicted 
TMD 
Queries 
Matched 
Wild Type LmjF25.0980 Dynein heavy chain, putative 538395 88 0 0 2 
  LmjF08.1230 Beta tubulin 50302 57 3 0 1 
  LmjF14.1440 Hypothetical protein, conserved 104705 56 1 0 1 
  LmjF13.0280 Alpha tubulin 50526 50 3 0 1 
  LmjF13.1650 Dynein heavy chain, putative 532336 42 0 0 2 
  LmjF27.0500 Calpain-like cysteine peptidase 702676 30 0 0 1 
∆GT LmjF13.1650 Dynein heavy chain, putative 532336 99 1 0 4 
  LmjF05.0380 
Microtubule-associated protein, 
putative 206884 49 0 0 1 
        
Band 6        
  
Accession 
Number Gene Annotation MWt 
Protein 
Score 
Sequence 
Coverage 
(%) 
Number 
of 
predicted 
TMD 
Queries 
Matched 
Wild Type LmjF03.0690 Hypothetical protein, conserved 249125 83 1 0 2 
  LmjF13.0280 Alpha-tubulin 50526 60 3 0 1 
  LmjF21.0800 Hypothetical protein, conserved 250810 50 0 0 1 
  LmjF14.1440 Hypothetical protein, conserved 104705 28 0 0 1 
∆GT LmjF03.0690 Hypothetical protein, conserved 249125 55 0 0 1 
  LmjF13.0280 Alpha-tubulin 50526 50 3 0 1 
  LmjF21.0800 Hypothetical protein, conserved 250810 39 0 0 1 
        
Band 7        
  
Accession 
Number Gene Annotation MWt 
Protein 
Score 
Sequence 
Coverage 
(%) 
Number 
of 
predicted 
TMD 
Queries 
Matched 
Wild Type LmjF16.0590 
Carbomoyl-phosphate synthase, 
putative 208165 90 2 0 2 
  LmjF29.2110 Hypothetical protein, conserved 193313 46 0 0 1 
  LmjF03.0690 Hypothetical protein, conserved 249125 43 0 0 1 
∆GT LmjF16.0590 
Carbamoyl-phosphate synthase, 
putative 208165 48 0 0 1 
        
Band 8        
  
Accession 
Number Gene Annotation MWt 
Protein 
Score 
Sequence 
Coverage 
(%) 
Number 
of 
predicted 
TMD 
Queries 
Matched 
Wild Type LmjF36.1630 Clathrin heavy chain, putative  192062 140 1 0 2 
  LmjF13.0280 alpha-tubulin 50526 52 3 0 1 
  LmjF29.2110 Hypothetical protein, conserved 193313 51 0 0 1 
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  LmjF09.1510 Hypothetical protein, conserved 175536 40 0 0 1 
∆GT LmjF36.1630 Clathrin heavy chain, putative  192062 80 2 0 3 
  LmjF13.0280  Alpha-tubulin 50526 56 6 0 2 
  LmjF11.0370 Hypothetical protein, conserved 67774 28 1 0 1 
        
Band 9        
  
Accession 
Number Gene Annotation MWt 
Protein 
Score 
Sequence 
Coverage 
(%) 
Number 
of 
predicted 
TMD 
Queries 
Matched 
Wild Type LmjF34.0990 MDR1, p-glycoprotein 148015 258 3 10 3 
  LmjF20.1180 
Calpain-like cysteine peptidase, 
putative 109171 63 1 0 1 
  LmjF13.0280 Alpha-tubulin  50526 58 3 0 1 
  LmjF29.2630 Hypothetical protein, conserved 132406 46 1 0 1 
  LmjF22.1500 
ATP-dependant DEAD/H RNA 
helicase, putative 120849 42 1 0 1 
  LmjF31.1500 Hypothetical protein, conserved 120776 42 1 0 1 
  LmjF36.1630 Clathrin heavy chain, putative 192062 28 0 0 1 
∆GT LmjF35.2080 
Calcium motive p-type ATPase, 
putative 123373 66 1 8 1 
  LmjF35.3100 
ATP-dependant RNA helicase, 
putative 100525 44 1 0 1 
  LmjF22.1500 
ATP-dependant DEAD/H RNA 
helicase, putative 120849 28 1 0 1 
        
Band 
10        
  
Accession 
Number Gene Annotation MWt 
Protein 
Score 
Sequence 
Coverage 
(%) 
Number 
of 
predicted 
TMD 
Queries 
Matched 
Wild Type LmjF34.0990 MDR1, p-glycoprotein 148015 100 1 10 1 
  LmjF35.3100 
ATP-dependant RNA helicase, 
putative 100525 14 3 0 2 
  LmjF13.0280 Alpha-tubulin 50526 52 3 0 1 
  LmjF31.1900 Ubiquitin-fusion protein 14958 38 12 0 1 
∆GT LmjF35.1180 
NADH-dependant fumarate 
reductase, putative 124204 93 1 0 1 
        
Band 
11        
  
Accession 
Number Gene Annotation MWt 
Protein 
Score 
Sequence 
Coverage 
(%) 
Number 
of 
predicted 
TMD 
Queries 
Matched 
Wild Type LmjF15.1010 Glutamate dehydrogenase 115588 119 1 0 1 
  LmjF36.0180 EF2-1, elongation factor 2 94928 94 1 0 1 
  LmjF32.3010 Hypothetical protein, conserved 97475 94 1 0 1 
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  LmjF13.0280 Alpha-tubulin 50526 57 3 0 1 
  LmjF22.1540 Alanyl-tRNA synthetase, putative 106882 50 1 0 1 
  LmjF15.1480 
cAMP specific phosphodiesterase, 
putative 105161 25 1 0 1 
∆GT LmjF36.0180 EF2-1, elongation factor 2 94928 162 8 0 4 
  LmjF32.3010 Hypothetical protein, conserved 97475 100 1 0 1 
  lmjF15.1010 Glutamate dehydrogenase 115588 87 1 0 1 
  LmjF13.0280 Alpha-tubulin 50526 66 3 0 1 
  LmjF18.0510 Aconitase, putative 98229 53 1 0 1 
  LmjF15.1480 
cAMP specific phosphodiesterase, 
putative 105161 52 1 0 1 
  LmjF30.3420 Hypothetical protein, conserved 97869 40 1 0 1 
        
Band 
12        
  
Accession 
Number Gene Annotation MWt 
Protein 
Score 
Sequence 
Coverage 
(%) 
Number 
of 
predicted 
TMD 
Queries 
Matched 
Wild Type LmjF36.0180 EF2-1, elongation factor 2 94928 378 14 0 8 
  LmjF13.0280 Alpha-tubulin 50526 116 7 0 2 
  LmjF18.0510 Aconitase, putative 98229 106 3 0 2 
  LmjF36.6980 
Eukaryotic translation initiator factor 
3 subunit 8, putative 82437 80 1 0 1 
  LmjF28.2620 Coatomer gamma subunit, putative 96256 55 1 0 1 
  LmjF36.1370 
Transitional endoplasmic reticulum 
ATPase, putative 87582 45 3 0 2 
  LmjF12.0250 Cysteinyl-tRNA synthetase, putative 88887 34 1 0 1 
  LmjF15.1480 cAMP specific phosphodiesterase 105161 33 1 0 1 
∆GT LmjF36.0180 EF2-1, elongation factor 2 94928 327 13 0 6 
  LmjF13.0280 Alpha-tubulin 50526 114 6 0 2 
  LmjF36.6980 
Eukaryotic translation initiator factor 
3 subunit 8, putative 82437 79 1 0 1 
  LmjF29.1750 
Paraflagellar rod protein 1D, 
putative 69390 74 2 0 1 
  LmjF27.0870 Hypothetical protein, conserved 85382 68 2 0 1 
  LmjF31.0390 
Calpain-like cysteine peptidase, 
putative 97703 68 3 0 1 
  LmjF11.1000 
Pyruvate phosphate dikinase, 
putative 101609 47 2 0 1 
  LmjF36.1370 
Transitional endoplasmic reticulum 
ATPase, putative 87582 32 2 0 1 
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Band 
13        
  
Accession 
Number Gene Annotation MWt 
Protein 
Score 
Sequence 
Coverage 
(%) 
Number 
of 
predicted 
TMD 
Queries 
Matched 
Wild Type LmjF29.1750 
Paraflagellar rod protein 1D, 
putative 69390 130 4 0 2 
  LmjF31.0010 
5-
methyltetrahydropteroyltriglutamate-
-homocyst ei nemethyltransferase, 
putative 86627 115 3 0 2 
  LmjF36.0180 EF2-1, elongation factor 2 94928 78 2 0 2 
  LmjF13.0280 Alpha-tubulin 50526 62 3 0 1 
  LmjF34.0230 Hypothetical protein, conserved 81994 58 1 0 1 
  LmjF28.2770 Heat-shock protein hsp70, putative 71893 53 3 0 2 
  LmjF31.0440 
Cytoskeleton-associated protein 
CAP5.5, putative 81042 51 2 0 1 
  LmjF01.0520 
Long chain fatty acid CoA ligase, 
putative 78255 27 3 0 1 
  LmjF32.2960 
Minichromosome maintenance 
(MCM) complex subunit, putative 81251 25 1 0 1 
∆GT LmjF31.0010 
5-
methyltetrahydropteroyltriglutamate-
-homocyst ei nemethyltransferase, 
putative 86627 145 5 0 3 
  LmjF16.1425 Paraflagellar rod protein 2c 69257 118 2 0 2 
  LmjF13.0280 Alpha-tubulin 50526 97 6 0 2 
  LmjF30.2460 
Heat-shock 70-related protein 1, 
mitochondrial precursor, putative 69532 87 3 0 1 
  LmjF29.1750 
Paraflagellar rod protein 1D, 
putative 69390 81 4 0 2 
  LmjF28.1200 
Glucose-regulated protein 78, 
putative 72067 74 3 1 1 
  LmjF28.2770 Heat-shock protein hsp70, putative 71893 68 3 0 2 
  LmjF32.0400 
ATP-dependant RNA helicase, 
putative 67276 46 1 0 1 
        
Band 
14        
  
Accession 
Number Gene Annotation MWt 
Protein 
Score 
Sequence 
Coverage 
(%) 
Number 
of 
predicted 
TMD 
Queries 
Matched 
Wild Type LmjF28.2770 Heat-shock protein hsp70, putative 71893 181 7 0 4 
  LmjF16.1425 Paraflagellar rod protein 2C 69257 149 2 0 2 
  LmjF30.2460 Heat shock 70-related protein 1 69532 109 3 0 1 
  LmjF29.1750 
Paraflagellar rod protein 1D, 
putative 69390 106 4 0 2 
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  LmjF34.3670 
Vacuolar ATP synthase catalytic 
subunit a, putative 68206 90 3 0 1 
  LmjF28.1200 
Glucose-regulated protein 78, 
putative 72067 90 3 1 1 
  LmjF13.0280 Alpha-tubulin 50526 88 6 0 2 
  LmjF32.0400 
ATP-dependant RNA helicase, 
putative 67276 80 8 0 3 
  LmjF26.1570 Thimet oligopeptidase, putative 77775 78 1 0 1 
  LmjF23.0540 Acetyl-CoA synthetase, putative 79156 53 2 0 1 
  LmjF24.1560 Hypothetical protein, conserved 67813 50 3 0 1 
∆GT LmjF28.2770 Heat-shock protein hsp70, putative 71893 312 13 0 6 
  LmjF16.1425 Paraflagellar rod protein 2C 69257 268 8 0 5 
  LmjF28.1200 
Glucose-regulated protein 78, 
putative 72067 211 13 1 4 
  LmjF30.2460 
Heat shock 70-related protein 1, 
mitochondrial precursor, putative 69532 155 3 0 1 
  LmjF26.1570 Thimet oligopeptidase, putative 77775 138 3 0 2 
  LmjF29.1750 
Paraflagellar rod protein 1D, 
putative 69390 102 4 0 2 
  LmjF34.3670 
Vacuolar ATP synthase catalytic 
subunit a, putative 68206 91 3 0 1 
  LmjF24.1560 Hypothetical protein, conserved 67813 85 3 0 1 
  LmjF13.0280 Alpha-tubulin 50526 78 6 0 2 
  LmjF23.0640 Hypothetical protein, conserved 63257 71 2 1 1 
  LmjF26.1240 
HSP70.4, heat shock protein 70-
related protein 71001 70 1 0 1 
  LmjF05.0960 Dipeptidylpeptidase III, putative 76262 66 2 0 1 
  LmjF32.0400 
ATP-dependant RNA helicase, 
putative 67276 56 5 0 2 
  LmjF23.0540 Acetyl-CoA synthetase, putative 79156 46 2 0 1 
        
Band 
15        
  
Accession 
Number Gene Annotation MWt 
Protein 
Score 
Sequence 
Coverage 
(%) 
Number 
of 
predicted 
TMD 
Queries 
Matched 
Wild Type LmjF28.2770 Heat shock protein hsp70, putative 71893 323 14 0 6 
  LmjF13.0280 Alpha-tubulin 50526 114 14 0 4 
  LmjF30.2460 
Heat shock 70-related protein 1, 
mitochondrial precursor, putative 69532 104 3 0 1 
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  LmjF29.1310 
Carnitine/choline acetyltransferase, 
putative 68959 99 3 0 2 
  LmjF24.1630 
Succinate dehydrogenase 
flavoprotein, putative 67605 98 2 0 1 
  LmjF29.1750 
Paraflagellar rod protein 1D, 
putative 69390 96 4 0 2 
  LmjF32.1000 
Chaperonin containing t-complex 
protein, putative 59978 80 4 0 1 
  LmjF28.1200 
Glucose-regulated protein 78, 
putative 72067 70 3 1 1 
  LmjF16.1425 Paraflagellar rod protein 2C 69257 59 2 0 1 
  LmjF08.1230 Beta-tubulin 50302 53 3 0 1 
  LmjF08.1110 Stress-induced protein sti1 62638 49 2 0 1 
  LmjF36.6650 
PGAM, 2,3-bisphosphoglycerate-
independent phosphoglycerate 
mutase 60903 45 7 0 2 
  LmjF26.1570 Thimet oligopeptidase, putative 77775 39 1 0 1 
  LmjF16.1180 Coatomer delta subunit-like protein  58116 38 2 0 1 
  LmjF32.2960 
Minichromosome maintenance 
(MCM) complex subunit, putative 81251 27 1 0 1 
∆GT LmjF28.2770 Heat-shock protein hsp70, putative 71893 312 11 0 6 
  LmjF13.0280 Alpha-tubulin 50526 236 17 0 5 
  lmjF36.2030 
Chaperonin Hsp60, mitochondrial 
precursor 59623 140 7 0 2 
  LmjF08.1230 Beta-tubulin 50302 120 6 0 2 
  LmjF32.1000 
Chaperonin containing t-complex 
protein, putative 59978 118 6 0 2 
  LmjF24.1630 
Succinate dehydrogenase 
flavoprotein, putative 67605 96 2 0 1 
  LmjF28.1200 
Glucose-regulated protein 78, 
putative 72067 67 3 1 1 
  LmjF35.3860 
t-complex protein 1, eta subunit, 
putative 62507 59 3 0 1 
  LmjF29.1310 
Carnitine/choline acetyltransferase, 
putative 68959 53 2 0 1 
  LmjF25.1170 ATPase beta subunit, putative 56541 29 2 0 1 
  LmjF02.0370 
Proteasome regulatory non-ATPase 
subunit 6, putative 59200 6 3 0 1 
        
Band 
16        
  
Accession 
Number Gene Annotation MWt 
Protein 
Score 
Sequence 
Coverage 
(%) 
Number 
of 
predicted 
TMD 
Queries 
Matched 
Wild Type LmjF13.0280 Alpha-tubulin 50526 218 17 0 5 
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  LmjF28.2770 Heat-shock protein hsp70 71893 207 11 0 5 
  LmjF24.1630 
Succinate dehydrogenase 
flavoprotein, putative 67605 90 2 0 1 
  LmjF08.1230 Beta tubulin 50302 68 3 0 1 
  LmjF25.1170 ATPase beta subunit, putative 56541 63 13 0 3 
  LmjF18.0610 
ATP-depndant zinc 
metallopeptidase, putative 65040 53 3 1 1 
  LmjF32.3270 Chaperonin alpha subunit, putative 59497 53 3 0 1 
  LmjF32.0400 
ATP-dependant RNA helicase, 
putative 67276 48 1 0 1 
  LmjF27.1805 
Glycosomal phosphoenolpyruvate 
carboxylase, putative 58670 46 2 0 1 
  LmjF36.0250 EIF3-interacting protein-like protein 732223 46 2 1 1 
  LmjF26.1570 Thimet oligopeptidase, putative 77775 33 1 0 1 
  LmjF29.1310 
Carnitine/choline acetyltransferase, 
putative 68959 31 2 0 1 
∆GT LmjF08.1230 Beta tubulin 50302 273 16 0 6 
  LmjF25.1170 ATPase beta subunit, putative 56541 157 5 0 2 
  LmjF13.0280 Alpha tubulin 50526 66 3 0 1 
  LmjF27.1805 
Glycosomal phosphoenolpyruvate 
carboxylase, putative 58670 40 2 0 1 
        
Band 
17        
  
Accession 
Number Gene Annotation MWt 
Protein 
Score 
Sequence 
Coverage 
(%) 
Number 
of 
predicted 
TMD 
Queries 
Matched 
Wild Type LmjF33.0792 Beta tubulin 50335 701 46 0 17 
  LmjF13.0280 Alpha tubulin 50526 322 23 0 7 
  LmjF27.1805 
Glycosomal phosphoenol pyruvate 
carboxykinase, putative 58670 111 7 0 3 
  LmjF36.2030 
Chaperonin Hsp60, mitochondrial 
precursor 59623 91 5 0 2 
  LmjF25.1170 ATPase beta subunit, putative 56541 62 7 0 2 
  LmjF36.1520 Hypothetical protein, conserved 57081 55 2 0 1 
  LmjF11.0100 Seryl-tRNA synthetase, putative 53850 51 2 0 1 
  LmjF35.0020 Pyruvate kinase, putative 57833 36 4 0 1 
∆GT LmjF33.0792 Beta tubulin 50335 368 27 0 10 
  LmjF13.0280 Alpha tubulin 50526 186 21 0 6 
  LmjF17.0080 Elongation factor 1-alpha 49485 58 5 0 1 
  LmjF32.3130 Ribosomal protein 13, putative 47743 49 3 0 1 
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  LmjF36.2020 
Chaperonin Hsp60, mitochondrial 
precursor 60484 29 3 0 1 
        
Band 
18        
  
Accession 
Number Gene Annotation MWt 
Protein 
Score 
Sequence 
Coverage 
(%) 
Number 
of 
predicted 
TMD 
Queries 
Matched 
Wild Type LmjF33.0792 Beta tubulin 50335 629 41 0 18 
  LmjF13.0280 Alpha tubulin 50526 217 20 0 6 
  LmjF32.3310 
Dihydrolipoamide dehydrogenase, 
putative 51173 58 2 0 1 
  LmjF17.0080 Elongation factor 1-alpha 49485 40 8 0 2 
  LmjF24.2110 Hypothetical protein, conserved 55619 27 2 0 1 
  LmjF27.1805 
Glycosomal phosphoenolpyruvate 
carboxykinase, putative 58670 26 2 0 1 
∆GT LmjF33.0792 Beta tubulin 50335 512 40 0 17 
  LmjF13.0280 Alpha tubulin 50526 373 28 0 8 
  LmjF17.0080 Elongation factor 1-alpha 49485 48 2 0 1 
  LmjF19.0160 Aminopeptidase, putative 43006 47 6 0 2 
  LmjF21.0240 Hexokinase, putative 52200 41 2 0 1 
        
Band 
19        
  
Accession 
Number Gene Annotation MWt 
Protein 
Score 
Sequence 
Coverage 
(%) 
Number 
of 
predicted 
TMD 
Queries 
Matched 
Wild Type LmjF08.1230 Beta tubulin 50302 438 21 0 1 
  LmjF13.0280 Alpha tubulin 50526 388 32 0 10 
  LmjF17.0080 Elongation factor 1-alpha 49485 105 18 0 6 
  LmjF14.1160 ENOL,enolase 46689 56 14 0 4 
  LmjF36.3910 S-adenosylhomocysteine hydrolase 48425 33 2 0 1 
∆GT LmjF08.1230 Beta tubulin 50302 115 6 0 2 
  LmjF16.0550 
Orotidine-5-phosphate 
decarboxylase/orotate 
phosphoribosyltransferase, putative 49811 43 10 0 2 
        
Band 
20        
  
Accession 
Number Gene Annotation MWt 
Protein 
Score 
Sequence 
Coverage 
(%) 
Number 
of 
predicted 
TMD 
Queries 
Matched 
Wild Type LmjF35.3230 Cystathione gamma lyase, putative 45074 140 9 0 2 
  LmjF21.1552  RNA helicase,putative 49741 65 3 0 1 
∆GT LmjF35.3230 Cystathione gamma lyase, putative 45074 162 9 0 2 
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  LmjF30.2970 
Glyceraldehyde 3-phosphate 
dehydrogenase, glycosomal 39370 116 4 0 1 
  LmjF36.2950 
Succinyl-CoA ligase [GDP-forming] 
beta-chain, putative 44616 54 2 0 1 
        
Band 
21        
  
Accession 
Number Gene Annotation MWt 
Protein 
Score 
Sequence 
Coverage 
(%) 
Number 
of 
predicted 
TMD 
Queries 
Matched 
Wild Type LmjF30.2970 
Glyceraldehyde 3-phosphate 
dehydrogenase, glycosomal 39370 112 4 0 1 
  LmjF29.1070 Ribosomal protein L1a, putative 41109 80 5 0 1 
  LmjF35.3230 Cystathione gamma lyase, putative 45074 29 5 0 1 
∆GT LmjF30.2970 
Glyceraldehyde 3-phosphate 
dehydrogenase, glycosomal 39370 119 4 0 1 
        
Band 
22        
  
Accession 
Number Gene Annotation MWt 
Protein 
Score 
Sequence 
Coverage 
(%) 
Number 
of 
predicted 
TMD 
Queries 
Matched 
Wild Type LmjF34.0140 Malate dehydrogenase 33622 85 12 0 2 
  LmjF30.0880 Adenosine kinase, putative 37703 63 7 0 1 
  LmjF13.0280 Alpha tubulin 50526 42 3 0 1 
  LmjF21.1250 Adenylate kinase, putative 30212 41 5 0 1 
∆GT LmjF34.0140 Malate dehydrogenase 33622 142 5 0 1 
        
Band 
23        
  
Accession 
Number Gene Annotation MWt 
Protein 
Score 
Sequence 
Coverage 
(%) 
Number 
of 
predicted 
TMD 
Queries 
Matched 
Wild Type LmjF34.0140 Malate dehydrogenase 33622 109 5 0 1 
∆GT LmjF34.0140 Malate dehydrogenase 33622 136 5 0 1 
  LmjF32.0450 40S ribosomal protein S2 28811 89 5 0 1 
  LmjF28.2740 
LACK1,activated protein kinase C 
receptor (LACK) 34891 89 5 0 1 
  LmjF13.0280 Alpha tubulin 50526 62 3 0 1 
        
Band 
24        
  
Accession 
Number Gene Annotation MWt 
Protein 
Score 
Sequence 
Coverage 
(%) 
Number 
of 
predicted 
TMD 
Queries 
Matched 
Wild Type LmjF34.0140 Malate dehydrogenase 33622 83 5 0 1 
  LmjF32.0450 40S ribosomal protein S2 28811 72 5 0 1 
  LmjF13.0280 Alpha tubulin 50526 68 3 0 1 
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∆GT LmjF32.0450 40S ribosomal protein S2 28811 84 5 0 1 
  LmjF13.0280 Alpha tubulin 50526 70 3 0 1 
        
Band 
25        
  
Accession 
Number Gene Annotation MWt 
Protein 
Score 
Sequence 
Coverage 
(%) 
Number 
of 
predicted 
TMD 
Queries 
Matched 
Wild Type No significant hits to report           
∆GT LmjF34.2580 Hypothetical protein, conserved 22634 29 9 0 1 
        
Band 
26        
  
Accession 
Number Gene Annotation MWt 
Protein 
Score 
Sequence 
Coverage 
(%) 
Number 
of 
predicted 
TMD 
Queries 
Matched 
Wild Type LmjF18.0620 60S ribosomal protein L10a 24970 31 7 0 1 
∆GT LmjF18.0620 60S ribosomal protein L10a 24970 65 7 0 1 
        
Band 
27        
  
Accession 
Number Gene Annotation MWt 
Protein 
Score 
Sequence 
Coverage 
(%) 
Number 
of 
predicted 
TMD 
Queries 
Matched 
Wild Type LmjF18.0620 
60S ribosomal protein L10a, 
putative 24970 78 7 0 1 
  LmjF14.0190 Hypothetical protein, conserved 22485 61 6 0 1 
∆GT LmjF18.0620 
60S ribosomal protein L10a, 
putative 24970 57 7 0 1 
  LmjF14.0190 Hypothetical protein, conserved 22485 55 6 0 1 
        
Band 
28        
  
Accession 
Number Gene Annotation MWt 
Protein 
Score 
Sequence 
Coverage 
(%) 
Number 
of 
predicted 
TMD 
Queries 
Matched 
Wild Type LmjF27.0760 
Small GTP-binding protein Rab1, 
putative 22424 87 8 0 1 
  LmjF04.0760 
Nascent polypeptide associated 
complex subunit-like protein, copy 2 26675 83 11 0 1 
  LmjF21.1700 
Proteosome alpha2 subunit, 
putative 25309 42 8 0 1 
∆GT LmjF27.0760 
Small GTP-binding protein Rab1, 
putative 22424 79 8 0 1 
  LmjF04.0760 
Nascent polypeptide associated 
complex subunit-like protein, copy 2 26675 63 11 0 1 
  LmjF28.0110 
Proteosome beta 3 subunit , 
putative 22790 62 7 0 1 
  LmjF18.0620 
60S ribosomal protein L10a, 
putative 24970 57 7 0 1 
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  LmjF14.0190 Hypothetical protein, conserved 22485 57 6 0 1 
  LmjF14.0650 Fatty acid elongase, putative 32476 34 4 7 1 
        
Band 
29        
  
Accession 
Number Gene Annotation MWt 
Protein 
Score 
Sequence 
Coverage 
(%) 
Number 
of 
predicted 
TMD 
Queries 
Matched 
Wild Type No significant hits to report           
∆GT LmjF27.0760 
Small GTP-binding protein Rab1, 
putative 22424 74 8 0 1 
  LmjF35.3700 Gim5A protein, putative 25339 56 5 1 1 
        
Band 
30        
  
Accession 
Number Gene Annotation MWt 
Protein 
Score 
Sequence 
Coverage 
(%) 
Number 
of 
predicted 
TMD 
Queries 
Matched 
Wild Type LmjF31.2790 adp-ribosylation factor, putative 20290 39 6 0 1 
∆GT LmjF11.0960 40S ribosomal protein S5 21398 93 7 0 1 
  LmjF30.3600 
ATP synthase, epsilon chain, 
putative 20429 83 6 0 1 
  LmjF31.2790 adp-ribosylation factor, putative 20290 58 11 0 1 
  LmjF35.3700 Gim5A protein, putative 25339 42 5 1 1 
        
Band 
31        
  
Accession 
Number Gene Annotation MWt 
Protein 
Score 
Sequence 
Coverage 
(%) 
Number 
of 
predicted 
TMD 
Queries 
Matched 
Wild Type LmjF24.2210 60S ribosomal protein L12, putative 17698 98 9 0 1 
  LmjF30.3600 
ATP synthase, epsilon chain, 
putative 20429 57 6 0 1 
∆GT LmjF36.0980 40S ribosomal protein S10, putative 18752 57 6 0 1 
        
Band 
32        
  
Accession 
Number Gene Annotation MWt 
Protein 
Score 
Sequence 
Coverage 
(%) 
Number 
of 
predicted 
TMD 
Queries 
Matched 
Wild Type LmjF36.2860 
S24E-1, 40S ribosomal protein 
S24e 15874 121 21 0 3 
  LmjF22.0420 40S ribosomal protein S15, putative 17424 121 10 0 1 
∆GT LmjF22.0420 40S ribosomal protein S15, putative 17424 107 10 0 1 
  LmjF36.2860 
S24E-1, 40S ribosomal protein 
S24e 15874 88 11 0 2 
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Band 
33        
  
Accession 
Number Gene Annotation MWt 
Protein 
Score 
Sequence 
Coverage 
(%) 
Number 
of 
predicted 
TMD 
Queries 
Matched 
Wild Type LmjF22.0420 40S ribosomal protein S15, putative 17424 127 10 0 1 
  LmjF36.2860 S24E-1, 40 ribosomal protein S24e 15874 77 10 0 1 
  LmjF36.3270 60S ribosomal protein L22, putative 15050 57 22 0 1 
  LmjF16.0600 Histone h3, putative 14826 48 24 0 1 
  LmjF09.0910 Calmodulin, putative 16814 38 24 0 1 
∆GT LmjF22.0420 40S ribosomal protein S15, putative 17424 131 10 0 1 
  LmjF21.0730 60S ribosomal protein 136, putative 11992 73 13 0 1 
  LmjF25.2090 Hypothetical protein, conserved 17898 67 17 0 1 
  LmjF13.0570 40S ribosomal protein S12, putative 15826 45 17 0 1 
  LmjF19.1100 Hypothetical protein, conserved 139733 41 1 0 1 
  LmjF35.2050 60S ribosomal protein L32 15367 36 13 0 1 
        
Band 
34        
  
Accession 
Number Gene Annotation MWt 
Protein 
Score 
Sequence 
Coverage 
(%) 
Number 
of 
predicted 
TMD 
Queries 
Matched 
Wild Type LmjF15.1470 Ribosomal protein S6, putative 13564 107 12 0 1 
  LmjF12.0520 
Vacuolar ATP synthase subunit, 
putative 15656 74 16 0 1 
  LmjF05.0500 ATPase alpha subunit 62794 47 2 0 1 
  LmjF27.1530 Hypothetical protein, conserved 11488 40 15 0 1 
∆GT LmjF05.0500 ATPase alpha subunit 62794 54 2 0 1 
  LmjF21.0730 60S ribosomal protein 136 11992 51 13 0 1 
        
Band 
35        
  
Accession 
Number Gene Annotation MWt 
Protein 
Score 
Sequence 
Coverage 
(%) 
Number 
of 
predicted 
TMD 
Queries 
Matched 
Wild Type LmjF26.0620 10kDa heat shock protein, putative 10651 70 14 0 1 
  LmjF05.0500 ATPase alpha-subunit 62794 47 2 0 1 
  LmjF33.0610 Hypothetical protein, conserved 21883 40 6 0 1 
  LmjF25.1015 
Protein transport protein sec 61 
gamma subunit, putative 7884 38 18 1 1 
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∆GT LmjF36.3750 
40S ribosomal protein S27-1, 
putative 10135 66 15 0 1 
  LmjF05.0500 ATPase alpha-subunit 62794 65 2 0 1 
  LmjF15.1470 Ribosomal protein S6, putative 13564 52 12 0 1 
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3.3.6  Membrane proteome from salt-extraction protocol 
3.3.6.1 Membrane proteome comparison from standard protocol 
(without IEF and DIGE) 
 Proteomic analysis was carried out to compare the membrane proteomes 
of wild type (WT) and glucose transporter null mutant (ΔLmGT) Leishmania. A 
salt-extraction protocol was chosen over the Triton-X 114 protocol for sample 
preparation for mass spectrometry analysis as detergent may cause interference 
to the mass spectrometry and in electrophoretic separation. 1-SDS gel loaded 
with the cell lines tested served as loading control (Figure 3-11) and 
subsequently 30 pieces of equal-sized bands were excised each from the samples 
lane. However, due the MS availability, only 9 bands (Band 2-Band 10) from each 
sample were analysed. The results from the mass spectrometry analysis are 
summarised in Table 3-2. 
 A number of membrane proteins were identified from both samples, and 
some were exclusively found in either of the samples. Proteins that were 
exclusively found in wild type were 1) LPG1R, beta-galactofuranosyltransferase-
like protein (LmjF33.0300), 2) LPG3, lipophosphoglycan biosynthetic protein, 
putative (LmjF29.0760), 3) Biopterin transporter, putative (LmjF35.5150), 4) 3’-
nucleoside/nuclease, putative (LmjF12.0400), 5) Pretranslocation protein, alpha 
subunit, putative (LmjF11.1050), 6) Fatty acid desaturase, putative 
(LmjF10.0010), 7) Fatty acid desaturase, putative (LmjF33.3270). 
 Membrane proteins that were identified exclusively in the null mutant 
were as follows: 1) ABC transporter, putative (LmjF29.0620), 2) Glucose-
regulated proetein 78, putative (LmjF28.1200), 3) Vacuolar-type protein 
translocating pyrophosphate 1, putative (LmjF31.1220), 4) GP63-1, GP63, 
leishmolysin (LmjF10.0470), 5) Hypothetical protein conserved, (LmjF28.0930), 
6) Nucleoside transporter 1, putative (LmjF15.1230), 7) NAD(p)-dependant 
steroid dehydrogenase-like protein (LmjF06.0350) and 8) Cytochrome C, oxidase 
VII, putative (LmjF25.1130). 
 Among other membrane proteins that were found in both cell lines are: 1) 
H1A-1, p-ATPase, putative (LmjF18.1510), 2) NT2, nucleoside transporter 1, 
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putative (LmjFF36.1940), 3) Hypothetical protein, conserved (LmjF30.1760), 4) 
Multidrug resistance protein, putative (LmjF23.0220), 5) Nucleobase/nucleoside 
transporter 8.1, putative (LmjF13.1210), 6) GP63-1, GP63, leishmolysin 
(LmjF10.0460), 7) Hypothetical protein, conserved (LmjF21.1555) and 8) 
Membrane-bound acid phosphatise 2, putative (LmjF36.2590). 
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Figure 3-11: SDS gel of membrane extraction from wild type (WT) and glucose transporter 
null mutant (ΔLmGT), stained with Coomassie blue. Each well were loaded with 
2μl=2x107cells. 
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Table 3-2: Results from mass spectrometry analysis comparing membrane proteomic 
between wild type and glucose transporter null mutant from salt-extraction protocol were 
summarised in this table. Blue column= proteins (with TMD) found only in wild type, red 
columns= proteins (with TMD) found only in glucose transporter null mutant, yellow 
columns= proteins (with TMD) found both in wild type and glucose transporter null mutant. 
 
Band 2        
  
Accession 
Number Gene Annotation MWt 
Protein 
Score 
Sequence 
Coverage 
(%) 
Number 
of 
predicted 
TMD 
Queries 
Matched 
Wild type LmjF33.0300 
LPG1R,beta-
galactofuronosyltransferase-
like protein 52125 33 1 1 3 
  LmjF26.1190 
Hypothetical protein, 
conserved 184507 31 1 0 3 
∆GT LmjF05.0380 
Microtubule-associated 
protein, putative 206884 46 0 0 1 
  LmjF27.0240 
Kinetoplast-associated 
protein-like protein 78813 38 1 0 1 
  LmjF35.2450 
Hypothetical protein, 
conserved 254600 35 1 0 3 
  LmjF33.2550 
Isocitrate dehydrogenase, 
putative 46591 30 2 0 1 
        
Band 3        
  
Accession 
Number Gene Annotation MWt 
Protein 
Score 
Sequence 
Coverage 
(%) 
Number 
of 
predicted 
TMD 
Queries 
Matched 
wild type LmjF27.0240 
Kinetoplast-associated 
protein-like protein 78813 51 1 0 1 
  LmjF05.0380 
Microtubule-associated 
protein, putative 206884 41 1 0 2 
  LmjF18.1510 H1A-1, P-ATPase, putative 108036 38 5 8 6 
  LmjF14.0800 
Hypothetical protein, 
conserved 42371 30 2 0 1 
  LmjF23.1540 
Hypothetical protein, 
conserved 106312 29 2 0 2 
∆GT LmjF27.0240 
Kinetoplast-associated 
protein-like protein 78813 70 1 0 1 
  LmjF36.4800 
Hypothetical protein, 
conserved 57011 40 5 0 6 
  LmjF14.0800 
Hypothetical protein, 
conserved 42371 35 2 0 1 
  LmjF29.0620 ABC transporter, putative 209023 31 1 16 5 
  LmjF23.0220 
Multidrug resistance protein, 
putative 175138 31 0 6 2 
  LmjF12.0110 
Hypothetical protein, 
unknown function 91587 30 7 0 5 
        
Band 4        
  
Accession 
Number Gene Annotation MWt 
Protein 
Score 
Sequence 
Coverage 
(%) 
Number 
of 
predicted 
TMD 
Queries 
Matched 
Wild type LmjF23.1540 
Hypothetical protein, 
conserved 106312 34 2 0 5 
  LmjF36.1940 
NT2, nucleoside transporter 
1, putative 54305 32 2 10 1 
∆GT LmjF18.1510 
H1A-1, P-type H1-ATPase, 
putative 108036 69 3 8 5 
  LmjF05.0800 
Microtubule-associated 
protein, putative 206884 35 1 0 2 
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  LmjF28.1880 
Hypothetical protein, 
conserved 140389 33 1 0 4 
  LmjF36.1940 
NT2, nucleoside transporter 
1, putative 54305 30 2 10 1 
        
Band 5        
  
Accession 
Number Gene Annotation MWt 
Protein 
Score 
Sequence 
Coverage 
(%) 
Number 
of 
predicted 
TMD 
Queries 
Matched 
Wild type LmjF15.1010 Glutamate dehydrogenase 115588 71 4 0 6 
  LmjF29.0760 
LPG3, lipophosphoglycan 
biosynthetic protein, 
putative 86561 46 9 1 7 
  LmjF11.1000 
Pyruvate phosphate 
dikinase, putative 101609 40 6 0 5 
  LmjF23.1540 
Hypothetical protein, 
conserved 106312 37 4 0 4 
∆GT LmjF15.1010 Glutamate dehydrogenase 115588 104 12 0 14 
  LmjF30.1760 
Hypothetical protein, 
conserved 210216 32 1 1 5 
  LmjF13.1210 
Nucleobase/nucleoside 
transporter 8.1, putative 55252 31 1 11 1 
  LmjF23.1540 
Hypoyhetical protein, 
conserved 106312 31 1 0 2 
  LmjF36.1940 
NT2, nucleoside transporter 
1, putative 54305 29 3 10 2 
        
Band 6        
  
Accession 
Number Gene Annotation MWt 
Protein 
Score 
Sequence 
Coverage 
(%) 
Number 
of 
predicted 
TMD 
Queries 
Matched 
Wild type LmjF33.0312 
HSP83, heat shock protein 
83-1 80997 49 11 0 7 
  LmjF08.1230 Beta tubulin 50302 46 16 0 7 
  LmjF15.1010 Glutamate dehydrogenase 115588 45 7 0 8 
  LmjF23.1540 
Hypothetical protein, 
conserved 106312 38 1 0 2 
  LmjF35.5150 
Biopterin transporter, 
putative 70130 36 1 14 3 
  LmjF36.1940 
NT2, nucleoside transporter 
1, putative 54305 31 2 10 1 
  LmjF20.1090 
Hypothetical protein, 
conserved 207668 30 2 0 4 
∆GT LmjF15.1010 Glutamate dehydrogenase 115588 35 2 0 2 
  LmjF31.1210 
Hypothetical protein, 
conserved 552349 34 1 0 5 
  LmjF30.2830 
Hypothetical protein, 
conserved 92082 34 0 0 1 
  LmjF23.1540 
Hypothetical protein, 
conserved 106312 34 3 0 7 
  LmjF25.1350 
Hypothetical protein, 
conserved 280794 32 1 0 3 
  LmjF32.3150 
Hypothetical protein, 
conserved 273868 30 1 0 3 
        
Band 7        
  
Accession 
Number Gene Annotation MWt 
Protein 
Score 
Sequence 
Coverage 
(%) 
Number 
of 
predicted 
TMD 
Queries 
Matched 
Wild type LmjF25.2420 
Hypothetical protein, 
conserved 30623 40 5 0 3 
  LmjF30.1760 
Hypothetical protein, 
conserved 210216 31 3 1 5 
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  LmjF23.0220 
Multidrug resistance protein, 
putative 175138 30 1 6 3 
∆GT LmjF28.1200 
glucose-regulated protein 
78, putative 72067 283 28 1 19 
  LmjF16.1425 Paraflagellar rod protein 2C 69257 230 30 0 17 
  LmjF30.2470 
Heat shock 70-related 
protein 1, mitochondrial 
precursor, putative 72346 195 23 0 15 
  LmjF08.1230 Beta tubulin 50302 175 27 0 13 
  LmjF30.2460 
Heat shock 70-related 
protein 1, mitochondrial 
precursor, putative 69532 143 19 0 14 
  LmjF29.1750 Paraflagellar rod protein 1D 69390 121 25 0 16 
  LmjF15.1010 Glutamate dehydrogenase 115588 92 10 0 10 
  LmjF28.2770 
Heat-shock protein hsp70, 
putative 71893 78 15 0 9 
  LmjF36.2590 
Membrane bound acid 
phosphatase 2, putative 63722 77 6 1 4 
  LmjF13.0280 Alpha tubulin 50526 77 20 0 8 
  LmjF31.1220 
Vacuolar-type protein 
translocating 
pyrophosphatase 1, putative 84195 47 8 15 6 
  LmjF33.0312 
HSP83, heat shock protein 
8.1, putative 55252 39 1 0 1 
  LmjF24.2060 Tranketolase, putative 72363 33 4 0 2 
  LmjF30.1160 
Hypothetical protein, 
conserved 177511 30 2 0 5 
  LmjF22.1110 
Dynein heavy chain, 
cytosolic, putative 624243 30 1 0 11 
  LmjF23.1540 
Hypothetical protein, 
conserved 106312 29 2 0 4 
        
Band 8        
  
Accession 
Number Gene Annotation MWt 
Protein 
Score 
Sequence 
Coverage 
(%) 
Number 
of 
predicted 
TMD 
Queries 
Matched 
Wild type LmjF33.0792 Beta tubulin 50335 565 53 0 33 
  LmjF13.0280 Alpha tubulin 50526 551 51 0 27 
  LmjF21.1860 Beta tubulin 50395 503 47 0 32 
  LmjF25.1180 
ATPase beta subunit, 
putative 56513 147 24 0 10 
  LmjF30.2470 
Heat shock 70-related 
protein 1, mitochondrial 
precursor, putative 72346 109 15 0 10 
  LmjF17.0080 Elongation factor 1-alpha  49485 71 6 0 3 
  LmjF29.1750 
Paraflagellar rod protein 1D, 
putative 69390 48 5 0 4 
  LmjF25.1120 
ALDH2, aldehyde 
dehydrogenase, 
mitochondrial precursor 54712 43 3 0 2 
  LmjF29.0530 
Hypothetical 
protein,conserved 315663 40 1 0 5 
  LmjF16.1425 Paraflagellar rod protein 2C 69257 38 10 0 6 
  LmjF35.2320 Protein kinase, putative 123069 35 6 0 5 
  LmjF13.1210 
Nucleobase/nucleoside 
transporter 8.1, putative 55252 35 1 11 1 
  LmjF24.2110 Hypothetical protein 55619 34 2 0 1 
  LmjF28.1710 Hypothetical protein 230686 33 3 0 6 
  LmjF10.0460 GP63-1, GP63, leishmolysin 65039 33 2 1 2 
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  LmjF34.0820 
eEF1B beta 1, elongation 
factor 1-beta 25630 33 10 0 2 
  LmjF25.2420 Hypothetical protein 30623 31 6 0 9 
  LmjF23.1540 
Hypothetical protein, 
conserved 106312 31 2 0 3 
  LmjF36.1940 
NT2, nucleoside transporter 
1, putative 54305 30 4 10 2 
∆GT LmjF08.1230 Beta tubulin 50302 280 41 0 19 
  LmjF25.1170 
ATPase beta subunit, 
putative 56541 211 31 0 12 
  LmjF13.0280 Alpha tubulin 50526 163 37 0 13 
  LmjF36.2030 
Chaperonin Hsp60, 
mitochondrial precursor 59623 112 18 0 8 
  LmjF36.2020 
Chaperonin Hsp60, 
mitochondrial precursor 60484 112 12 0 5 
  LmjF27.1805 
Glycosomal 
phosphoenolpyruvate 
carboxykinase,putative 58670 96 13 0 8 
  LmjF36.1940 
NT2, nucleoside transporter 
1, putative 54305 55 6 10 3 
  LmjF03.0200 
delta1-pyrroline-5-
carboxylate dehydrogenase, 
putative 62658 52 7 0 5 
  LmjF10.0470 GP63-1, GP63, leishmolysin 70545 40 2 2 2 
  LmjF27.1880 
Hypothetical protein, 
conserved 57214 36 1 0 1 
  LmjF24.0770 Malic enzyme, putative 64003 34 1 0 1 
  LmjF16.1425 Paraflagellar rod protein 2C 69257 34 14 0 9 
  LmjF25.1130 
Cytochrome C oxidase VII, 
putative 19058 33 8 1 1 
  LmjF31.1220 
Vacuolar-type proton 
translocating 
pyrophasphatase 1, putative 84195 32 5 15 4 
  LmjF18.1510 
H1A, P-type H+-ATPase, 
putative 108036 29 1 8 1 
        
Band 9        
  
Accession 
Number Gene Annotation MWt 
Protein 
Score 
Sequence 
Coverage 
(%) 
Number 
of 
predicted 
TMD 
Queries 
Matched 
Wild type LmjF05.0500 ATPase alpha subunit 62794 241 28 0 14 
  LmjF08.1230 Beta tubulin 50302 234 30 0 16 
  LmjF21.0240 Hexokinase, putative 52200 112 28 0 11 
  LmjF36.2950 
Succinyl-CoA ligase [GDP-
forming] beta chain, putative 44616 90 22 0 7 
  LmjF13.1210 
Nucleobase/nucleoside 
transporter 8.1, putative 55252 69 1 11 1 
  LmjF10.0290 
Isocitrate dehydrogenase 
[NADP], mitochondrial 
precursor, putative 48802 64 22 0 8 
  LmjF36.6940 
PDI-2, protein disulfide 
isomerase 52799 59 14 0 6 
  LmjF21.1555 
Hypothetical protein, 
conserved 46704 55 16 1 6 
  LmjF36.1940 
NT2, nucleoside transporter 
1, putative 54305 52 4 10 4 
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  LmjF28.2770 
Heat-shock protein hsp70, 
putative 71893 44 5 0 4 
  LmjF31.1640 Thiolase protein-like protein  47260 41 5 0 2 
  LmjF13.0280 Alpha tubulin 50526 37 11 0 5 
  LmjF19.1160 
Hypothetical protein, 
conserved 41275 35 2 0 1 
  LmjF23.1540 
Hypothetical protein, 
conserved 106312 33 6 0 6 
  LmjF28.2385 
DNA replication licensing 
factor, putative 97755 33 4 0 4 
  LmjF12.0400 
3'-nucleoside/nuclease, 
putative 41184 33 12 2 4 
  LmjF35.4130 
Poly(a) binding protein, 
putative 65536 31 2 0 2 
  LmjF35.1620 
Hypothetical protein, 
conserved 214361 30 1 0 5 
∆GT LmjF08.1230 Beta tubulin 50302 297 39 0 17 
  LmjF16.0550 
Orotidine-5-phosphate 
decarboxylase, orotate 
phosphoribosyltransferase, 
putative 49811 158 24 0 11 
  LmjF13.0280 Alpha tubulin 50526 130 27 0 10 
  LmjF32.3130 
Ribosomal protein 13, 
putative 47743 72 20 0 8 
  LmjF17.0080 Elongation factor 1-alpha 49485 69 14 0 5 
  LmjF28.0930 
Hypothetical protein, 
conserved 45661 53 13 1 6 
  LmjF30.2470 
Heat shock 70-related 
protein 1, mitochondrial 
precursor, putative 72346 46 10 0 6 
  LmjF10.0460 GP63-1,GP63, leishmolysin 65039 45 2 1 2 
  LmjF28.2420 
2-oxoglutarate 
dehydrogenase, E2 
component, 
dihydrolipoamide succinyl 
transferase, putative 41934 38 6 0 3 
  LmjF36.1940 
NT2, nucleoside transporter 
1, putative 54305 37 3 10 2 
  LmjF36.6940 
PDI-2, protein disulfide 
isomerase 52799 35 12 0 5 
  LmjF15.1230 
Nucleoside transporter 1, 
putative 72867 30 2 10 2 
        
Band 
10        
  
Accession 
Number Gene Annotation MWt 
Protein 
Score 
Sequence 
Coverage 
(%) 
Number 
of 
predicted 
TMD 
Queries 
Matched 
Wild type LmjF08.1230 Beta tubulin 50302 398 37 0 27 
  LmjF21.1860 Beta tubulin 50395 383 37 0 27 
  LmjF13.0280 Alpha tubulin 50526 338 41 0 16 
  LmjF08.1100 Hypothetical protein 42247 162 28 0 14 
  LmjF30.2970 
Glyceraldehyde 3-
phosphate dehydrogenase, 
glycosomal 39370 65 28 0 11 
  LmjF36.2380 
Sterol 24-c-
methyltransferase, putative 40484 61 3 0 1 
  LmjF17.0080 Elongation factor 1-alpha 49485 59 4 0 2 
  LmjF36.2590 
Membrane-bound acid 
phosphatase 2, putative 63722 46 3 2 2 
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  LmjF11.1050 
Pretranslocation protein, 
alpha subunit, putative 54275 42 8 9 5 
  LmjF25.1180 
ATPase beta subunit, 
putative 56513 42 17 0 8 
  LmjF27.1805 
Glycosomal 
phosphoenolpyruvate 
carboxykinase, putative 58670 35 3 0 2 
  LmjF23.1680 
Hypothetical protein, 
conserved 176704 34 2 0 4 
  LmjF34.0820 
eEF1B beta 1, elongation 
factor 1-beta 25630 34 21 0 4 
  LmjF21.0825 
Hypothetical protein, 
conserved 349096 34 1 0 6 
  LmjF10.0010 
Fatty acid desaturase, 
putative 45438 33 4 6 2 
  LmjF36.1940 
NT2, nucleoside transporter 
1, putative 54305 33 2 10 1 
  LmjF21.0780 
Hypothetical protein, 
conserved 86910 32 3 0 2 
  LmjF23.1540 
Hypothetical protein, 
conserved 106312 32 1 0 2 
  LmjF15.1010 Glutamate dehydrogenase 115588 32 0 0 1 
  LmjF33.3270 
Fatty acid desaturase, 
putative 45949 31 8 5 4 
  LmjF27.0420 Ribokinase, putative 35719 31 9 0 3 
  LmjF16.0550 
Orotidine-5-phosphate 
decarboxylase/orotate 
phosphoribosyltransferase, 
putative 49811 30 3 0 2 
  LmjF35.1620 
Hypothetical protein, 
conserved 214361 29 1 0 5 
∆GT LmjF08.1230 Beta tubulin 50302 243 29 0 16 
  LmjF30.2970 
Glyceraldehyde 3-
phosphate dehydrogenase, 
glycosomal 39370 220 32 0 1 
  LmjF13.0280 Alpha tubulin 50526 194 33 0 11 
  LmjF05.0500 ATPase alpha subunit 62794 137 17 0 8 
  LmjF29.1070 
Ribosomal protein L1a, 
putative 41109 126 20 0 7 
  LmjF08.1100 
Hypothetical protein, 
conserved 42247 64 11 0 5 
  LmjF13.1210 
Nucleobase/nucleoside 
transporter 8.1, putative 55252 63 1 11 1 
  LmjF36.1260 
ALD, fructose-1,6-
bisphosphate aldolase 41201 62 17 0 8 
  LmjF19.1160 
Hypothetical protein, 
conserved 41275 54 4 0 2 
  LmjF27.0930 
Isovaleryl-coA 
dehydrogenase, putative 44973 54 8 0 3 
  LmjF17.0080 Elongation factor 1-alpha 49485 49 8 0 4 
  LmjF36.1940 
NT2, nucleoside transporter 
1, putative 54305 48 3 10 2 
  LmjF12.0670 
Cytochrome C oxidase 
subunit IV 39581 48 15 0 6 
  LmjF06.0350 
NAD(p)-dependant steroid 
dehydrogenase-like protein 43231 43 3 1 2 
  LmjF14.0990 
ADP/ATP mitochondrial 
carrier-like protein 40715 34 6 0 3 
  LmjF36.2030 
Chaperonin 
Hsp60,mitochondrial 
precursor 59623 34 9 0 4 
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  LmjF30.2460 
Heat shock 70-related 
protein 1, mitochondrial 
precursor, putative 69532 33 5 0 4 
  LmjF21.1555 
Hypothetical protein, 
conserved 46704 33 4 1 2 
  LmjF23.1540 
Hypothetical protein, 
conserved 106312 31 2 0 5 
  LmjF31.0760 
Hypothetical protein, 
unknown function 33719 30 7 0 2 
  LmjF18.1380 
Pyruvate dehydrogenase E1 
component alpha subunit, 
putative 43359 29 8 0 3 
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3.3.7 IEF Fractionation 
 Solution-phase isoelectric focusing (IEF) was tested as a means to further 
fractionate membrane protein samples, to generate a less complex protein 
mixture for mass spectrometry analysis. The membrane protein extraction 
protocol alone generated a mixture of proteins that was too complex to resolve 
fully by SDS-PAGE. Direct MS analysis of such SDS-PAGE fraction led to the 
identification of large numbers of non-integral membrane proteins, particularly 
tubulins, hence limiting the identification of low abundant membrane proteins, 
IEF was exploited to decrease the unrelated membrane proteins in the samples. 
 Unlike the standard protocol where the whole lane will be cut into 30-35 
equal-sized bands, here we only chose bands that show an apparent discrepancy 
in their expression on the gel. After the salt-extraction, the protein samples 
were subjected to IEF fractionation using an AGILENT 3100 Off-Gel fractionator. 
In the machine, after the samples were prepared according to the manufacturer 
manual, each sample was loaded into 24 well in the AGILENT 3100’s tray with 
each well receiving the same volume of sample. The fractionation started as the 
current was applied (first dimension fractionation). At the end of the 
fractionation, samples were loaded onto a SDS gel for second dimension 
fractionation of the protein. 12 bands from each sample (Figure 3-12) were 
excised and subjected to trypsin digest and mass spectrometry analysis. The 
results from mass spectrometry are summarised in Table 3-3.  
 The samples fractionated on the SDS gel showed a better resolution 
compared to samples that were not fractionated by IEF (Figure 3-12). However, 
subsequent MS analysis showed only non-membrane related proteins and tubulins 
were found to be more abundant compared to the previous membrane proteomic 
result. Most of the proteins found are beta and alpha tubulins and hypothetical 
proteins with no TMD (transmembrane domain). Other proteins found were 
kinesin (only in ΔLmGT), heat shock protein (hsp70) and ATP synthase epsilon 
chain.  
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3.3.7.1 IEF Fractionation without DiGE labelling 
 
Figure 3-12: 1-SDS gel stained with Coomasie blue, loaded with membrane protein samples 
of WT (wild type) and ΔLmGT (glucose transporter null mutant) from salt extraction after IEF 
fractionation.  Lanes WT1-WT4 loaded with samples from tray number 1-4 respectively 
which fractionates WT samples. Lane ΔLmGT 1-ΔLmGT 4 loaded with samples from tray 
number 1-4  respectively which fractionates samples ΔLmGT. The blue coloured marks (W1-
W12) indicate bands excised from WT and purple coloured marks (Δ1-Δ12) indicate bands 
excised from ΔLmGT. These bands that are labelled with coloured marks were chosen to be 
excised and further analysed as their expression on the gel were different. Hence the 
protein levels between bands from 2 adjacent lanes could be different from each other. 
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3.3.7.2 Membrane proteomic comparison from IEF   
 fractionation 
Table 3-3: Membrane proteomic result from membrane fractions fractionated with isoelectric 
(IEF) focusing and 1-SDS gel. 
 
Band 1        
  
Accession 
Number 
Gene 
Annotation MWt 
Protein 
Score 
Sequence 
Coverage (%) 
Number of 
predicted 
TMD 
Queries 
Matched 
Wild Type LmjF10.1040  
Hypothetical 
protein, 
conserved 125995 44 1 0 2 
  LmjF31.2655 
Hypothetical 
protein, 
unknown 
function 60979 30 1 0 2 
∆LmGT No significant hits to report           
        
Band 2        
  
Accession 
Number 
Gene 
Annotation MWt 
Protein 
Score 
Sequence 
Coverage (%) 
Number of 
predicted 
TMD 
Queries 
Matched 
Wild Type LmjF08.1230 Beta tubulin 50302 32 11 n/a 5 
  LmjF03.0720 
Hypothetical 
protein, 
conserved 94247 31 1 0 1 
∆LmGT No significant hits to report           
        
Band 3        
  
Accession 
Number 
Gene 
Annotation MWt 
Protein 
Score 
Sequence 
Coverage (%) 
Number of 
predicted 
TMD 
Queries 
Matched 
Wild Type LmjF33.0792 Beta tubulin 50335 58 26 0 7 
∆LmGT LmjF08.1230 Beta tubulin 50302 86 11 0  5 
        
Band 4        
  
Accession 
Number 
Gene 
Annotation MWt 
Protein 
Score 
Sequence 
Coverage (%) 
Number of 
predicted 
TMD 
Queries 
Matched 
Wild Type No significant hits to report           
∆LmGT LmjF19.0580 
Hypothetical 
protein, 
conserved 295765 31 0 0 2 
        
Band 5        
  
Accession 
Number 
Gene 
Annotation MWt 
Protein 
Score 
Sequence 
Coverage (%) 
Number of 
predicted 
TMD 
Queries 
Matched 
Wild Type LmjF28.2770 
Heat shock 
protein 
hsp70, 
putative 71893 32 5 0 4 
∆LmGT LmjF28.2770 
Heat shock 
protein, hsp 
70, putative 71893 83 23 0 14 
        
Band 6        
  
Accession 
Number 
Gene 
Annotation MWt 
Protein 
Score 
Sequence 
Coverage (%) 
Number of 
predicted 
TMD 
Queries 
Matched 
Wild Type LmjF08.1230 Beta tubulin 50302 275 34 0 19 
  LmjF21.1860 Beta tubulin 50395 257 34 0 19 
  LmjF03.0280 
Hypothetical 
protein 103798 30 3 0 2 
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∆LmGT LmjF08.1230 Beta tubulin 50302 532 48 0 29 
  LmjF21.1860 Beta tubulin 50395 507 48 0 29 
        
Band 7        
  
Accession 
Number 
Gene 
Annotation MWt 
Protein 
Score 
Sequence 
Coverage (%) 
Number of 
predicted 
TMD 
Queries 
Matched 
Wild Type LmjF08.1230 Beta tubulin 50302 80 17 0 7 
  LmjF29.0380 
Hypothetical 
protein, 
conserved 104683 36 2 0 2 
∆LmGT LmjF28.2770 
Heat shock 
protein, hsp 
70, putative 71893 85 21 0 11 
  LmjF08.1230 Beta tubulin 50302 69 11 0 4 
  LmjF23.1280 
Hypothetical 
protein, 
conserved 125443 33 0 0 1 
  LmjF19.0680 
Kinesin, 
putative 119533 32 2 0 3 
        
Band 8        
  
Accession 
Number 
Gene 
Annotation MWt 
Protein 
Score 
Sequence 
Coverage (%) 
Number of 
predicted 
TMD 
Queries 
Matched 
Wild Type LmjF33.0792 Beta tubulin 50335 569 63 0 35 
  LmjF21.1860 Beta tubulin 50395 489 57 0 34 
  LmjF13.0280 
Alpha 
tubulin 50526 34 24 0 8 
∆LmGT LmjF33.0792 Beta tubulin 50335 535 62 0 32 
  LmjF13.0280 
Alpha 
tubulin 50526 155 30 0 13 
        
Band 9        
  
Accession 
Number 
Gene 
Annotation MWt 
Protein 
Score 
Sequence 
Coverage (%) 
Number of 
predicted 
TMD 
Queries 
Matched 
Wild Type LmjF13.0280 
Alpha 
tubulin 50526 337 62 0 27 
  LmjF33.0792 Beta tubulin 50335 267 47 0 19 
  LmjF21.1860 Beta tubulin 50395 216 41 0 18 
∆LmGT LmjF33.0792 Beta tubulin 50335 408 57 0 25 
  LmjF13.0280 
Alpha 
tubulin 50526 274 69 0 25 
  LmjF06.0810 
Hypothetical 
protein, 
unknown 
function 348424 33 0 0 1 
        
        
Band 10        
  
Accession 
Number 
Gene 
Annotation MWt 
Protein 
Score 
Sequence 
Coverage (%) 
Number of 
predicted 
TMD 
Queries 
Matched 
Wild Type LmjF13.0280 
Alpha 
tubulin 50526 201 36 0 17 
  LmjF08.1230 Beta tubulin 50302 124 17 0 9 
  LmjF30.3600 
ATP 
Synthase, 
episilon 
chain, 
putative 20429 33 6 0 1 
∆LmGT LmjF13.0280 
Alpha 
tubulin 50526 162 39 0 18 
  LmjF33.0792 Beta tubulin 50335 148 27 0 13 
   LmjF34.3690 
Hypothetical 
protein, 
conserved 143897 33 4 0 4 
  LmjF30.3600 
ATP 
synthase, 
epsilon 20429 32 6 0 1 
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chain, 
putative 
  LmjF31.1470 
Hypothetical 
protein, 
unknown 
function 110948 30 1 0 1 
  LmjF13.0520 
Hypothetical 
protein, 
unknown 
function 31830 30 5 0 2 
  LmjF23.1280 
Hypothetical 
protein, 
conserved 125443 30 0 0 1 
        
Band 11        
  
Accession 
Number 
Gene 
Annotation MWt 
Protein 
Score 
Sequence 
Coverage (%) 
Number of 
predicted 
TMD 
Queries 
Matched 
Wild Type LmjF08.1230 Beta tubulin 50302 262 25 0 12 
  LmjF21.1860 Beta tubulin 50395 232 25 0 12 
∆LmGT LmjF33.0792 Beta tubulin 50335 187 32 0 12 
        
Band 12        
  
Accession 
Number 
Gene 
Annotation MWt 
Protein 
Score 
Sequence 
Coverage (%) 
Number of 
predicted 
TMD 
Queries 
Matched 
Wild Type LmjF08.1230 Beta tubulin 50302 107 16 0 8 
  LmjF13.0280 
Alpha 
tubulin 50526 63 21 0 8 
∆LmGT LmjF08.1230 Beta tubulin 50302 137 13 0 8 
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3.3.7.3 DiGE 
 We incorporated a DiGE protocol in an attempt to quantitate the 
proteome of the membrane (For method, refer to ‘3.2.9 Labelling and 
separation of membrane proteins’). First, membrane preparation samples from 
the wild type and glucose transporter null mutant were tagged with Cy3 and Cy5 
respectively and mixed prior to the IEF fractionation according to the 
manufacturer instruction. Subsequently, the mixture was subjected to 
isoelectric focusing fractionation (AGILENT 3100) according to the 
manufacturer’s protocol in the manual. Following the IEF fractionation, all 
samples in all wells were loaded onto 1-SDS for a second dimension 
fractionation. These gels (Figure 3-13), were then visualised immediately using 
‘Image Quant 5.2’, and stained with Coomassie blue. We decided, based on what 
we have seen under the ‘Image Quant 5.2’, to choose lane number 6 to cut into 
30 equal-sized bands for the further mass spectrometry analysis. The fluorescent 
image was meant to help tp detect the level of proteins different between WT 
and ΔLmGT. 
 Due to time constraint, the bands were not analysed further in mass 
spectrometry.  
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Figure 3-13: Membrane preparation samples from salt-extraction in SDS gel after IEF and 
SDS page fractionation. The membrane extraction in the IEF compatible solution were 
labelled with Cydyes (Cy5 (WT) and Cy3 (ΔLmGT)) and both samples were mixed together 
prior to fractionation by IEF 24-well tray in AGILENT 3100. After the IEF fractionation was 
completed, each individual well containing the sample was fractionated again in 1-SDS gel. 
The gels were viewed under ‘Typhoon 9400 Variable Mode Imager’ software as soon as the 
electrophoresis wascompleted. Numbers on top of each gel indicate the number of the well 
in tray that each of samples came from after the fractionation. Three gels were needed as 24 
samples were retrieved in the Agilent 3100. The imager uses 2 filters with different UV 
wavelengths i.e. filter with 532nm UV’s wavelength fluoresces green colour on null mutant 
and filter with 633nm UV’s wavelength fluoresces red colour on the wild type.  The red 
colour on the gel indicates the upregulation of the protein in the wild type and green colour 
indicates the upregulation of the protein in  null mutant. The yellow colour indicates the 
proteins that have similar amounts in both cells. Due to time constraint, the bands were not 
analysed further in mass spectrometry. 
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Figure 3-14: The same gel 1 (loaded with membrane protein) from Figure 3-13.Unfortunately, 
the differences in the bands expression couldn’t be detected. This could be due to cell loss 
or protein loss during the experiment. This method should be improvised first before any 
conclusion can be made regarding its performance and efficiency in membrane protein 
analysis. However, due to time constraints, the bands were not analysed further in mass 
spectrometry. 
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3.4 Discussion  
 In this chapter, the goal is to analyse the efficiency of the enrichment, 
fractionation and identification protocol for integral membrane proteins of 
Leishmania mexicana. The efficiency of the techniques used is reflected in how 
many integral membrane proteins were identified after the MS analysis.  
 The plasma membrane is a phospholipid bilayer with fatty acids facing 
inwards and hydrophilic polar heads located on the cell’s external and the 
cytosolic environment. Within the bilayer are a number of significantly 
hydrophobic proteins with different properties and functions. These proteins 
include  (Cordwell & Thingholm 2010): 
1)  Integral membrane proteins, spanning the bilayer structure with 1 or more 
hydrophobic transmembrane domains (TMD),   
2)  Integral membrane proteins (IMPs), that are clustered to form a channel or 
pore to transport nutrients and/or for the elimination of toxic substances 
3)  Integral membrane proteins that are embedded in the inner or outer surface 
of the bilayer but do not span the entire bilayer structure. 
4)  Proteins that are located peripherally to the lipid bilyayer, and are indirectly 
associated with the bilayer through protein:protein interaction, as opposed to 
protein:lipid interaction.  
 As the protein mixtures recovered by subcellular fractionation can 
represent, at best, enriched populations of these proteins, MS analysis of these 
fractions will not only result in the identification of proteins that are associated 
with the membrane under physiological conditions, but also of proteins that 
have become artifactually associated with membrane fractions during 
subcellular fractionation. The later proteins are contaminants, but it is not 
possible to distinguish them from bona fide peripheral membrane proteins, 
without the application of targeted approaches such as subcellular localisation 
by immunofluorescene analysis.  
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 Transmembrane spanning integral membrane proteins (class 1 and 2 
above) are characterised by the possession of multiple hydrophobic 
transmembrane domains, which can be revealed bioinformatically by hydropathy 
analysis (http://tritrypdb.org/tritrypdb/). This approach can be used to predict 
proteins that have a likely integral membrane localisation.  
 To monitor the efficiency of the extraction protocols, a myc-tagged 
glucose transporter (myc-GT2) was chosen to be the marker for plasma 
membrane recovery. The observation that the myc-tagged glucose transporter 
was able to mediate robust glucose uptake confirms that the tagged protein is 
expressed in a functional conformation in the plasma membrane. 
 Two techniques of membrane fractionation were applied i.e. salt-
extraction and Triton X-114.  The salt extraction protocol was used by Piper et al 
(Piper et al. 1995)  to determine the subcellular location of Pro-1 and Pro-2 
glucose transporters in Leishmania enrietti. They used epitope tagging to 
differentiate and identify the location of the 2 individual glucose transporter 
isoforms. In the current experiment, an epitope tag named myc was used to 
monitor the membrane fractionation recovery by screening myc expression in 
western blot. The salt extraction protocol exploits alkaline sodium carbonate to 
disrupt the electrostatic interactions between proteins, liberating hydrophilic 
proteins that are tethered to the membrane by protein:protein interactions, but 
retaining proteins that are associated with the membrane by solubility in the 
lipid bilayer. By removing the membrane associated proteins, it was hoped to 
reduce interference from peripheral (non-integral) membrane proteins(Speers & 
Wu 2007). 
 Figure 3-6, Figure 3-7 and Figure 3-8 show the western blot screening for 
myc expression in all 3 fractions i.e. the whole cell lysate, supernatant and 
membrane extraction that came from wild type, glucose transporter null mutant 
and myc-tagged glucose transporter cells lines. All 3 fractions were collected 
from the same sample preparation i.e. the whole cell lysate, supernatant and 
membrane extractions were prepared from the same preparation. Figure 3-6, is 
a western blot of a whole cell lysates from wild type, glucose transporter null 
mutant and myc-tagged glucose transporter cell lines using myc antibody and 
anti-mouse secondary antibody. The western blot (Figure 3-6) shows a band  
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expressed in a lane containing the myc-tagged glucose transporter cell line. As 
expected, no expression was seen in the supernatant fraction (Figure 3-7) from 
all three cell lines tested. In western blot loaded with membrane extraction 
(Figure 3-8), a strong expression was seen in the lane loaded with lower cell 
amounts of myc-tagged- glucose transporter compared to the lane that was 
loaded with same cell amount but with higher cell counts. This could be 
explained by the fact that with more cells loaded in a lane, the faster the 
substrate was consumed by the peroxidase.  
However, the molecular weights of the bands expressed in the myc-
tagged glucose transporter lanes from whole cell lysate (Figure 3-6) and 
membrane preparation (Figure 3-8) are different. The bands may represent the 
same molecule e.g. myc-tagged glucose transporter, but due to stringent 
extraction technique, the molecule may have undergone some changes i.e. 
phosphorylation.  Nevertheless, this can only be confirmed if the gels were 
originally where the blots were pressed against, are analysed further by cutting 
the gel area where the the bands were located and sent for mass spectrometry 
analysis.   
 Triton X-114 is reported to preferentially solubilise hydrophobic integral 
membrane proteins (Bordier 1981;Maclay 1956;Tanford & Reynolds 1976). 
Expression of the myc-tagged glucose transporter was screened in aqueous and 
detergent phase fractions from Triton X-114 extracted Leishmania. As in integral 
membrane protein is highly hydrophobic the myc –tagged glucose transporter is 
expected to be found only in the detergent phase. Anti-myc antisera reacted 
only with material in the lane loaded with myc-tagged-glucose transporter, but 
no clear band was visible. One possible explanation for this could be the 
formation of mixed micelles of SDS and Triton in the gel, resulting in poor 
separation in SDS-PAGE (Piper et al. 1995). It was noticeable that 
electrophoresis proceeded much more slowly than normal with these samples, 
suggesting that the presence of Triton X-114 may interfere with SDS-PAGE. Bands 
of the same molecular weight were also revealed in aqueous phase, suggesting 
that Triton X-114 extraction is of limited efficiency for the isolation of integral 
membrane proteins such LmGT2.  
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Although both extraction techniques showed some potential for the 
enrichment of integral membrane proteins, salt-extraction of membrane-
enriched subcellular fractions appeared to be more reliable than detergent 
extraction. However further investigation need to be done to explain on 
expression of bands on the myc-tagged glucose transporter lane from both whole 
cell lysate and membrane fraction which have different molecular weightsb. 
Furthermore, the interference produced by the presence of Triton in detergent 
extracted samples hampered subsequent gel-based separation. In this light, only 
salt-extracted membrane fractions were subjected to membrane proteomic 
analysis.  
Proteomic Analysis: This study was focused on the identification of membrane 
proteins from Leishmania. Membrane proteins are of relatively low abundance 
and are detected rather infrequently in whole organism proteomic studies. 
Nevertheless, to establish a baseline for the detection of membrane proteins by 
proteomic approaches, a preliminary proteomic analysis was performed on 
unfractionated Leishmania lysates. Several integral membrane proteins were 
identified in this whole cell proteome. Some IMPs were exclusively identified in 
wild type and some were exclusively found in the null mutant. The only protein 
found in both whole cell proteome  was glucose regulated protein 78 
(LmjF28.1200). In David Henderson’s (Henderson, D., MRes Project, University of 
Glasgow 2007)proteomic analysis, paraflagellar rod protein 2C (LmjF16.1425) 
was found to be upregulated in glucose transporter null mutant Leishmania. This 
protein was found in both cell lines but, as it was not a quantitative proteomic 
analysis, the results can only reveal the presence of the proteins and it is not 
possible with the current data to make any inference as to the relative 
abundance of the paraflagellar rod protein, nor any other proteins.Three 
techniques were used to facilitate membrane proteomic analysis: 
1) Samples where directly sent from SDS gel to trypsin digestion prior to MS 
analysis 
2) Samples were separated by IEF separation prior to SDS-PAGE, followed by 
trypsin digestion 
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3) Samples where Cy-Dye labelled, fractionated by IEF followed by SDS- page 
prior to MS analysis.  
 Due to constraints on mass spectrometry access, only samples generated 
from protocols 1 and 2 were analysed by MS. The results from protocol 3 are 
nevertheless of interest because they represent an innovative approach to 
relative quantitation of membrane subproteomes.  
 Separation of enriched membrane proteins by SDS-PAGE, followed by 
tryptic digest of apparent molecular weight fractions, led to the identification of 
a greater number of putative IMPs than were observed in a similar analysis of 
whole cell lysate. This suggests that the subcellular fractionation and salt-
extraction method does enrich membrane proteins from the Leishmania 
mexicana promastigotes.  
 Fujiki et al (Fujiki et al. 1982) used 100mM Na2 CO3 treatment for 
isolation of intracellular membranes and obtained membranes  that, by several 
criteria, were intact and relatively pure : 
1) They preserved integral membrane proteins (cytochrome b5 , cytochrome 
P-450, ribophorins I and II) 
2) They maintained the active of several integral membrane enzymes 
(NADPH-cytochrome c reductase and NADH-ferricyanide reductase).  
 In the current experiment, membrane enrichment followed by  salt 
extraction did lead to the identification of quite a number of IMPs (Sauvage et 
al. 2009).  
 However, the complexity of the sub-proteomic fractions that were 
analysed was still very significant and the stained gel lanes revealed many 
hundred protein bands that were poorly resolved in this 1 dimensional 
separation. It was not possible to see any clear differences in banding pattern 
between wild type and glucose transporter null mutant lines.  
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 Although it is tempting to suggest that nucleobase and nucleoside 
transporter might be upregulated in glucose transporter null Leishmania, 
perhaps reflecting a change in nutrient acquisition, these proteomic data are not 
quantitative and comparisons of protein identifications from these two parallel 
analyses are not justified. 
 To address the issue of relative quantitation, we wished to enhance the 
resolution of our proteomic separation by adding a second dimension. We chose 
to employ solution-phase isoelectric focusing, as an alternative to gel-based IEF 
that might be better suited to separation of hydrophobic membrane proteins. 
The second membrane proteomic analysis protocol thus employed in-solution IEF 
fractionation prior to SDS-PAGE. This approach gave rise to a number of fractions 
that, when resolved on SDS-PAGE as a second dimension separation, did indeed 
appear to be less complex than samples separated by SDS-PAGE in a single 
dimension. Furthermore, a number of significant differences were visible 
between adjacent, comparable lanes loaded with samples from wild type and 
glucose transporter null mutant fractions. Several of these gel regions were 
excised for analysis, but most of the identified proteins were tubulins. Tubulins 
are amongst the most abundant proteins in Leishmania, and are indeed 
associated with membrane as they are the major constituent of the 
cytoskeleton, which lies beneath, and in intimate contact with, the plasma 
membrane. The presence of tubulin would likely hamper the identification of 
low abundance IMPs, and no IMPs were identified by this approach. It is not clear 
why tubulin was present in all of the samples analysed, but one possibility is that 
tubulins did not separate well by solution-phase IEF and were thus present in 
every sample that was loaded on SDS-PAGE. Alternatively, it is possible that the 
salt extraction procedure was inefficient during the fractionation of these 
particular samples, giving rise to fractions that were unusually heavily 
contaminated with tubulin. 
 Some significant differences were expected to be detected between 
adjacent lanes which compared lanes loaded with samples from wild type and 
glucose transporter null mutant fractions (Figure 3-12). However none significant 
differences were seen. Samples were prepared by the same same salt-extrcation 
protocol but samples extracted were labelled with spectrally resolvable CyDyes 
prior to 2 dimensional separation by solution-phase IEF followed by SDS-PAGE. 
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The Cy Dyes used are mass and charge matched, so that identical proteins in 
each sample will migrate together but are independently detectable by 
fluorescent scanning at specific wavelengths. This protocol represents a novel 
adaptation of the Difference Gel Electrophoresis (DiGE) protocol, for which 
these CyDye tags were developed. Labelled samples were mixed and separated 
by IEF and SDS-PAGE and the resulting gel was scanned at 2 discrete 
wavelengths, to generate images that could be overlaid. This approach revealed 
several protein bands that showed differential expression between wild type and 
glucose transporter-null mutant samples. The enhanced resolution of the 2 
dimensional separation should enable excision and MS analysis of discrete 
protein bands, but it was not possible to complete this during the present 
project. 
Isolation, separation, identification and quantitation of integral membrane 
proteins are all challenges in proteomics. The data presented in Chapter 2 
clearly demonstrate functional differences between wild type and glucose 
transporter null mutant Leishmania. These differences, such as changes in amino 
acid transport activity, would likely be apparent at the proteomic level, if 
appropriate tools were available to look. Furthermore, there may be other 
changes in membrane protein expression that are not revealed by targeted 
analyses of the type reported in Chapter 2, and that could only be revealed by 
comparative membrane proteomic analysis. These results presented here 
underscore the challenges involved, but some progress has been made with each 
of these steps and the data may contribute to future efforts to investigate 
changes in membrane protein expression by proteomic approaches. 
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3.5 Conclusion 
 Despite the challenges to the study of integral membrane proteins, the 
results reported in this chapter show that, by improving the enrichment and 
fractionation strategy, comparison of membrane protein expression between 
wild type and glucose transporter null mutant is possible. Although there are 
many issues that still need to be addressed, by integrating methods that have 
high sensitivity for detecting low abundance and highly hydrophobic proteins, 
progress has been made towards comparative membrane proteomic analysis. 
  
 
 
 
 
 
 
 
 
 
 
 
 
Dhilia U Lamasudin                                                                                                       Chapter 4, 149 
 
Chapter 4 
 Phenotypic Changes in Glucose Transporter null 
Leishmania mexicana 
4.1 Introduction 
 Leishmania mexicana have three genes that encode putative glucose 
transporters. These genes, named LmGT1, LmGT2 and LmGT3 are present at the 
same genomic locus and are very similar to each other, and to functionally 
characterised glucose transporters in other trypanosomatid species. In previous 
studies, both heterologous and homologous expression has confirmed that the 
LmGT genes encode bona fide glucose transporters. The individual isoforms 
display unique expression patterns, substrate specificity and kinetic properties 
(Burchmore et al. 2003;Burchmore & Landfear 1998). Genetic ablation of the 
complete LmGT locus gives rise to mutant parasites that grow well when 
cultured in vitro in a complex media but which are unable to transport glucose. 
Several studies have shown that glucose transporter null mutant (∆LmGT) 
Leishmania promastigotes have phenotypic differences compared to the wild 
type (WT) promastigotes. Some of the changes reported are that they are 
smaller in volume, unable to replicate as amastigotes thus explaining the non-
viability of this mutant inside macrophage (Burchmore et al. 2003;Rodriguez-
Contreras et al. 2007).  
 Significant phenotypic changes are to be expected in cells that can no 
longer utilise exogenous glucose as an energy source, and we set out to 
undertake a comparative proteomic characterisation of WT and ∆LmGT, to 
reveal some of the molecular changes behind observed phenotypic changes and 
to highlight changes that might give rise to more subtle phenotypic 
consequences. At the outset of this project, a comparative 2D gel-based analysis 
was performed by David Henderson, as part of a Masters project (Henderson, D., 
MRes Project, University of Glasgow 2007). This study highlighted several 
proteomic changes that I have investigated, using a variety of approaches, 
during my PhD studies. From David Henderson’s study, he found that there are 
distinct changes in the proteome of Leishmania mexicana due to abnormality of 
genes in charge for the transport of glucose from the external medium. The 
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removal of genes LmGT1, LmGT2 and LmGT3 causing the differential regulation 
of proteins involved in glucose metabolism and carbohydrate formation, 
oxidative stress and cellular structure.  He demonstrated that there as down-
regulation of enzymes that were involved in carbohydrate metabolism i.e. 
mannose-1-phosphate guanylyltransferase and myo-inositol-1-phosphate 
synthase in the null mutant, down-regulation of tryparedoxin peroxidase in the 
null mutant which in return increased sensitivity of the null mutant toward 
oxidative stress and up-regulation of paraflagellar rod protein 2C (protein PFR 
2C) in null mutant which is one of the structural in flagellar formation.  
 Thus, following observations from David Henderson’s Masters Project in 
2007, I was interested in investigating further on proteins such as tryparedoxin 
peroxidase (TP) and paraflagellar rod protein 2C (PFR).  In this chapter we will 
investigate these differences by several methods.  
 
4.1.1 Flagellar Structure in Leishmania mexicana promastigotes 
One of the distinguishing organelles possessed by all of the 
trypanosomatid protozoa is the flagellum. The motility and sensory abilities are 
among the functions currently recognised for trypanosomatid’s flagella. The 
surface membrane of Leishmania species and other kinetoplastid protozoa can 
be divided into 3 morphologically divergent subdomains i.e. the flagellar 
membrane, the flagellar pocket and the pellicular plasma membrane (Balber 
1990) where each domain is known to embody a highly specialised membrane 
with characteristic functions with unique protein and, possibly, lipid 
composition(Landfear & Ignatushchenko 2001). It has been reported that the 
flagellum has increased sterol content and reduced integral protein content 
(Vickerman & Tetley 1990). One possible reason for increased sterol content in 
the flagellar membrane might be that it makes the flagellar membrane more 
rigid, therefore lowering the risks of distortion during movement. The reduced 
integral membrane protein might be possible because of the elimination of 
transport sites for molecules which are not essential for flagellar activity but 
only vital for bodily function (Vickerman & Tetley 1990).  
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The flagellum of Leishmania and of related organisms contains a structure 
called the paraflagellar rod (PFR; also known as paraxial rod). The PFR is a 
massive network of woven cytoskeletal filaments which resides along the 
axoneme in the flagella. The function of the axoneme is believed to control the 
beating in all eukaryotic flagella(Portman & Gull 2010). Two PFR structure is a 
unique feature that can be found in all kinetoplastids studied to date, with the 
exception of the amastigote, where the condensed flagellum does not arise from 
the flagellar pocket (Portman & Gull 2010). The PFR comprises 2 major subunits, 
PFR1 and PFR2, depending on the organism. PFR1 and PFR2 are relatively large 
proteins (mobility (Mr) can range from 70,000 to 80,000 for PFR1 and from 68,000 
to 72,000 for PFR2). PFR1 and PFR2 genes are highly conserved inT.brucei, 
T.cruzi and Leishmania species, with over 80% amino acid identity (Maga & 
LeBowitz 1999) . PFR 1 and PFR2 assemble into a complex structure, and null 
mutants in L. mexicana of either one of the subunits or both of the subunits 
assemble abnormal PFR structures (Maga & LeBowitz 1999). It has been reported 
that protozoans lacking native PFR structure demonstrate a distinct  reduction in 
cell motility Santrich et al. 1997, Maga & LeBowitz 1999). It also has been shown 
that Leishmania mexicana PFR null mutants swim 4-5 times slower than the wild 
type in aqueous media (Maga et al. 1999;Santrich et al. 1997). In the experiment 
conducted by Santrich et al, they described and characterised L.mexicana as 
lacking the PFR-2 genes which was constructed by targeted gene replacement 
(Santrich et al. 1997). In their report, it reveals that PFR-2 null mutants have a 
residual inner substructure of PFR which contains PFR-1 protein. These null 
mutants however exhibit significant changes in the flagellar beat waveform and 
forward swimming velocity and reduced the internal elastic bending resistance. 
These results signify an important role of PFR and flagellum for Leishmania’s 
motility (Santrich et al. 1997).  
 No experiment has been done to look at specific changes in the expression 
of adjacent genes to GT locus. However, the proteins that were found to be 
differentially expressed by Feng (Feng et al. 2011) and David Henderson (Master 
Project) were not adjacent to LmGT locus. The microarray experiment in Feng 
(Feng et al. 2011) did not reveal modulation of adjacent genes. In fact, there 
was no significant change in any other genes on the relevant chromosome. Also, 
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through our observation, the phenotype doesn’t seem to change whether or not 
antibiotic selection is maintained. 
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Figure 4-1: The images have been removed due to copyright restrictions. 
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4.1.2 Oxidative stress response in Leishmania mexicana 
 Tryparedoxin peroxidase is one component of the thioredoxin system, 
which is important for guarding the cells against oxidative challenge by reducing 
harmful peroxides such as H2O2. The down-regulation of this protein in ∆LmGT, 
suggested by observations in a previous comparative proteomic analysis 
(Henderson, D., MRes Project, University of Glasgow 2007), provides a possible 
explanation for increased susceptibility to oxidative stress.  
As digenetic organisms, response to oxidative stress is an important factor 
in the survival of trypanosomatids such as Leishmania spp. Upon entry to the 
mammalian host, the protozoan encounters a great amount of reactive oxygen 
intermediates (ROI) and reactive nitrogen intermediates (RNI), which are 
produced by the host as a means to form a hostile living condition for intruding 
pathogenic microorganisms, hence facilitating their elimination from the host 
(Iyer et al. 2008). All living cells generate the intermediates of the partial 
reduction of oxygen, O2 i.e. O2-. and hydrogen peroxide (H2O2) through side 
reactions of physiological electron transfer which is run by multienzyme redox 
systems (Chance et al. 1979). A cascade of enzymes in trypanosomatids that are 
involved in the defence mechanisms of toxic ROI and RNI generated by the host 
or vector has attracted the attention of researchers in finding a drug target in 
combating the disease.   Trypanosomatids lack the enzymes catalase and 
selenium-dependent glutathione peroxidase which exist in higher eukaryotes. 
The enzymes that are involved in combating toxic peroxides in these protozoa 
are trypanothione reductase, tryparedoxin and tryparedoxin peroxidase and the 
mediator that supplies reducing equivalents is called trypanothione (N1,N8-
bis(glutathionyl)-spermidine) (Fairlamb & Cerami 1992;Iyer et al. 2008;Jaeger & 
Flohe 2006;Nogoceke et al. 1997). It also has been reported that overexpression 
of tryparedoxin peroxidase is linked to the resistance to arsenite (Lin et al. 
2005) and antimony (Wyllie et al. 2008).  
Daneshvar et al have demonstrated that a Leishmania infantum attenuated 
by selection with the aminoglycoside antibiotic gentamicin ( H-Line) was unable 
to survive within bone-marrow-derived macrophages of BALB/c mice while 
unselected L.infantum wild type survived and multiplied in the macrophages 
(Daneshvar et al. 2010).  Proteomic studies indicated that several proteins 
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involved in thiol redox control were differentially regulated in L.infantum H-line 
(Daneshvar et al, 2011). Redox control is important for Leishmania as they are 
exposed to an oxidative burst when they encounter their host cell’s macrophages 
(Goyal et al. 1996;Miller et al. 2000;Pearson et al. 1982;Wilson et al. 1994). The 
H-Line L.infantum has a different pattern in the expression of tryparedoxin 
peroxidise, peroxidoxin and tryparedoxin (Daneshvar et al. 2011). These 
enzymes are the main machinery of trypanothione-mediated hydroperoxide 
metabolism in Leishmania(Castro et al. 2008). 
 
Figure 4-2: Cascade of Trypanothione  peroxidase. (Picture by Dr Richard Burchmore, 
University of Glasgow) 
 
In the light of the published observation that ΔLmGT promastigotes show 
increased sensitivity to oxidative stress (Rodriguez-Contreras et al. 2007), we 
have further explored the expression of tryparedoxin peroxidase in ΔLmGT.   
 
4.1.3 Taxis Response in Leishmania mexicana 
 Leishmania promatigotes are highly motile organisms. Movement is 
facilitated by the flagellum, located at the anterior end of the protozoan. During 
development of promastigotes in the sand fly vector stage, transformation to the 
infectious metacyclic stage is accompanied by migration from the multiplication 
site in the midgut to the pharynx and proboscis (mouth area) of the sand fly 
vector, ready to be transmitted to the mammalian host vector (Bray 1983;Leslie 
et al. 2002). Motility may be important for this migration, which may also 
involve environmental sensing to enable chemotaxis. Motility may also be 
important in the initial stages of mammalian infection. A study by Bray (Bray 
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1983), found that promastigotes of Leishmania gradually move towards a 
concentration gradient of various sugars. Sugars have been postulated to play an 
important function as chemotaxins that attract the protozoan to move from the 
midgut to the oesophagus of the sand fly before being transmitted to the 
mammalian host as an infectious metacyclic form.  
 Oliveira et al (Oliveira et al. 2000) have tested the movement of 
promastigotes of Leishmania chagasi and Leishmania amazonensis towards 
concentrations of a variety of sugars i.e glucose, fructose, sucrose, raffinose, 
mannose, galactose, maltose, melibiose. The results produced the proof of sugar 
chemotaxis (Leslie et al. 2002;Oliveira et al. 2000).  
 Leslie et al performed a similar assay to that conducted by Oliveira et al. 
In this experiment, the assay measured the accumulation of promastigote cells 
that move from a buffered cell suspension into the open end of a capillary tube 
that contained a solidified agarose gel containing a putative chemoattractant, 
over a period of 1 hour. A concentration gradient was generated within and 
diffused from the open end of the capillary tube (Leslie et al. 2002;Oliveira et 
al. 2000). In the experiment, the promastigote’s movement has been tested in 
two conditions i.e. in the presence and absence of solute gradients. It has been 
demonstrated that promastigotes were not passively carried up concentration 
gradients but moved actively up an osmotic gradient (Leslie et al. 2002). 
 When sand flies feed on plant material (usually sap or aphid nectar), 
ingested material is diverted to a blind-ending sugar crop, where water is 
extracted before sugars are released to enter the midgut for digestion and 
absorption. This anatomical feature may lead to the establishment of a sugar 
concentration gradient between oesophagus and midgut. Hence osmotaxis or 
chemotaxis may explain how promastigotes move from the midgut to the 
mouthparts. Additionally, or alternatively, osmotaxis may represent an 
adaptation for promastigotes to avoid osmotic stress (Leslie et al. 2002). 
 Leishmania mexicana has 3 isoforms of glucose transporters encoded by 
LmGT glucose transporter gene superfamily namely glucose transporter 1 
(LmGT1), glucose transporter 2 (LmGT2) and glucose transporter 3 (LmGT3) 
(Burchmore & Landfear 1998). Subcellular localisation of all three isoforms has 
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been investigated by Burchmore et al (Burchmore et al. 2003) and it has been 
demonstrated that LmGT2 and LmGT3 are localised to the cell body whereas 
LmGT1 was localised specifically to the flagellum structure. However, a 
functional characterisation study revealed that LmGT1 has lower affinity for 
glucose compared to LmGT2 and LmGT3, hence cells transfected with plasmid 
containing only LmGT1, transport less glucose compared to the other 2 isoforms.  
Axoneme -based structures, such as flagella, are known to be involved in 
environmental sensing (Landfear & Ignatushchenko 2001) , and there are several 
examples of glucose transporter proteins that function as glucose sensors (Ozcan 
et al. 1996;Ozcan et al. 1998)I wished to test the hypothesis that a glucose 
transporter, localised to the anteriorly-oriented flagellum, might sense sugars 
and mediate chemotaxis (Burchmore et al. 2003). 
 In this project, to further characterise the LmGT1 in Leishmania 
mexicana, a taxis assay was performed to look at the response of towards 
glucose LmGT1 transfected Leishmania compared with a glucose transporter null 
mutant (ΔLmGT). The method used was based on the modification of methods 
from Oliveira et al (Oliveira et al. 2000) and Leslie et al (Leslie et al. 2002). 
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Figure 4-3: Sand fly feeds on bloodmeal and plant sugar (sugar meals) alternately. When the 
sand fly feeds on plant, the sugar meal will be moved to the sugar crop and stored here and 
become concentrated by removing excess water and release slowly into the midgut under 
the control of stamodial valve (purple-lined box) (Tang & Ward 1998). Whereas when the 
sand fly takes a bloodmeal, it will be transfered directly into the midgut (Killick-Kendrick 
1978;Killick-Kendrick 1999;Schlein 1986). Killick-Kendrick suggested that a sugar gradient 
exists in the alimentary tract of the sand fly thus stimulating the migration of promastigotes 
during development (Killick-Kendrick 1978). (Picture by Dr Richard Burchmore, University of 
Glasgow). 
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4.2  Materials and Methods 
4.2.1  Materials 
Homem (Invitrogen), PBS (Sigma), Sodium β-glycerophosphate (Fluka analytical), 
NaCl , KCl, MgCl2 (Fischer Scientific), BSA (Sigma) and agarose (Invitrogen), 
glutaraldehyde solution (Sigma), osmium tetroxide solution (Sigma) , cacodylate 
(Sigma), ethanol(Fischer), propylene oxide (icis), borax buffer (Fishcer), uranyl 
acetate (Sigma), sucrose (Sigma), toluidine blue (Sigma), Chicken polyclonal 
antirat IgG peroxidase conjugate(Abcam), Goat Anti-Mouse IgG peroxidase 
conjugate (Calbiochem), Goat Anti-Rabbit IgG Peroxidase Conjugate (Merck), FBS 
Gold(PAA), G418 sulfate (Calbiochem), Prestained protein marker (New England 
Biolabs), peroxidase SuperSignal® substrate (Novagen), Tryparedoxin peroxidase 
antisera( A gift from Dr Susan Wyllie, University of Dundee), L8C4 and L13D6 
antibodies (Both were gifts from Professor Keith Gull, University of Oxford) . 
 
4.2.2  Western blot for PFR1&2, PFR2 and Tryparedoxin 
 peroxidase 
Wild type and glucose transporter null mutant Leishmania promastigote 
cultures were grown, as described in Chapter 2, to the concentration of up 1X107 
cells/ml and the Western Blot protocol, as in Chapter 3, was followed. 
Monoclonal antibodies used in this study were L8C4 which recognises PFR2 in 
Leishmania mexicana by Western blot and L13D6 which recognises PFR1 and 
PFR2 in Trypanosoma brucei. Both antisera were raised against Trypanosoma 
brucei and were gifts from Professor Keith Gull, University of Oxford. 
Tryparedoxin peroxidase antisera raised in adult male Wister rat (Wyllie et al. 
2008)  was a gift from Dr Susan Wyllie, University of Dundee. For the PFR1&2 
immunoblots the primary antibody used was 1:1000 and 1:50,000 for the anti 
mouse secondary antibody. The PFR2 immunoblots, primary antibody was diluted 
to 1:500 and 1:50,000 for the anti mouse secondary antibody, respectively. For 
tryparedoxin peroxidase immunoblot, 1:2000 and 1:50,000 of tryparedoxin 
peroxidase antisera and anti rat secondary antisera, respectively.  
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4.2.3  Processing Cells for Transmission Electron 
 Microscopy and Scanning Electron Microscopy 
4.2.3.1 Transmission Electron Microscopy 
 Glucose transporter knock-out and wild type cell line were harvested at 
1x107 cells /ml in 10mls each. The cultures were centrifuged at 1000rcf for 10 
minutes. The pellets were fixed in 2.5% glutaraldehyde in 0.1M phosphate buffer 
for 30 minutes. Then the pellets were rinsed a few times with 0.1M buffer with 
2% sucrose followed by fixing in 1% osmium tetroxide in 0.1 M cacodylate buffer 
for 1 hour followed by a wash with distilled water to remove the osmium 
solution. The cells were dehydrated from 70% alcohol through 90%, and 3 
changes of absolute alcohol at 10 minutes each. The final change is absolute 
ethanol dried over molecular sieve, decanted carefully to avoid sieve residue 
carryover. The processing of the specimens was continued by replacing the 
alcohol with propylene oxide twice at 5 minutes each. Add resin 
(araldite/epoxy) to prop oxide in 1:1 and mix. Replace final change of pure prop 
oxide with resin/PO and leave on rotator in the fume hood for 3 hrs or overnight. 
Replace with resin mix plus accelerator and rotate, capped for 6 hours.  
 Flat embed pellet pieces in fresh resin/accelerator in silicon moulds or in 
BEEM capsules and polymerize at 60oC for 48hours. Finally, semi-thin sections 
were obtained from trimmed blocks and stained in borax buffered 1% toluidine 
blue on a glass slide for 30secs on a hotplate, rinsing in water to carefully wash 
off excess stain. Cell preservation and position in the block was confirmed by 
LM. Re-trimming was performed if needed and ultrathin sectioning for TEM 
performed.  
This experiment and the results were done with help from Professor 
Laurence Tetley and Margaret Mullin from FBLS integrated Microscopy Facility, 
University of Glasgow. 
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4.2.3.2  Scanning Electron Microscopy 
  Cells were pre-washed from culture medium in 0.1M phosphate buffer, 
rinse and concentrated by spinning at 1000g , 2 x 5 mins and fixed by 
resuspending the pellet in 2.5% glutaraldehyde /0.1M PO4 buffer for 30 - 40mins.         
Terminate fixation by replacing fix with 0.1M PO4 / 2% sucrose rinse, spinning 3 x 
5mins.  Resuspend between washes. In all subsequent steps care must be taken 
to avoid drying the specimens until the final stage. 
 Apply droplets of concentrated suspension in rinse buffer to 10mm 
diameter PLL-coated glass coverslips and allow 15 mins for cells to attach.  
Remove unattached cells by washing off with rinse buffer before adding 2% OsO4 
in distilled water in equal volume to rinse buffer. Leave to fix for 30 mins. 
Remove  OsO4 with 3 changes of distilled water and add 0.5% aqueous. Uranyl 
Acetate for 30 mins in dark. Wash in distilled water twice and dehydrate cells 
using an alcohol series 
                                         70% Alcohol                      - 5mins 
                                        90% Alcohol                       - 5mins 
                                        Absolute Alcohol                - 2x5mins 
                                        Dried Abs Alcohol              - 5mins 
Transfer coverslips cell-side up into a covering volume of hexamethyldisilazane 
(HMDS). 
 Parasites were dried from HMDS by overnight evaporation of the solvent in 
the fume hood. The specimens were then mounted on stubs using conductive 
tape and coated with gold/palladium in a Polaron SC515 sputter coater prior to 
examination in a JEOL 6400 SEM operating at 6kV and secondary electron images 
recorded using an ADDA3 digital capture system (Olympus/SIS, Germany). 
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This experiment and the results analysis were done with the help from 
Professor Laurence Tetley and Margaret Mullin from FBLS integrated Microscopy 
Facility, University of Glasgow. 
 
4.2.4 Taxis assay 
 Cell cultures of GT1 and ∆LmGT were grown, as described in Chapter 2, to 
the concentration of up 1X107 cells/ml and these are the cell suspensions to be 
used in for the taxis assay. The method was modified from a previous 
paper(Oliveira, Melo, & Gontijo 2000). Washing and incubation solution (WIS) 
was prepared, composing of  30mM sodium β-glycerophosphate (Fluka 
analytical), 87mM NaCl , 27 mM KCl, 2mM MgCl2 (pH 7.1) (Fischer Scientific), 
0.004% enriched BSA (Sigma) and 0.2% agarose (Invitrogen). Before the gel 
solidified, 6 capillaries were filled with WIS containing 100mM glucose by 
capillary action, where one of capillary ends was submerged in WIS buffer for a 
few minutes until the WIS buffer filled up approximately ¾ of the capillary 
length.  After the WIS in all capillaries had solidified, one end of the capillary 
was submerged into a cell suspension of 5X106 cells/ml in PBS (with 3 capillaries 
in each GT1 and ∆LmGT cell suspensions, respectively) and left for 1 hour at 
room temperature.  
After 1 hour, cell suspension from each capillaries were drawn and 
counted under the microscope (the cell suspension was diluted 3X for easier 
counting i.e 8μl cell suspension + 16μl counting buffer).  
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4.3  Results 
4.3.1  Western blot loading control 
 Pre-cast gradient SDS gel, Novex 4-20% Tris Glycine (Invitrogen) loaded 
with whole cell lysate from wild type and glucose transporter null mutant was 
used as a loading control for western blot for the PFR analysis and tryparedoxin 
peroxidase (Figure 4-4) analysis. Transketolase was one of the loading controls 
that were initially chosen for the analysis. However, after several trials, TKT had 
to be excluded as a loading control as it gave an inconsistent result throughout 
the experiments i.e. it expressed in only a few trials. Furthermore, 
transketolase expression in glucose transporter null mutant has not been tested, 
therefore the result is questionable. 
 Hence, in this project Coomassie staining was chosen as loading control 
(Welinder & Ekblad 2011).A whole cell lysate from wild type and glucose 
transporter null mutant grown to equal cell density i.e. 3x1010cells/ml, were 
loaded into several wells in the gel using various volumes (or cell numbers) and 
after electrophoresis, the gel was stained with Coomassie blue (Figure 4-4). 
Proteins in all lanes were compared for their expression intensities, and the 
volume (or cell number) that showed similar intensity of expression for wild type 
and glucose transporter null mutant was chosen for western blot analysis of PFR 
and tryparedoxin peroxidase (Daneshvar et al. 2011)).    
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Figure 4-4: Gel from SDS-PAGE stained with Coomassie blue that served as a loading 
control. Gel was loaded with whole cell lysate of wild type and glucose transporter null 
mutant cells of Leishmania mexicana. M is the protein ladder. At the end of the whole cell 
lysate (WCL) preparation, both WT and ∆LmGT cells were resuspended at the concentration 
of 3x1010cells/ml. Each lane was then loaded with different volumes (or number of cells). 
Volume (number of cells) from WT and ∆LmGT lanes that show the same intensity of the 
protein expression after staining will then be chosen to be used in the following western 
blot. Lane 1 and 2 are loaded with WT with lane 1 loaded with 20μl WCL (cell numbers, 6 x 
108 cells=20μl x 3x1010cells/ml) and lane 2 loaded with 25μl WCL (cell numbers, 7.5 x 108 
cells=25μl x 3x1010cells/ml). Lane 3, 4 and 5 are loaded with ∆LmGT. Lane 3 loaded with 25μl 
WCL (cell numbers, 7.5 x 108 cells=25μl x 3x1010cells/ml), lane 4 loaded with 30μl WCL (cell 
numbers, 9 x 108 cells=30μl x 3x1010cells/ml), lane 5 loaded with 35 μl WCL(cell numbers, 
1.05 x 109 cells=35μl x 3x1010cells/ml). Although the chosen volume and cell numbers are 
not the same between cell lines, they may have the same protein content. It has been 
reported that the null mutants are smaller in size and volume but null mutants may need 
more cells to have the same amount of protein in WT with lower cell numbers.  
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4.3.2  Paraflagellar Rod Protein 
 Monoclonal antibodies raised against conserved epitopes of Trypanosome 
brucei PFR1 and PFR 2 were obtained from Professor Keith Gull. One antibody 
recognises both PFR1 and PFR2 (L13D6; anti-PFR1/2), another recognised PFR2, 
but not PFR1 (L8C4; anti-PFR2), in T. brucei. These antibodies have previously 
been observed to recognise PFR in Leishmania mexicana, but it is not clear that 
they have the same capacity to distinguish between PFR1 and PFR2. Studies in 
the Gull lab suggest that L8C4; anti-PFR2 recognises L. mexicana PFR2 by 
Western blot, but may also recognise PFR1. L13D6; anti-PFR1/2 has not 
previously been tested with L. mexicana. These antibodies were used to probe 
lysates of WT and ∆LmGT promastigotes on Western blots.  
 Figure 4-5 shows a Western blot probed with anti-PFR1/2. A single band is 
observed that is much more intense in wild type than in ∆LmGT.  Although this 
band is at approximately the expected size for L. mexicana PFR, we cannot 
conclude that the band represents either (or both) of the L. mexicana PFR 
isoforms.  
Figure 4-6 shows a Western blot probed with L8C4; anti-PFR2. A single 
band is observed in wild type, but a clear doublet is seen in ∆LmGT. Each lane 
presents a band of similar size and intensity, but the ∆LmGT lane presents an 
additional, slightly larger band that is not observed in WT. This suggests that an 
additional PFR isoform is expressed in ∆LmGT. Since this additional band has a 
larger apparent molecular weight, it is likely that it represents a post-
translational modification of PFR that is induced in ∆LmGT.  
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Figure 4-5: Western blot analysis of PFR1&2. Whole cell lysate prepared from wild type and 
glucose transporter null mutant Leishmania mexicana and PFR1&2 monoclonal antibody 
(L3D16) was used to probe the protein contained in the whole cell lysate in the western blot. 
Lane 1 is whole cell lysate from wild type and lane 2 is whole cell lysate from glucose 
transporter null mutant. The proteins were probed with PFR1&2 monoclonal antibody at 
1:1000 dilution and anti-mouse secondary antibody at 1:50,000 dilution. The volume for WT 
and null mutant used were 20μl (cell numbers, 6 x 108 cells=20μl x 3x1010cells/ml) and 30μl 
(cell numbers, 9 x 108 cells=30μl x 3x1010cells/ml) respectively.  
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Figure 4-6:  Western blotting analysis of PFR2. Whole cell lysate prepared from wild type 
and glucose transporter null mutant Leishmania mexicana and PFR2 monoclonal antibody 
(L8C4) was used to probe the protein contained in the whole cell lysate in the western blot. 
Lane 1 is whole cell lysate from wild type and lane 2 is whole cell lysate from glucose 
transporter null mutant. The proteins were probed with PFR2 monoclonal antibody at 1:500 
dilution and anti-mouse secondary antibody at 1:50,000 dilution. The volume for WT and 
null mutant used were 20μl (cell numbers, 6 x 108 cells=20μl x 3x1010cells/ml) and 30μl (cell 
numbers, 9 x 108 cells=30μl x 3x1010cells/ml) respectively. 
 
 
 
 
 
 
 
Dhilia U Lamasudin                                                                                                       Chapter 4,   
  
168
4.3.3  Tryparedoxin Peroxidase 
 Tryparedoxin peroxidase in Leishmania mexicana wild type and glucose 
transporter null mutant was analysed by Western blot (Figure 4-7). Equal 
numbers of WT and ∆LmGT promatigotes were lysed in sample buffer and 
separated by SDS-PAGE. The gel was blotted and probed with antisera raised 
against tryparedoxin peroxidase from Leishmania donovani. The antisera 
detected a single band at the anticipated molecular weight for tryparedoxin 
peroxidase. The band appeared to have similar intensity in both WT and ∆LmGT 
lanes.  
  
 
Figure 4-7: Western blotting analysis of tryparedoxin peroxidase. Whole cell lysate prepared 
from wild type and glucose transporter null mutant Leishmania mexicana and tryparedoxin 
peroxidise antisera were used to probe the protein contained in the whole cell lysate in the 
western blot. Lane 1 is whole cell lysate from wild type and lane 2 is whole cell lysate from 
glucose transporter null mutant. The proteins were probed with tyrparedoxin peroxidase 
antisera at 1:2000 dilution and anti-rat secondary antibody at 1:50,000 dilution. The volume 
for WT and null mutant used were 20μl (cell numbers, 6 x 108 cells=20μl x 3x1010cells/ml) 
and 30μl (cell numbers, 9 x 108 cells=30μl x 3x1010cells/ml) respectively. 
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4.3.4  Flagellar structure analysis 
The ultrastructure of the flagellum in wild type and ∆LmGT promastigotes 
was compared by both transmission electron microscopy (TEM) and scanning 
electron microscopy (SEM). TEM images were taken to analyse the structure of 
PFR in WT and ΔLmGT.  
The structure of the flagellum of wild type seems to be intact after the 
treatment for TEM (Figure 4-8). The cross-sections of the several flagella were 
also seen and both the axoneme and microtubule tubule seem to be intact. 
 
Figure 4-8: TEM image of wild type L.mexicana. The Black (          ) arrow shows the opening 
of the flagellar pocket. The blue (            ) arrows show the PFR of the flagellum and the 
orange (              ) arrows show the axoneme structure. ‘A’ shows a longitudal section. ‘B’ 
and ‘C’ are the cross sections of flagellum. This was a preliminary experiment. 
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 Figure 4-9(1) shows that the flagellum was truncated at the opening of 
the flagellar pocket (indicated by the pink arrow). In Figure 4-9(2), the flagellum 
started to ‘degrade’ (C) at the opening of the flagellar pocket.  The cross-
section of the flagellum (D), which is from another cell, indicates that the 
axoneme and microtubule were present in both WT and ∆LmGT. Intact flagella 
were rarely seen in TEM of the glucose transporter null mutant, indicating that 
their flagella were probably degraded during the TEM treatment. 
 
Figure 4-9: TEM images of glucose transporter null mutant. (1) A and B show the structure 
of the flagellum. The pink arrows (            ) in the GT knockout mutants show the opening of 
the flagellar pocket, the flagellum A, seems to be truncated at the opening of the flagellar 
pocket. (2) C is the flagellum remain that seem to be degraded at the opening of the flagellar 
pocket (arrow). D is a cross section of a flagellum. The cross section, although not clearly 
showing the details of the structure, does show that the axoneme (orange arrow         ) and 
the PFR    (blue arrow              ) structure are intact. This was a preliminary experiment. 
 
 
 
 
 
 
   
 
Dhilia U Lamasudin                                                                                                       Chapter 4,   
  
171
4.3.5  Analysis of the cell shapes and flagellar length 
The TEM images did not show the intact flagella of the glucose transporter 
null mutant. Scanning Electron Microscopy (SEM) was done to measure the body 
of the promastigote and its flagellum. The measurement is taken using software 
called ‘iTEM’ (The TEM Imaging Platfrom, Olympus) and then the results were 
compared between the promastigotes of wild type and glucose transporter null 
mutant. 268 cells from each cell line were randomly selected from the SEM 
images produced (Figure 4-10 (WT) and Figure 4-11 (ΔLmGT)) and the 
measurements were taken by iTEM software. From the images, we can see a 
reasonable number of cells that are from different physiological stages i.e. 
procyclic amd metacyclic promastigotes. Metacyclic promastigotes were found 
to be represented fairly equally in both the wild type and ΔLmGT samples. 
Generally, the shape of the promastigotes between the WT and ΔLmGT do not 
really show significant differences. 
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Figure 4-10: SEM images of wild type (WT). 268 cells were randomly chosen and the body 
length and the flagella were measured by iTEM software.  
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Figure 4-11: SEM images for glucose transporter null mutant (∆LmGT). 268 cells were 
randomly chosen and the body length and the flagella were measured by iTEM software.  
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Figure 4-12: SEM images from wild type and glucose transporter null mutant promastigotes 
Leishmania mexicana. 
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 The measurements of the body length and the flagellae of promastigotes 
were collected, the mean of each measurement was calculated and plotted on a 
histogram (Figure 4-13), showing mean body and flagellum length for wild type 
and glucose transporter null mutant Leishmania. A t-test was performed to test 
the significance of the data. 268 cells from each cell line were chosen randomly 
and each cell’s body length and flagellum length were measured by iTEM 
software, and means were calculated. There was no significant difference in 
body length between wild type and glucose transporter null mutant (P=0.474). 
However, the mean flagellum length of the glucose transporter null mutant 
promastigotes was significantly greater than the mean flagellum length of wild 
type promastigotes (P<0.001).  
 
 
Figure 4-13: Comparison of the body length and flagellum length of wild type and glucose 
transporter null mutant.  Body length and flagellum was measured for representative 
populations of the two cells line and means were compared. The body length of the two cell 
lines has similar measurement whereas the glucose transporter null mutants have 
significantly longer flagellae than the wild type promastigotes. 
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Figure 4-14 Distribution graph of wild type cells body length.  
 
 
Figure 4-15 Distribution graph of glucose transporter null mutant cells body length. 
 
 
Dhilia U Lamasudin                                                                                                       Chapter 4,   
  
177
 
Figure 4-16 Distribution graph of wild type cells flagellum length. 
 
 
Figure 4-17 Distribution graph of glucose transporter null mutant cells flagellum length. 
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4.3.6  Characterisation of Taxis response in LmGT1 and  
 ∆LmGT  
 To investigate the possibility that differences in flagellar length 
and composition might result in changes in motility or taxis, chemotaxis 
assays were performed. The response of promastigotes to exogenous 
glucose tested using a previously developed chemostaxis assay (Leslie et 
al. 2002). The chemotaxis response of glucose transporter null mutant 
promastigotes (ΔLmGT) was compared with glucose transporter null 
mutant promastigotes expressing LmGT1 (GT1), a glucose transporter 
isoform that has previously been found to localise to the flagellum.  
LmGT1 expression was maintained via an episome which is vector pX63 
NEO.This is selected with 50μg/ml G418 (neomycin). Expression was 
validated by functional assay i.e. glucose transport was measured in 
LmGT1 expressors (Naula et al. 2010). The concentration on glucose that 
was used in the experiment was 100mM.  
 It was found that LmGT1 promastigotes were more attracted to 
glucose compared to ΔLmGT promastigotes. The mean of the LmGT1 
calculated in the capillary tube after 1 hour incubation of the capillary 
tube containing WIS and glucose in cell suspension was 1.2X106 and mean 
reading for ∆LmGT cells drawn from the capillary tube was 4.1 X105 cells, 
where the difference of means was 7.95X105. 
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Figure 4-18: Chemotaxis assay of GT1 and ∆LmGT. The experiments were done in triplicate. 
The plotted number of each cells in the graph represents the mean number of 
promastigotes cells in the capillary tube containing WIS buffer mixed with 0.1M glucose. 
GT1 mean±SEM,n=2 was 1.2X106 ± 2.1 X 105 and for ∆LmGT mean±SEM,n=2 was 4.1X105 
±1.35 x 105.(SEM:Standard error mean). GT1- glucose transporter null mutant promastigotes 
expressing LmGT1, ∆LmGT-glucose transporter null mutant.  
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4.4 Discussion 
Paraflagellar Rod Protein:  
 A whole cell proteomic investigation on wild type and glucose transporter 
null mutants, performed as part of a Masters project by David Henderson has 
revealed that a paraflagellar rod protein, PFR2, is expressed at a significantly 
higher level in glucose transporter null mutant promastigotes than in wild type 
promastigotes.  
 Western blotting was performed to investigate the expression of the 2 
most abundant PFR isoforms in Leishmania mexicana i.e. PFR 1 and 2, to 
validate the previous proteomic experiment done by David Henderson. L13D6, a 
mouse monoclonal antibody (raised against Trypanosoma brucei brucei Ca2+ 
flagellar prep which recognised both PFR1 and PFR2 in T.brucei (Gadelha et al. 
2004;Kohl et al. 1999), recognised a band in both wild type and glucose 
transporter null mutant cell lysates, though the band was less intense in the null 
mutant lane. Although this single clear band appears at an apparent molecular 
weight that is consistent with detection of PFR 1 and/or PFR2, this antibody has 
not previously been tested against Leishmania and may not efficiently recognise 
PFR 1 or PFR2 homologues in L. mexicana. 
 However, a second monoclonal antibody, L8C4, which recognises T. brucei 
PFR2 but not PFR1, has previously been shown also to recognise PFR2 in L. 
mexicana. This antisera recognised a single intense band at the expected 
molecular weight in wild type L. mexicana lysates, but gave 2 bands, of similar 
intensity, in glucose transporter null mutant lysates. The additional band 
detected in the glucose transporter null mutant may represent expression of a 
post-translationally modified isoform of PFR2, a result that is consistent with the 
original proteomic study that suggested upregulation of PFR2 in glucose 
transporter null mutant promastigotes. 
 One possibility is that the additional band detected in the glucose 
transporter null mutant, which is of a slightly higher apparent molecular weight, 
might represent a phosphorylated form. The observed differences in expression 
of PFR2 between wild type and glucose transporter null mutant promastigotes 
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may contribute to some of the structural and functional changes observed in this 
mutant 
 Other experiments should be carried out to further confirm the results as 
there are many factors. Hence, a transmission electron microscopy analysis on 
the PFR structure was performed. The transmission electron microscopy images 
were intended for structural investigation particularly on the axoneme and 
paraflagellar rod protein of wild type and glucose transporter null mutant.  
 In figure 4-8, TEM images from wild type cross-section clearly show  
axoneme structure with PFR structure next to it. These PFR structure seem to be 
intact in the images. However, the discrepancies that were expected in PFR 
structure between wild type and glucose transporter null mutant were unable to 
be analysed as the flagellar structure in the glucose transporter null mutant 
(Figure 4-9) cells seem to be degraded following the TEM samples preparation. 
The degradation seems to exhibit the ‘fragility’ of the flagellum to the 
chemicals used in the treatment.  This ‘fragility’ must be further investigated in 
order to give a better insight of the causes that result in the failure of the 
flagellum to remain intact after the TEM treatment.  As it is well understood 
that removing the glucose transporter in Leishmania mexicana promastigotes 
changes certain phenotypes of the protozoan, the strength of the flagellum 
structure could be one of the phenotype changes. However, this can only be 
confirmed if such investigation was carried out where one of the methods of 
studying this is by performing the optical tweezer method (Pozzo et al. 2009). 
TEM analysis in the project was done once hence it was a preliminary result. 
 In view of the fact that TEM could not give a satisfactory finding, the 
Scanning Electron Microscopy (SEM) images were generated to investigate the 
difference in the body and flagellum length between the wild type and glucose 
transporter null mutant.  From the SEM images generated for wild type (Figure 
4-10) and glucose transporter null mutant (Figure 4-11), the cell shapes between 
the cell lines did not show a clear difference. Both populations seem to have a 
similar proportion of metacyclic and procyclic promastigotes. There were 
numbers of dividing cells found in the wild type and glucose transporter null 
mutant. Randomly, approximately 268 cells were chosen from each cell line to 
measure the length of the cell body and flagella. The average length of the cell 
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body and flagellum were then calculated and a bar graph was generated (Figure 
4-13). The cell body length of the two cell lines were almost the same with 
P=0.474. The flagellum length showed a significant difference with the average 
length for wild type and glucose transporter null mutant at 10267.26μm and 
13009.17μm respectively. In addition, the wild type’s flagellum is 21% shorter 
than the mutant’s flagellum and P<0.001.  Rodriguez-contreras et al. have 
showed that glucose transporter null mutant decreased in cell volume 
(Rodriguez-Contreras et al. 2007) and with the current experiment, it can be 
concluded that the exclusion of LmGT genes superfamily in Leishmania mexicana 
promastigotes affected the cell volume of the null mutant to decrease but it did 
not change the body length of the cell.   
Tryparedoxin peroxidase: Figure 4-7 shows Western blot expressing 
tyrparedoxin peroxidase in whole cell lysate from wild type and glucose 
transporter null mutant exposed to tryparedoxin peroxidase antisera.  
Tryparedoxin peroxidase is involved in oxidative stress defense mechanism in 
Leishmania. It has been reported that glucose transporter null mutants are more 
prone to oxidative stress hence they are unable to survive as amastigotes in 
macrophages (Rodriguez-Contreras et al. 2007). However, in the current 
experiment, no significant discrepancies were noticed on the band expression 
between wild type and null mutant after being probed with tryparedoxin 
peroxidase antisera. Nevertheless, antisera is prone to have a cross reaction 
with other proteins. Thus, whether or not the tryparedoxin peroxidase in null 
mutant has similar regulation as in wild type, the question remains to be 
answered.     
Taxis assay: Taxis can be defined as a response by free motile organisms or cells 
that move towards or away from certain environment stimuli. There are a 
number of different kinds of taxis characterised by organisms depending on the 
type of the stimuli. For example, chemotaxis is a taxis response to certain 
chemical or substances like glucose, NaCl or even toxic molecules. When an 
osmotic gradient is applied to the environment, cells will change its adaptation 
to the condition by moving towards an environment that is favourable to their 
survival and this response to osmotic gradient is defined as osmotaxis.  
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 The result from the taxis assay showed a different response between the 
glucose transporter null mutant, and a line expressing only one glucose 
transporter isoform. The stronger taxis response observed in the line expressing 
LmGT1 (GT1 cell lines), which has a flagellar localisation, suggests that this 
glucose transporter might be involved in mediating a response to glucose in the 
environment of the cell. Further experiments are required to determine whether 
expression of other glucose transporter isoforms can also have this affect, and to 
test whether expression of LmGT1 leads to a change in expression of proteins 
such as PFR2. 
 However, this response may be a result of the osmotaxis of the cells. To 
determine if this response is either chemotaxis or osmotaxis, another 
experiment could give a better insight as performed by (Barros et al. 2006). 
Oliveira et al (Oliveira et al. 2000) performed an experiment to test the 
chemotaxis capability of Leishmania amazonensis and Leishmania chagasi 
towards a number of chemoattractants that were mixed in WIS buffer which 
partially filled the capillary tube that was submerged in a cell suspension. 
Among the chemoattractants that were tested were glucose, fructose, sucrose, 
raffinose, manose, glalactose, maltose and melibiose. The number of 
promastigotes that moved into the capillary was compared to the control (WIS 
buffer with no added chemoattractant) and counted and the mean average was 
calculated. The result from the experiment was concluded as chemotaxis of the 
cell. However, Leslie et al. (Leslie et al. 2002) carried out an experiment where 
the protocol was based on the modification of the experiment conducted by 
Oliveira et al. (Oliveira et al. 2000). The result generated from the experiment 
challenged the result from Oliveira et al’s by stating that the result from 
Oliveira may be a resultant of an osmotaxis. In 2006, Barros et al (Barros et al. 
2006) performed an experiment that could determine the taxis response of a cell 
to be either chemotaxis or osmotaxis.  
 From the experiment, it showed that even at very low concentration, 
sucrose, lactose, mannitol and glycine promastigotes showed a taxis response 
towards these chemoattractant but when the same concentration of NaCl, Hepes 
and guanosine were submitted to the environment, no taxis responses were 
recorded.  
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 Hence, from this previous work done by Barros et al, the result from the 
current experiment can be concluded to be chemotaxis, and not osmotaxis as 
the concentration of glucose used was 100mM (Barros et al. 2006). As the 
current experiment was intended to investigate the LmGT1 protein function in 
the flagellum, it can be concluded that the sensor capability of the flagellum 
was therefore facilitated by LmGT1 as the number of promastigotes lacking this 
protein attracted towards the glucose in the capillary tube was lower than the 
LmGT1’s. As LmGT1 was demonstrated to promote a very small increase in 
growth over the level of  ∆LmGT and is low-affinity glucose transporter in 
addition to its subcellular location in the flagellum (Burchmore et al. 2003), the 
possibility that LmGT1 functions as glucose sensor is very likely.  Apart from the 
sensory capability, the result from the graph also suggested that LmGT1 
expressing cells may have moved faster towards the glucose-containing capillary 
compared to ∆LmGT. 
4.5 Conclusion  
 The experiments in this chapter support the hypothesis that ablation of 
glucose transport in Leishmania promastigotes gives rise to cells that have 
altered flagellar structure (length and robustness) and function (motility and/or 
sensing). It is not known how these changes are related to loss of glucose 
transport capacity. One interesting possibility is that the imposed shift in energy 
source, from glucose to alternatives such as amino acids, results in 
compensatory changes in the flagellum. These changes may have little 
consequence to cells in culture, but may have more profound effects in the 
insect host. 
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Chapter 5 
                           General discussion 
 Like all parasites, Leishmania acquire their nutrients only through their 
hosts and this requires an efficient transport system within the parasites. As the 
nutrient transport systems are crucial for survival to all living organisms, 
Leishmania nutrients acquisition systems are potential drug targets and worth to 
be researched and investigated in order to gives more insight on how does the 
mechanisms work. For this reason, the current project’s interest is focuses on 
the mechanisms of nutrient acquisition in Leishmania. 
5.1 The Problem 
  It is known that the promastigote stage of Leishmania spp.use glucose as 
their main energy source for their survival (Burchmore & Hart 1995;Hart & 
Coombs 1982) as they living in a vector’s midgut that feed on plants sugar 
(Schlein 1986;Tang & Ward 1998) hence they are bathed in sugar-rich 
environment in the sandfly host. In culture, promastigotes acquire glucose from 
media via membrane transporters (Burchmore & Hart 1995;Burchmore & 
Landfear 1998) and metabolise glucose to generate energy and for anabolic 
processes (Hart & Coombs 1982;Langford et al. 1994). However, it has been 
demonstrated that promastigotes can also grow in glucose-free media although 
they grew slowly compared to the when glucose is available (Burchmore et al. 
2003). 
 A glucose transport null mutant Leishmania mutant has been generated by 
targeted gene knockout (Burchmore et al. 2003). The three genes  i.e. LmGT1, 
LmGT2 and LmGT3, are single copy genes that are clustered together at a single 
locus, encodes three distinct glucose transporter isoforms i.e. LmGT1, LmGT2 
and LmGT3 (Burchmore & Landfear 1998). Although this line does not have the 
capacity to transport glucose, nevertheless, it is able to survive in culture. 
Interestingly, it has been shown that glucose transporter null mutant 
promastigotes are significantly compromised in ability to survive in the sandfly 
host. However they were demonstrated to be unable to multiply and survive in 
macrophage host cells (Burchmore et al. 2003;Rodriguez-Contreras et al. 2007). 
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These observations raised a suggestion on the existence of possible alternative 
mechanisms for nutrient acquisition in glucose transport null mutant Leishmania 
for energy requirement and carbon supply important for their growth and 
survival in glucose free environment although these alternative mechanisms may 
not sufficient to permit the protozoan parasites to grow and survive as the 
clinically-relevant stage, the amastigotes. Hence, together with the observations 
and suggestions that have been raised, the potential that glucose transport 
system may have as antileishmanial drug targets is highlighted and it is 
worthwhile to study and research further the system to shed light on how these 
system works in Leishmania. 
5.2 The Approach 
 The central aim of this project was to investigate the molecular 
mechanism behind the phenotypic changes observed in glucose transporter null 
mutant Leishmania. This aim was approached by incorporation of different fields 
of research methods i.e. combination of targeted analyses, using conventional 
and analytical approaches such as uptake assays and western blotting, and 
through more global proteomic and metabolomic analyses. The results generated 
demonstrate that glucose transport null Leishmania have undergone changes in 
metabolism and some phenotypic changes.  
 At the beginning of the current project, a master student (Henderson., D. 
Master Student, University of Glasgow, 2007) had undertaken a comparative 
proteomic analysis of wild type and glucose transporter null promastigotes of 
Leishmania mexicana.   The most pronounced proteomic change observed in this 
study was in the expression of a major structural component of the flagellum 
i.e. the paraflagellar rod protein. Paraflagellar rod proteins are essential for full 
motility and provides support for metabolic regulators that may control flagellar 
beating(Gadelha et al. 2005) and deletion genes encode for these proteins 
results in impairment to flagellum movement (Santrich et al. 1997). Rodriguez-
Contreras et al. showed that glucose transporter null mutant Leishmania 
mexicana decreased in cell volume compared to the wild type (Rodriguez-
Contreras et al. 2007) but none has mentioned on flagellum structure change in 
glucose transporter null mutant. Henderson’s study revealed that, despite the 
decreasing in volume size, the paraflagellar rod protein 2C (PFR2, accession: 
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LmjF16.1425) was significantly upregulated within the null mutant Leishmania. 
In order to validate this finding and to investigate the flagellar structure and 
function, Western blotting, microscopic analysis and taxis assay were carried 
out.  
 Lysates of wild type and glucose transporter null promastigotes were 
probed with 2 antisera raised against flagellar components of Trypanosoma 
brucei. Both antibodies detected bands at the expected apparent molecular 
weight for PFR proteins but L8C4 detected a clear doublet in lysates of the 
glucose transporter null mutant, but not in wild type. This result is consistent 
with expression of an additional isoform of PFR2 in the glucose transport null 
line. This isoform might be post-translationally modified, and it would be of 
interest to investigate this possibility in future work. These data validate the 
observation from a proteomic screen which suggested that PFR2 expression is 
upregulated in the glucose transporter null mutant. 
 Transmisson electron microscopy (TEM) analysis revealed interesting 
images for glucose transporter null mutant’s flagellum. Initially , TEM was 
applied to look at PFR and axoneme structures as these structure were linked to 
the abnormality phenotype found in PFR null mutant Leishmania mexicana (Maga 
& LeBowitz 1999). Western blotting supported the hypothesis that expression of 
paraflagellar rod components is altered in the glucose transporter null mutant, 
which might result in some structural changes in the flagellum of glucose 
transporter null mutant Leishmania. However, unlike the wild type’s TEM images 
which were intact and the structure of flagellum was clearly shown, the null 
mutant’s flagellum seems to either ‘degrading’ or ‘truncated’ at the flagellar 
pocket of the protozoan parasite. Hence, the axoneme and PFR structures and 
composition were unable to be analysed in the null mutant. There is no evidence 
that the flagellum is truncated in vivo, so it seems likely that the flagellum of 
the glucose transporter null mutant is more fragile under the fixation conditions 
used to prepare samples for TEM. Though this “fragility” meant that it was not 
possible to obtain images of glucose transporter null mutant with intact 
flagellae, it does indicate a significant structure difference between the 
flagellae of wild type and null mutant promastigotes. 
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 Scanning electron microscopy (SEM) analysis was done to look at the 
length of the cell body and flagellum of the Leishmania cells. Rodriguez-
Contreras et al. has reported that cell volume in the glucose transporter-null 
mutant has decreased compared to the wild type’s. However none published 
paper has reported on the flagellum’s length. From the SEM analysis, the body 
length of both cell lines did not show a large difference. The flagellum length on 
the other hand, has showed that the null mutant has significantly longer 
flagellum compared to the wild type.  
 Taxis assay was performed to look at the Leishmania taxis response 
towards glucose.  LmGT1 is one of 3 glucose transporter isoforms and has been 
shown to be located at the flagellum (Burchmore et al. 2003). As the flagellum is 
also hypothesised to be involved in environmental sensing (Landfear & 
Ignatushchenko 2001), LmGT1 was suggested to be involved in glucose sensing 
based on its location on the flagellum (Burchmore et al. 2003). In the taxis assay 
that performed in the current project, restoration of LmGT1 in glucose 
transporter null mutant Leishmania seems to have different phenotype of GT1 
line compared to glucose transporter null mutant. The number of GT1 cells 
drawn from the capillary tube containing the glucose-contaning WIS gel was 
significantly higher compared to the null mutant’s.  This result show that the 
hypotheses that LmGT1 in flagellum may involves in glucose sensing (Burchmore 
et al. 2003) may be is true. Given the position of flagellum to be in the anterior 
of the cell, this may further support the involvement of flagellum and LmGT1 in 
environmental sensing and not just in motility. These results, though 
preliminary, are of considerable interest and future work may focus on the 
chemotaxis phenotype of wild type and of other relevant mutants. 
 Changes in flagellar structure and function analyses through Western blot, 
electron microscopy and taxis assay in the current project have confirmed that 
phenotypic differences between the flagellae of wild type and glucose 
transporter null promastigotes but it was not possible to relate these changes to 
the lesion in glucose transport capacity. It would be of interest in the future to 
further investigate these changes in glucose transporter null mutant Leishmania 
line that express individual glucose transporter isoforms(one of which has a 
flagellar localisation) but these experiments need to be well planned and longer 
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duration to be completed hence the experiments were beyond the timescale 
available for this project.  
 Glucose transporter null mutant Leishmania mexicana under study has a 
lesion in membrane transport. Hence, one of the aims of the current project was 
to look at these membrane transporters expressions in the null mutant. 
However, it is well-known that the challenges of investigating membrane 
transporters can be cumbersome because membrane proteins have relatively low 
abundance and are typically under-represented in proteomic analyses (Speers & 
Wu 2007). 
 Comprehensive analysis of cell proteomes is very challenging due to its 
complexity and dynamic range of protein concentrations. Hence the success of 
the proteome analysis is greatly dependent on the quality of the fractionation 
employed prior to MS analysis(Horth et al. 2006). For this reason, comparative 
analysis of similar fractions derived from wild type and glucose transporter null 
mutant promastigotes required further resolution of the complex mixture of 
proteins that comprised this plasma membrane-enriched fraction. An alternative 
approach which combine the use of solution-phase isoelectric focusing (IEF), 1-
SDS page and differential labelling of proteins (DiGE) were applied. Solution-
phase isoelectric focusing gives rise to unique fractions of reduced complexity, 
nevertheless the MS analysis revealed that there were great amount of tubulins 
and this may be the reason the low abundant proteins and IMPs could not be 
identified (Table 3-3) although previously in the same project where samples 
that had not been fractionated by OFFGEL has identified some IMPs both in the 
wild type and glucose transport null mutant (Table 3-2). The reason for not 
being able to identify IMPs in OFFGEL-fractionated samples could be due loss of 
samples during the fractionation due to leakage or drying of samples due to the 
long fractionation period which took 96 hours to complete. In addition to that, 
prior to fractionation, the membrane preparation samples had to be diluted into 
OFFGEL compatible solution hence this will decreasing the concentration of the 
IMPs which are already of relatively low abundance.  This could be improved by 
using 2-5 higher concentration of proteins.  
 DiGE labelling involves incorporating fluorescent dyes , Cy3-NHS and Cy5-
NHS, which are cyanine based, molecular-weight matched, amine reactive and 
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positively charged (Viswanathan et al. 2006). The combination of OFF-Gel with 
DiGE to analyse the membrane preparation samples did give an encouraging 
outcome. Differential labelling of proteins isolated from wild type and glucose 
transport null mutant promastigotes Leishmania enabled comparison of protein 
expression between these samples and some apparent differences were 
detected. However, due to time constraint and limited resources, further 
analysis i.e. mass spectrometry analysis, could not be carried out to complete 
proteomic analysis of these sub-fractions. 
 The Leishmania genome project reveals many genes that encode putative 
nutrients transporters (Aslett et al. 2010;Myler et al. 2001;Myler & Stuart 
2000;Peacock et al. 2007). It has been suggested that high concentration of 
amino acids in Leishmania are accumulated by  plasma membrane permeases 
(Zilberstein & Gepstein 1993). HOMEM, the growth media used in this study for 
Leishmania culture has a high concentration of numerous amino acids 
(Appendix). Amino acid in the culture media are the most likely used by the 
parasite as a carbon source (Krassner & Flory 1971). In culture, Leishmania can 
use amino acids as a carbon source when glucose is limiting for growth(Saunders 
et al. 2010). In addition, catabolic metabolism of numerous amino acids that 
generate intermediates for Krebs cycle have also been revealed or predicted 
(glutamine/glutamic acid, proline, asparagine/aspartic acid, alanine, serine, 
glycine, threonine, isoleucine, methionine, valine, cysteine) in Leishmania 
(Opperdoes & Coombs 2007). Ablation of glucose transport in glucose transporter 
null mutant promastigotes may have been possible because the cells were able 
to utilise amino acids as an alternative carbon and energy source to glucose. To 
test this possibility, the capacity of wild type and glucose transporter null 
mutant promastigotes to acquire various amino acids was compared. 
 The results of uptake assays for these four particular amino acid are clear 
and encouraging. But to assay for the uptake of individual amino acids, or of 
nutrients in general is time consuming and costly. Furthermore, targeted assays 
can only report on the metabolites that are under study and for which tracer 
compounds exist. Hence a global approach is an attractive alternative that could 
facilitate our understanding of uptake or requirements of other compounds than 
glucose that may be essential to Leishmania when glucose is limiting for growth.  
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 To make a more global approach, I chose to perform an experiment which 
incorporate’s the used of LC-MS-based comparative metabolomic analysis in 
order to screen for changes on metabolic pathways between wild type and 
glucose tranpporter null mutant Leishmania promastigotes. These analyses 
supported the results obtained through amino acid upatake assays. On top of 
that, it has also revealed a fascinating diversity of metabolic changes in glucose 
transport null mutant promastigotes.  
  The results generated from the current project have showed clearly that 
there are considerable changes in nutrient acquisition, phenotype and 
metabolism in glucose transporter null mutant Leishmania mexicana. These 
changes reflect the ability of the null mutant to adapt to a genetic lesion in the 
glucose transport capacity and the upregulation of the amino acid uptake 
activity is the most obvious adaptation metabolism seen in these null mutants 
where glucose is unable to be transported into the cells for energy metabolism.  
5.3 Future Directions 
 Many previous publications have showed that Leishmania comprise genes 
that encodes a battery of putative amino acid transporters in promastigotes 
stage. However, there is little evidence that these promastigotes encounter 
abundant amino acids in the sandfly host and it is well known that the sandfly 
host feeds primarily on plant sap. The current project presented herein show 
that uptake of amino acids in glucose transporter null mutant promastigotes but 
it can not specify if this upregulation was due to augmented expression of the 
transporters or to changes in transport activity. In that light, genomic study of 
Leishmania could offer details of the regulation of gene expression and it would 
be interesting to investigate whether some amino acid transporter genes are 
amplified in glucose transport null mutant Leishmania.  
 The molecular analysis involving western blot, taxis assay and 
transmission electron microscopy and scanning electron microscopy has provide 
proof that lesion in membrane transport in Leishmania not only caused changes 
in nutrient acquisition adaptation and sensitivity to environment stimuli but as 
well as structural changes 
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 Both uptake assay and metabolomic results have proven that certain 
amino acids are important to the glucose transporter null mutant Leishmania 
and probably are equally important in growth conditions where glucose is 
unavailable or scarce. It would be of interest in future studies to look at systems 
that may be involved in the regulation of transporter expression or activity.  This 
could give insights on how important are those amino acids and could the lesion 
in those amino acid transport impose lethal effect on the cells. 
 Despite the inability to prove whether the bands expressed in membrane 
fractionation was a myc-tagged glucose transporter (Figure 3-6 and Figure 3-8), 
the data from proteomic results from whole cell lysate (Table 3-1) and salt-
extraction method (Table 3-2), demonstrate that salt-extraction needs to be 
improvised before the method can be declared as ‘not suitable’ for the 
Leishmania’s membrane protein extraction. The combination of subcellular 
fractionation and solution phase isoelectric focussing will present a high 
resolution method for plasma membrane proteomics and these approaches might 
successfully be combined with differential CyDye labelling to facilitate 
comparative plasma membrane proteomics. Hence they should be tested again 
in the future.  
 Nevertheless, although each aspects of study in this project has proved 
that all disciplines applied were challenging in terms of its reproducibility or 
technicality, the results demonstrate that the genetic lesion in glucose transport 
in Leishmania has caused major changes to the structural, phenotype and 
nutrient acquisition in the extracellular promastigotes of protozoan Leishmania. 
However, the study has also raised interesting new sets of questions that could 
be addressed in future research. Since serine accumulation and uptakes seem to 
be significantly different between wild type and glucose transporter null 
mutant, it would probably be best to generate a null mutant cell line that lack  
important proteins, where they can either be enzymes or transporters, that are 
responsible in transporting or converting serine Leishmania.   
5.4 Summary 
 This project has highlighted some of the challenges that surround 
attempts at comparative proteomic analyses, particularly where membrane 
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proteins are in the spotlight. In addition, the uptake assays and metablomic 
analyses have further confirmed the importance of amino acids for the survival 
and growth of Leishmania in an environment where glucose is scarce. Despite 
the complexity of the metabolomic results generated from the project, it has 
also revealed the potential for comparative metabolomic analysis as an 
alternative unbiased approach to give a better insight into the molecular 
changes behind a complex phenotype. The work described in the project has no 
doubt provided a new set of knowledge that could be used for improving related 
research in the future.  
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Appendices 
Appendix 1 
HOMEM Recipe (Invitrogen-GIBCO) 
 
Sodium Dihydrophosphate 2H2O   1.58 gram 
 
Magnesium Sulphate 7H2O EP   0.2 gram 
 
Sodium Chloride EP     6.8 gram 
 
Potassium Chloride E    0.4 gram 
 
Sodium Pyruvate     0.11 gram 
 
Dextrous Anhydrous E    3 gram 
 
L-Glutamine      0.292 gram    
 
D-Biotin EP+      0.0001gram 
 
P-Aminobenzoic acid    0.001gram 
 
Phenol RED NA Salt     0.0gram 
 
HEPES       5.9575gram 
 
Sodium bicarbonate     0.3gram 
 
 
 
 
 
 
 
MEM Non-Essential AM (100x liquid)  0.01 liter 
 
   L-Alanine   890 mg/L 
   L-Asparagine   1320mg/L 
   L-Aspartic Acid  1330mg/L  
   L-Glutamic Acid  1470mg/L 
   Glycine   750mg/L 
   L-Proline   1150mg/L 
   L-Serine   1050mg/L 
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MEM Amino Acid Solution (50x liquid)   0.03 liter 
 
   L-Arginine HCL  6320mg/L 
   L-Cysteine   1201.00mg/L 
   L-Histidine.HCL.H2O 2096.00mg/L 
   L-Isoleucine   2623.00mg/L 
   L-Leucine   2623.00mg/L 
   L-Lysine HCL   3653.00mg/L 
   L-Methionine   746.00mg/L 
   L-Phenylalanine  1651.00mg/L 
   L-Threonine   2382.00mg/L 
   L-Tryptophan  510.00mg/L 
   L-Tyrosine   1811.00mg/L 
   L-Valine   2343.00mg/L 
 
 
 
 
MEM Vitamin Solution (100x liquid)  0.01 liter 
 NaCl   8500.00mg/L 
 D-Ca Pantothenate 100.00mg/L 
 Choline Chloride 100.00mg/L 
 Folic Acid  100.00mg/L 
 i-Inositol  200.00mg/L 
 Nicotinamide 100.00mg/L 
 Pyridoxal HCl 100.00mg/L 
 Riboflavin  10.00mg/L 
 Thiamine HCl 100.00mg/L 
  196 
  
List of References 
 
Abu-Dayyeh, I., Hassani, K., Westra, E. R., Mottram, J. C., & Olivier, M. 2010, 
"Comparative study of the ability of Leishmania mexicana promastigotes and 
amastigotes to alter macrophage signaling and functions", Infect.Immun., vol. 
78, no. 6, pp. 2438-2445. 
Ait-Oudhia, K., Gazanion, E., Vergnes, B., Oury, B., & Sereno, D. 2011, 
"Leishmania antimony resistance: what we know what we can learn from the 
field", Parasitol.Res. 
Alexander, B. & Maroli, M. 2003, "Control of phlebotomine sandflies", 
Med.Vet.Entomol., vol. 17, no. 1, pp. 1-18. 
Anderson, L. & Seilhamer, J. 1997, "A comparison of selected mRNA and protein 
abundances in human liver", Electrophoresis, vol. 18, no. 3-4, pp. 533-537. 
Antinori, S., Calattini, S., Longhi, E., Bestetti, G., Piolini, R., Magni, C., 
Orlando, G., Gramiccia, M., Acquaviva, V., Foschi, A., Corvasce, S., Colombo, 
C., Titone, L., Parravicini, C., Cascio, A. & Corbellino, M. 2007, "Clinical use of 
polymerase chain reaction performed on peripheral blood and bone marrow 
samples for the diagnosis and monitoring of visceral leishmaniasis in HIV-
uninfected patients: a single-center, 8-year experience in Italy and review of the 
literature", Clin. Infect. Dis., vol. 44, no. 12, pp. 1602-10. 
Antoine, J. C., Prina, E., Jouanne, C., & Bongrand, P. 1990, "Parasitophorous 
vacuoles of Leishmania amazonensis-infected macrophages maintain an acidic 
pH", Infect.Immun., vol. 58, no. 3, pp. 779-787. 
Arana, F. E., Perez-Victoria, J. M., Repetto, Y., Morello, A., Castanys, S., & 
Gamarro, F. 1998, "Involvement of thiol metabolism in resistance to glucantime 
in Leishmania tropica", Biochem.Pharmacol, vol. 56, no. 9, pp. 1201-1208. 
Aronow, B., Kaur, K., McCartan, K. & Ullman, B. 1987,"Two high affinity 
nucleoside transporters in Leishmania donovani", Mol. Biochem. Parasitol., vol. 
22., no. 1, pp. 29-37. 
Aslett, M., Aurrecoechea, C., Berriman, M., Brestelli, J., Brunk, B. P., 
Carrington, M., Depledge, D. P., Fischer, S., Gajria, B., Gao, X., Gardner, M. J., 
Gingle, A., Grant, G., Harb, O. S., Heiges, M., Hertz-Fowler, C., Houston, R., 
Innamorato, F., Iodice, J., Kissinger, J. C., Kraemer, E., Li, W., Logan, F. J., 
Miller, J. A., Mitra, S., Myler, P. J., Nayak, V., Pennington, C., Phan, I., Pinney, 
D. F., Ramasamy, G., Rogers, M. B., Roos, D. S., Ross, C., Sivam, D., Smith, D. 
F., Srinivasamoorthy, G., Stoeckert, C. J., Jr., Subramanian, S., Thibodeau, R., 
Tivey, A., Treatman, C., Velarde, G., & Wang, H. 2010, "TriTrypDB: a functional 
genomic resource for the Trypanosomatidae", Nucleic Acids Res., vol. 38, no. 
Database issue, p. D457-D462. 
Bailey, M. S. & Lockwood, D. N. 2007, "Cutaneous leishmaniasis", Clin.Dermatol., 
vol. 25, no. 2, pp. 203-211. 
  197 
  
Balber, A. E. 1990, "The pellicle and the membrane of the flagellum, flagellar 
adhesion zone, and flagellar pocket: functionally discrete surface domains of the 
bloodstream form of African trypanosomes", Crit Rev.Immunol., vol. 10, no. 3, 
pp. 177-201. 
Barata, R. A., Silva, J. C., Silva, J. C., Almeida, S. N., Teixeira, L. A., & Dias, E. 
S. 2011, "[Control of visceral leishmaniasis in the town of Porteirinha, state of 
Minas Gerais, Brazil, from 1998 to 2003]", Rev.Soc.Bras.Med.Trop., vol. 44, no. 
3, pp. 386-388. 
Barrett, M. P. 1997, "The pentose phosphate pathway and parasitic protozoa", 
Parasitol.Today, vol. 13, no. 1, pp. 11-16. 
Barros, V. C., Oliveira, J. S., Melo, M. N., & Gontijo, N. F. 2006, "Leishmania 
amazonensis: chemotaxic and osmotaxic responses in promastigotes and their 
probable role in development in the phlebotomine gut", Exp.Parasitol., vol. 112, 
no. 3, pp. 152-157. 
Basu, N. K., Kole, L., Ghosh, A., & Das, P. K. 1997, "Isolation of a nitric oxide 
synthase from the protozoan parasite, Leishmania donovani", FEMS 
Microbiol.Lett., vol. 156, no. 1, pp. 43-47. 
Bates, P. A. & Tetley, L. 1993, "Leishmania mexicana: induction of 
metacyclogenesis by cultivation of promastigotes at acidic pH", Exp.Parasitol., 
vol. 76, no. 4, pp. 412-423. 
Bente, M., Harder, S., Wiesgigl, M., Heukeshoven, J., Gelhaus, C., Krause, E., 
Clos, J., & Bruchhaus, I. 2003, "Developmentally induced changes of the 
proteome in the protozoan parasite Leishmania donovani", Proteomics., vol. 3, 
no. 9, pp. 1811-1829. 
Berens, R. L., Deutsch-King, L. C., & Marr, J. J. 1980, "Leishmania donovani and 
Leishmania braziliensis: hexokinase, glucose 6-phosphate dehydrogenase, and 
pentose phosphate shunt activity", Exp.Parasitol., vol. 49, no. 1, pp. 1-8. 
Berman, J. D. 1996, "Treatment of New World cutaneous and mucosal 
leishmaniasis", Clin. Dermatol., vol. 14, no. 5. pp. 519-22. 
Besteiro, S., Williams, R. A., Coombs, G. H., & Mottram, J. C. 2007, "Protein 
turnover and differentiation in Leishmania", Int.J.Parasitol., vol. 37, no. 10, pp. 
1063-1075. 
Besteiro, S., Williams, R. A. M., Morrison, L. S., Coombs, G. H. & Mottram, J. C., 
2006, "Endosome sorting and autophagy are essential for differentiation and 
virulence of leishmania major", J. Biol. Chem., vol 281, no. 16, pp. 11384-11396. 
Blonder, J., Goshe, M. B., Moore, R. J., Pasa-Tolic, L., Masselon, C. D., Lipton, 
M. S., & Smith, R. D. 2002, "Enrichment of integral membrane proteins for 
proteomic analysis using liquid chromatography-tandem mass spectrometry", 
J.Proteome.Res., vol. 1, no. 4, pp. 351-360. 
Blum, J. A. & Hatz, C. F. 2009a, "Treatment of cutaneous leishmaniasis in 
travelers 2009", J.Travel.Med., vol. 16, no. 2, pp. 123-131. 
  198 
  
Blum, J. A. & Hatz, C. F. 2009b, "Treatment of cutaneous leishmaniasis in 
travelers 2009", J.Travel.Med., vol. 16, no. 2, pp. 123-131. 
Blum, J. J. 1991, "Effects of osmotic pressure on the oxidative metabolism of 
Leishmania major promastigotes", J.Protozool., vol. 38, no. 3, pp. 229-233. 
Bordier, C. 1981, "Phase separation of integral membrane proteins in Triton X-
114 solution", J.Biol.Chem., vol. 256, no. 4, pp. 1604-1607. 
Braun, R. J., Kinkl, N., Beer, M., & Ueffing, M. 2007, "Two-dimensional 
electrophoresis of membrane proteins", Anal.Bioanal.Chem., vol. 389, no. 4, pp. 
1033-1045. 
Bray, R. S. 1983, "Leishmania: chemotaxic responses of promastigotes and 
macrophages in vitro", J.Protozool., vol. 30, no. 2, pp. 322-329. 
Brewis, I. A. & Brennan, P. 2010, "Proteomics technologies for the global 
identification and quantification of proteins", Adv.Protein Chem.Struct.Biol., 
vol. 80, pp. 1-44. 
Bridges, D. J., Pitt, A. R., Hanrahan, O., Brennan, K., Voorheis, H. P., Herzyk, 
P., de Koning, H. P., & Burchmore, R. J. 2008, "Characterisation of the plasma 
membrane subproteome of bloodstream form Trypanosoma brucei", Proteomics., 
vol. 8, no. 1, pp. 83-99. 
Bringaud, F., Riviere, L., & Coustou, V. 2006, "Energy metabolism of 
trypanosomatids: adaptation to available carbon sources", Mol 
Biochem.Parasitol., vol. 149, no. 1, pp. 1-9. 
Brobey, R. K. B., Mei, F. C., Cheng, X., & Soong, L. 2006, "Comparative two-
dimensional gel electrophoresis maps for promastigotes of Leishmania 
amazonensis and Leishmania major", Brazilian Journal of Infectious Diseases, 
vol. 10, pp. 1-6. 
Burchmore, R., Janssen, C. S., & Turner, C. M. 2001, "After the genome--where 
next?", Mol Biochem.Parasitol., vol. 118, no. 2, pp. 129-131. 
Burchmore, R. J. & Barrett, M. P. 2001, "Life in vacuoles--nutrient acquisition by 
Leishmania amastigotes", Int.J.Parasitol., vol. 31, no. 12, pp. 1311-1320. 
Burchmore, R. J. & Hart, D. T. 1995, "Glucose transport in amastigotes and 
promastigotes of Leishmania mexicana mexicana", Mol Biochem.Parasitol., vol. 
74, no. 1, pp. 77-86. 
Burchmore, R. J. & Landfear, S. M. 1998, "Differential regulation of multiple 
glucose transporter genes in Leishmania mexicana", J.Biol.Chem., vol. 273, no. 
44, pp. 29118-29126. 
Burchmore, R. J., Rodriguez-Contreras, D., McBride, K., Merkel, P., Barrett, M. 
P., Modi, G., Sacks, D., & Landfear, S. M. 2003, "Genetic characterization of 
glucose transporter function in Leishmania mexicana", Proc.Natl.Acad.Sci.U.S.A, 
vol. 100, no. 7, pp. 3901-3906. 
  199 
  
Camargo, E. P., Coelho, J. A., Moraes, G., & Figueiredo, E. N. 1978, 
"Trypanosoma spp., Leishmania spp. and Leptomonas spp.: enzymes of ornithine-
arginine metabolism", Exp.Parasitol., vol. 46, no. 2, pp. 141-144. 
Carter, N. S., Drew, M. E., Sanchez, M., Vasudevan, G., Landfear, S. M. & 
Ullman, B., 2000,"Cloning of a novel inosine-guanosine transporter gene from 
Leishmania donovani by functional rescue of a transport-deficient mutant", J. 
Biol. Chem., vol. 275, no. 27, pp. 20935-20941. 
Castro, H., Romao, S., Gadelha, F. R., & Tomas, A. M. 2008, "Leishmania 
infantum: provision of reducing equivalents to the mitochondrial 
tryparedoxin/tryparedoxin peroxidase system", Exp.Parasitol., vol. 120, no. 4, 
pp. 421-423. 
Castro-Pinto, D. B., Genestra, M., Menezes, G. B., Waghabi, M., Goncalves, A., 
De Nigris, D. C., Sant'Anna, C. M., Leon, L. L., & Mendonca-Lima, L. 2008, 
"Cloning and expression of trypanothione reductase from a New World 
Leishmania species", Arch.Microbiol., vol. 189, no. 4, pp. 375-384. 
Cazzulo, J. J., Arauzo, S., Decazzulo, B. M. F., & Cannata, J. J. B. 1988, "On the 
Production of Glycerol and L-Alanine During the Aerobic Fermentation of Glucose 
by Trypanosomatids", Fems Microbiology Letters, vol. 51, no. 2-3, pp. 187-191. 
Chadbourne, F. L., Raleigh, C., Ali, H. Z., Denny, P. W., & Cobb, S. L. 2011, 
"Studies on the antileishmanial properties of the antimicrobial peptides temporin 
A, B and 1Sa", J.Pept.Sci. 
Chance, B., Sies, H., & Boveris, A. 1979, "Hydroperoxide metabolism in 
mammalian organs", Physiol Rev., vol. 59, no. 3, pp. 527-605. 
Chavali, A. K., Whittemore, J. D., Eddy, J. A., Williams, K. T., & Papin, J. A. 
2008, "Systems analysis of metabolism in the pathogenic trypanosomatid 
Leishmania major", Molecular Systems Biology, vol. 4. 
Cho, W. C. 2007, "Proteomics technologies and challenges", Genomics 
Proteomics Bioinformatics., vol. 5, no. 2, pp. 77-85. 
Cohen-Freue, G., Holzer, T. R., Forney, J. D., & McMaster, W. R. 2007, "Global 
gene expression in Leishmania", Int.J.Parasitol., vol. 37, no. 10, pp. 1077-1086. 
Colotti, G. & Ilari, A. 2011, "Polyamine metabolism in Leishmania: from arginine 
to trypanothione", Amino.Acids, vol. 40, no. 2, pp. 269-285. 
Conn, P. M. 2003, Handbook of Proteomic Methods Humana Press. 
Coombs, G. H., Craft, J. A., & Hart, D. T. 1982, "A comparative study of 
Leishmania mexicana amastigotes and promastigotes. Enzyme activities and 
subcellular locations", Mol Biochem.Parasitol., vol. 5, no. 3, pp. 199-211. 
Cordwell, S. J. & Thingholm, T. E. 2010, "Technologies for plasma membrane 
proteomics", Proteomics., vol. 10, no. 4, pp. 611-627. 
Creek, D. J., Jankevics, A., Burgess, K. E., Breitling, R. & Barrett, M. P. 2012, 
"IDEOM: and Excel interface for analysis of LC-MS- based metabolomics data", 
Bioinformatics, vol. 28, no. 7, pp. 1048-1049.  
  200 
  
Cruz, A., Coburn, C. M., Beverley, S. M. 1991, "Double targeted gene 
replacement for creating null mutants", Proc. Natl. Acad. U S A, vol. 88, no. 16, 
pp. 7170-4. 
Dagger, F., Dunia, I., Hernandez, A. G., Pradel, L. A. & Benedetti, E. L., 1989, 
"Plasma membraneand cytoskeletal constituents in Leishmannia mexicana", 
Molecular Biology Reports, vol. 13, pp. 197-206. 
Daneshvar, H., Molaei, M. M., Kamiabi, H., Burchmore, R., Hagan, P., & 
Stephen, P. R. 2010, "Gentamicin-attenuated Leishmania infantum: cellular 
immunity production and protection of dogs against experimental canine 
leishmaniasis", Parasite Immunol., vol. 32, no. 11-12, pp. 722-730. 
Daneshvar, H., Wyllie, S., Philip, S., Hagan, P, Burchmore, R., 
2011,"Comparative proteomics profiling of a gentamicin-attenuated Leishmania 
infantum cell line identifies key changes in parasite thiol-redox metabolism", J. 
Proteomics, vol. 75, no. 5, pp. 1463-71. 
Dantas-Torres, F. 2011, "Dogs as reservoirs for Leishmania braziliensis", 
Emerg.Infect.Dis., vol. 17, no. 2, pp. 326-327. 
Darlyuk, I., Goldman, A., Roberts, S. C., Ullman, B., Rentsch, D., & Zilberstein, 
D. 2009, "Arginine Homeostasis and Transport in the Human Pathogen Leishmania 
donovani", Journal of Biological Chemistry, vol. 284, no. 30, pp. 19800-19807. 
David, C. V. & Craft, N. 2009, "Cutaneous and mucocutaneous leishmaniasis", 
Dermatol.Ther., vol. 22, no. 6, pp. 491-502. 
Desjeux, P. 2001, "The increase in risk factors for leishmaniasis worldwide", 
Transactions of the Royal Society of Tropical Medicine and Hygiene, vol. 95, no. 
3, pp. 239-243. 
Desjeux, P. 2004, "Leishmaniasis: current situation and new perspectives", Comp 
Immunol.Microbiol.Infect.Dis., vol. 27, no. 5, pp. 305-318. 
De Souza, W., 1984, "Cell biology of Trypanosoma cruzi", Int. Rev. Cytol., vol.86, 
pp. 197-283. 
De Souza, W.(editor),2010, in Structures and Organelles in Pathogenis Protists, 
Springer-Verlag Berlin Heidelberg. 
Docampo, R., Scott, D. A., Vercesi, A. E. & Moreno, S. N. 1995, " Intracellular 
Ca2+ storage in acidocalcisomes of Trypanosoma cruzi", Biochem. J.,vol. 310, pp. 
1005–1012. 
dos Santos, M. G., Paes, L. S., Zampieri, R. A., da Silva, M. F., Silber, A. M., & 
Floeter-Winter, L. M. 2009, "Biochemical characterization of serine transport in 
Leishmania (Leishmania) amazonensis", Mol Biochem.Parasitol., vol. 163, no. 2, 
pp. 107-113. 
Doyle, M. A., Macrae, J. I., DE Souza, D. P., Saunders, E. C., McConville, M. J., & 
Likic, V. A. 2009, "LeishCyc: a biochemical pathways database for Leishmania 
major", Bmc Systems Biology, vol. 3. 
  201 
  
Drew, M. E., Langford, C. K., Klamo, E. M., Russell, D. G., Kavanaugh, M. P. & 
Landfear, S. M. 1995,"Functional expression of a myo-inositol/H+ symporter from 
Leishmania donovani", Mol. Cell. Biol., vol. 15, no. 10, pp.5508-5515. 
Dridi, L., Haimeur, A., & Ouellette, M. 2010, "Structure-function analysis of the 
highly conserved charged residues of the membrane protein FT1, the main folic 
acid transporter of the protozoan parasite Leishmania", Biochemical 
Pharmacology, vol. 79, no. 1, pp. 30-38. 
Drummelsmith, J., Brochu, V., Girard, I., Messier, N., & Ouellette, M. 2003, 
"Proteome mapping of the protozoan parasite Leishmania and application to the 
study of drug targets and resistance mechanisms", Mol Cell Proteomics., vol. 2, 
no. 3, pp. 146-155. 
Drummelsmith, J., Girard, I., Trudel, N., & Ouellette, M. 2004, "Differential 
protein expression analysis of Leishmania major reveals novel roles for 
methionine adenosyltransferase and S-adenosylmethionine in methotrexate 
resistance", J.Biol.Chem., vol. 279, no. 32, pp. 33273-33280. 
Dujardin, J. C. 2009, "Structure, dynamics and function of Leishmania genome: 
resolving the puzzle of infection, genetics and evolution?", Infect.Genet.Evol., 
vol. 9, no. 2, pp. 290-297. 
El Fadili, K., Drummelsmith, J., Roy, G., Jardim, A., & Ouellette, M. 2009, 
"Down regulation of KMP-11 in Leishmania infantum axenic antimony resistant 
amastigotes as revealed by a proteomic screen", Exp.Parasitol., vol. 123, no. 1, 
pp. 51-57. 
Fairlamb, A. H. & Cerami, A. 1992, "Metabolism and functions of trypanothione 
in the Kinetoplastida", Annu.Rev.Microbiol., vol. 46, pp. 695-729. 
Feng, X., Rodriguez-Contreras, D., Buffulo, C., Archie Bouwer, H. G., Kruvand, 
E., Beverley, S. M. & Landfear, S. M. 2009, "Amplification of an alternate 
transporter gene suppresses the avirulent phenotype of glucose transporter null 
mutants in Leishmania mexicana", Mol. Microb., vol. 72, no. 2, pp. 369-381. 
Feng, X., Feistel, T., Buffalo, C., McCormack, A., Kruvand, E., Rodriguez-
Contreras, D., Akopyants, N. S., Umasankar, P. K., David, L., Jardim, A., 
Berverley, S. M. & Landfear, S. M. 2011,"Remodelling of protein and mRNA 
expression in Leishmania mexicana induced by deletion of glucose transporter 
genes", Mol. Biochem. Parasitol., vol. 175, no.1, pp.39-49. 
Fenn, J. B., Mann, M., Meng, C. K.,Wong, S. F. & Whitehouse, C. M., 1989, 
"Electrospray Ionization of Large Biomolecules", Science, vol. 246, no. 4926, pp. 
64-71. 
Ferguson, P. L. & Smith, R. D. 2003, "Proteome analysis by mass spectrometry"., 
Annu.Rev.Biophysis. Biomol. Struct. , vol 32, pp. 399-424. 
Field, M. C. & Carrington, M., 2004, "Intracellular membrna transport systems in 
Trypanosoma brucei", Traffic, vol. 5, pp. 905-913. 
  202 
  
Forget, G., Gregory, D. J., Whitcombe, L. Ae., & Olivier, M. 2006, "Role of host 
protein tyrosine phosphatase SHP-1 in Leishmania donovani-induced inhibition of 
nitric oxide production", Infect.Immun., vol. 74, no. 11, pp. 6272-6279. 
Foucher, A. L., Papadopoulou, B., & Ouellette, M. 2006, "Prefractionation by 
digitonin extraction increases representation of the cytosolic and intracellular 
proteome of Leishmania infantum", J.Proteome.Res., vol. 5, no. 7, pp. 1741-
1750. 
Frezard, F. & Demicheli, C. 2010, "New delivery strategies for the old 
pentavalent antimonial drugs", Expert Opin.Drug Deliv., vol. 7, no. 12, pp. 1343-
1358. 
Fujiki, Y., Hubbard, A. L., Fowler, S., & Lazarow, P. B. 1982, "Isolation of 
intracellular membranes by means of sodium carbonate treatment: application 
to endoplasmic reticulum", J.Cell Biol., vol. 93, no. 1, pp. 97-102. 
Gadelha, C., LeBowitz, J. H., Manning, J., Seebeck, T., & Gull, K. 2004, 
"Relationships between the major kinetoplastid paraflagellar rod proteins: a 
consolidating nomenclature", Mol Biochem.Parasitol., vol. 136, no. 1, pp. 113-
115. 
Gadelha, C., Wickstead, B., de Souza, W., Gull, K., & Cunha-e-Silva 2005, 
"Cryptic paraflagellar rod in endosymbiont-containing kinetoplastid protozoa", 
Eukaryot.Cell, vol. 4, no. 3, pp. 516-525. 
Galbraith, R. A. 1991, "Intermediary Metabolism in Leishmania-Mexicana", 
Journal of Nutritional Biochemistry, vol. 2, no. 4, pp. 180-185. 
Genestra, M., Guedes-Silva, D., Souza, W. J., Cysne-Finkelstein, L., Soares-
Bezerra, R. J., Monteiro, F. P., & Leon, L. L. 2006a, "Nitric oxide synthase (NOS) 
characterization in Leishmania amazonensis axenic amastigotes", Arch.Med.Res., 
vol. 37, no. 3, pp. 328-333. 
Genestra, M., Souza, W. J., Guedes-Silva, D., Machado, G. M., Cysne-Finkelstein, 
L., Bezerra, R. J., Monteiro, F., & Leon, L. L. 2006b, "Nitric oxide biosynthesis 
by Leishmania amazonensis promastigotes containing a high percentage of 
metacyclic forms", Arch.Microbiol., vol. 185, no. 5, pp. 348-354. 
Geraldo, M. V., Silber, A. M., Pereira, C. A., & Uliana, S. R. 2005, 
"Characterisation of a developmentally regulated amino acid transporter gene 
from Leishmania amazonensis", FEMS Microbiol.Lett., vol. 242, no. 2, pp. 275-
280. 
Ghaemmaghami, S., Huh, W. K., Bower, K., Howson, R. W., Belle, A., Dephoure, 
N., O'Shea, E. K., & Weissman, J. S. 2003, "Global analysis of protein expression 
in yeast", Nature, vol. 425, no. 6959, pp. 737-741. 
Ginger, M. L., Portman, N., & McKean, P. G. 2008, "Swimming with protists: 
perception, motility and flagellum assembly", Nat.Rev.Microbiol., vol. 6, no. 11, 
pp. 838-850. 
  203 
  
Glaser, T. A. & Mukkada, A. J. 1992, "Proline transport in Leishmania donovani 
amastigotes: dependence on pH gradients and membrane potential", Mol 
Biochem.Parasitol., vol. 51, no. 1, pp. 1-8. 
Goyard, S. & Beverley, S. M. 2000, "Blasticidin resistance: a new independent 
marker for stable transfection of Leishmania", Mol. Biochem. Parasitol., vol. 
108, no. 2, pp. 249-52. 
Gossage, S. M, Matthew, E. R. & Bates, P. A. 2003, "Two separate growth phases 
during the development of Leishmania in sand flies: implications for 
understanding the life cycle", Int. J. Parasitol., vol. 33, no. 10, pp.1027-1034. 
Gottlieb, M. & Dwyer, D. M. 1981, "Leishmania donovani: surface membrane acid 
phosphatase activity of promastigotes", Exp.Parasitol., vol. 52, no. 1, pp. 117-
128. 
Gotoh, T. & Mori, M. 1999, "Arginase II downregulates nitric oxide (NO) 
production and prevents NO-mediated apoptosis in murine macrophage-derived 
RAW 264.7 cells", J.Cell Biol., vol. 144, no. 3, pp. 427-434. 
Goyal, N., Roy, U., & Rastogi, A. K. 1996, "Relative resistance of promastigotes 
of a virulent and an avirulent strain of Leishmania donovani to hydrogen 
peroxide", Free Radic.Biol.Med., vol. 21, no. 5, pp. 683-689. 
Guerbouj, S., Victoir, K., Guizani, I., Seridi, N., Nuwayri-Salti, N., Belkaid, M., 
Ismail, R. B., Le Ray, D., & Dujardin, J. C. 2001, "Gp63 gene polymorphism and 
population structure of Leishmania donovani complex: influence of the host 
selection pressure?", Parasitology, vol. 122 Pt 1, pp. 25-35. 
Gull, K., 1999, "The cytoskeleton of the trypanosomatid parasites", Annu. Rev. 
Microbiol., vol. 53., 629-655. 
Gygi, S. P., Rochon, Y., Franza, B. R., & Aebersold, R. 1999, "Correlation 
between protein and mRNA abundance in yeast", Mol Cell Biol., vol. 19, no. 3, 
pp. 1720-1730. 
Hanada, K. 2003, "Serine palmitoyltransferase, a key enzyme of sphingolipid 
metabolism", Biochim.Biophys.Acta, vol. 1632, no. 1-3, pp. 16-30. 
Hannaert, V., Bringaud, F., Opperdoes, F. R. & Michels, P. A. 2003,"Evolution of 
energy metabolism and its compartmentation in kinetoplastida", Kinetoplastida 
Biol. Dis., vol. 2, no.11, pp.1-30. 
Harms, G., Schonian, G., & Feldmeier, H. 2003, "Leishmaniasis in Germany", 
Emerging Infectious Diseases, vol. 9, no. 7, pp. 872-875. 
Hart, D. T. & Coombs, G. H. 1982, "Leishmania mexicana: energy metabolism of 
amastigotes and promastigotes", Exp.Parasitol., vol. 54, no. 3, pp. 397-409. 
Hart, D. T. & Opperdoes, F. R. 1984, "The occurrence of glycosomes 
(microbodies) in the promastigote stage of four major Leishmania species", Mol 
Biochem.Parasitol., vol. 13, no. 2, pp. 159-172. 
Herwaldt, B. L. 1999, "Leishmaniasis", Lancet, vol. 354, no. 9185, pp. 1191-1199. 
  204 
  
Horth, P., Miller, C. A., Preckel, T., & Wenz, C. 2006, "Efficient fractionation 
and improved protein identification by peptide OFFGEL electrophoresis", Mol 
Cell Proteomics, vol. 5, no. 10, pp. 1968-1974. 
Hunt, P. W. 2011, "Molecular diagnosis of infections and resistance in veterinary 
and human parasites", Vet.Parasitol., vol. 180, no. 1-2, pp. 12-46. 
Inbar, E., Canepa, G. E., Carrillo, C., Glaser, F., Suter, G. M., Rentsch, D., 
Zilberstein, D., & Pereira, C. A. 2010, "Lysine transporters in human 
trypanosomatid pathogens", Amino.Acids. 
Inga, R., De Doncker, S., Gomez, J., Lopez, M., Garcia, R., Le Ray, D., Arevalo, 
J., & Dujardin, J. C. 1998, "Relation between variation in copy number of 
ribosomal RNA encoding genes and size of harbouring chromosomes in 
Leishmania of subgenus Viannia", Mol Biochem.Parasitol., vol. 92, no. 2, pp. 
219-228. 
Iniesta, V., Gomez-Nieto, L. C., & Corraliza, I. 2001, "The inhibition of arginase 
by N(omega)-hydroxy-l-arginine controls the growth of Leishmania inside 
macrophages", J.Exp.Med., vol. 193, no. 6, pp. 777-784. 
Iniesta, V., Gomez-Nieto, L. C., Molano, I., Mohedano, A., Carcelen, J., Miron, 
C., Alonso, C., & Corraliza, I. 2002, "Arginase I induction in macrophages, 
triggered by Th2-type cytokines, supports the growth of intracellular Leishmania 
parasites", Parasite Immunol., vol. 24, no. 3, pp. 113-118. 
Iovannisci, D. M., Kaur, K., Young, L. & Ullman, B. 1984,"Genetic analysis of 
nucleoside transport in Leishmania donovani", Mol. Cell. Biol., vol. 4, no. 6,pp. 
1013-9. 
Iyer, J. P., Kaprakkaden, A., Choudhary, M. L. & Shaha, C. 2008, "Crucial role of 
cytosolic tryparedoxin peroxidase in Leishmania donovani survival, drug response 
and virulance", Mol. Microbiol., vol. 68, no. 2, pp. 372-91.  
Jaeger, T. & Flohe, L. 2006, "The thiol-based redox networks of pathogens: 
unexploited targets in the search for new drugs", Biofactors, vol. 27, no. 1-4, pp. 
109-120. 
Josic, D. & Clifton, J. G. 2007, "Mammalian plasma membrane proteomics", 
Proteomics., vol. 7, no. 16, pp. 3010-3029. 
Kamleh, M. A., Dow, J. A., & Watson, D. G. 2009, "Applications of mass 
spectrometry in metabolomic studies of animal model and invertebrate systems", 
Brief.Funct.Genomic.Proteomic., vol. 8, no. 1, pp. 28-48. 
Kato, H., Gomez, E. A., Caceres, A. G., Vargas, F., Mimori, T., Yamamoto, K., 
Iwata, H., Korenaga, M., Velez, L., & Hashiguchi, Y. 2011, "Natural infections of 
man-biting sand flies by Leishmania and Trypanosoma species in the northern 
Peruvian Andes", Vector.Borne.Zoonotic.Dis., vol. 11, no. 5, pp. 515-521. 
Kaye, P. & Scott, P. 2011, "Leishmaniasis: complexity at the host-pathogen 
interface", Nat.Rev.Microbiol., vol. 9, no. 8, pp. 604-615. 
  205 
  
Kell, D. B. & Westerhoff, H. V. 1986, "Metabolic control theory: its role in 
microbiology and biotechnology", Fems Microbiology Letters, vol. 39, no. 4, pp. 
305-320. 
Killick-kendrick, R., Molyneux D. H. and Ashford, R. W., 1974, "Leishmania in 
phlebotomid sandflies I. Modifications of the flagellum associated with 
attachment to the mid-gut and oesophageal valve of the sandfly", Proc. R. Soc. 
Lond. B, vol. 187, pp. 409–419. 
Killick-Kendrick, R. 1978, "Recent advances and outstanding problems in the 
biology of phlebotomine sandflies. A review", Acta Trop., vol. 35, no. 4, pp. 297-
313. 
Killick-Kendrick, R. 1999, "The biology and control of phlebotomine sand flies", 
Clin.Dermatol., vol. 17, no. 3, pp. 279-289. 
Kohl, L., Sherwin, T., & Gull, K. 1999, "Assembly of the paraflagellar rod and the 
flagellum attachment zone complex during the Trypanosoma brucei cell cycle", 
J.Eukaryot.Microbiol., vol. 46, no. 2, pp. 105-109. 
Krassner, S. M. 1969, "Proline metabolism in Leishmania tarentolae", 
Exp.Parasitol., vol. 24, no. 3, pp. 348-363. 
Krassner, S. M. & Flory, B. 1971, "Essential amino acids in the culture of 
Leishmania tarentolae", J.Parasitol., vol. 57, no. 4, pp. 917-920. 
Krassner, S. M. & Flory, B. 1972, "Proline metabolism in Leishmania donovani 
promastigotes", J.Protozool., vol. 19, no. 4, pp. 682-685. 
Kweku, M. A., Odoom, S., Puplampu, N., Desewu, K., Nuako, G. K., Gyan, B., 
Raczniak, G., Kronmann, K. C., Koram, K., Botero, S., Boakye, D., & Akuffo, H. 
2011, "An outbreak of suspected cutaneous leishmaniasis in Ghana: lessons learnt 
and preparation for future outbreaks", Glob.Health Action., vol. 4. 
Lafon, S. W., Nelson, D. J., Berens, R. L., & Marr, J. J. 1982, "Purine and 
Pyrimidine Salvage Pathways in Leishmania-Donovani", Biochemical 
Pharmacology, vol. 31, no. 2, pp. 231-238. 
Landfear, S. M. 2000, "Genetics and biochemistry of Leishmania membrane 
transporters", Curr.Opin.Microbiol., vol. 3, no. 4, pp. 417-421. 
Landfear, S. M. 2010, "Glucose transporters in parasitic protozoa", Methods Mol 
Biol., vol. 637, pp. 245-262. 
Landfear, S. M. 2011, "Nutrient Transport and Pathogenesis in Selected Parasitic 
Protozoa", Eukaryot.Cell. 
Landfear, S. M. 2001,"Molecular genetics of nucleoside transporters in 
Leishmania and African trypanosomes", Biochem. Phramacol., vol.62, no. 2, pp. 
149-55.  
Landfear, S. M. & Ignatushchenko, M. 2001, "The flagellum and flagellar pocket 
of trypanosomatids", Mol Biochem.Parasitol., vol. 115, no. 1, pp. 1-17. 
  206 
  
Landfear, S. M., Ullman, B., Carter, N. S., & Sanchez, M. A. 2004, "Nucleoside 
and nucleobase transporters in parasitic protozoa", Eukaryot.Cell, vol. 3, no. 2, 
pp. 245-254. 
Langford, C. K., Ewbank, S. A., Hanson, S. S, Ullman, B. & Landfear, S. M, 
1992,"Molecular characterisation of two genes encoding members of the glucose 
transporter superfamily in the parasitic protozoan Leishmania donovani", Mol. 
Biochem. Parasitol., vol. 55, pp. 51-64. 
 
LeBowitz, J. H., Coburn, C. M., McMohan-Pratt, D. & Beverley, S. M. 1990, 
"Developlment of  a stable Leishmania expression vector and application to the 
study of parasite surface antigen genes", Proc. Natl. Acad. Sci. U S A., vol 87, 
no. 24, pp. 9736-40. 
LeBowitz, J. H., Smith, H. Q., Rusche, L., Beverley S.M., 1993, "Coupling of 
poly(A) site selection and trans-splicing in Leishmania",Genes Dev., vol. 7, pp. 
996-1007.  
LeFurgey, A., Ingram, P. & Blum, J. J., 2001, "Compartmental responsesto acute 
osmotic stress in Leishmania major in rapid loss of Na+ and Cl-", Comp. Biochem. 
Physiol.  A Mol. Integr. Physiol., vol. 128, pp. 385-394. 
Leifso, K., Cohen-Freue, G., Dogra, N., Murray, A., & McMaster, W. R. 2007, 
"Genomic and proteomic expression analysis of Leishmania promastigote and 
amastigote life stages: the Leishmania genome is constitutively expressed", Mol 
Biochem.Parasitol., vol. 152, no. 1, pp. 35-46. 
Leprohon, P., Legare, D., Raymond, F., Madore, E., Hardiman, G., Corbeil, J., & 
Ouellette, M. 2009, "Gene expression modulation is associated with gene 
amplification, supernumerary chromosomes and chromosome loss in antimony-
resistant Leishmania infantum", Nucleic Acids Res., vol. 37, no. 5, pp. 1387-
1399. 
Leslie, G., Barrett, M., & Burchmore, R. 2002, "Leishmania mexicana: 
promastigotes migrate through osmotic gradients", Exp.Parasitol., vol. 102, no. 
2, pp. 117-120. 
Lin, Y. C., Hsu, J. Y., Chiang, S. C., & Lee, S. T. 2005, "Distinct overexpression 
of cytosolic and mitochondrial tryparedoxin peroxidases results in preferential 
detoxification of different oxidants in arsenite-resistant Leishmania amazonensis 
with and without DNA amplification", Mol Biochem.Parasitol., vol. 142, no. 1, 
pp. 66-75. 
Lopez-martin, C., Perez-Victoria, J. M., Carvalho, L., Castanys, S., & Gamarro, 
F., 2008, "Sitamaquine sensitivity in Leishmania species is not mediated by drug 
accumulation in acidocalcisomes", Antimicrob. Agents Chemother., vol. 52, no. 
11, pp 4030-4036. 
Lu, B., McClatchy, D. B., Kim, J. Y., & Yates, J. R., III 2008, "Strategies for 
shotgun identification of integral membrane proteins by tandem mass 
spectrometry", Proteomics., vol. 8, no. 19, pp. 3947-3955. 
Lynn, M. A. & McMaster, W. R. 2008, "Leishmania: conserved evolution--diverse 
diseases", Trends Parasitol., vol. 24, no. 3, pp. 103-105. 
  207 
  
Maclay, W. N. 1956, Journal of Colloid Science, vol. 11, no. 3, pp. 272-285. 
Maga, J. A. & LeBowitz, J. H. 1999, "Unravelling the kinetoplastid paraflagellar 
rod", Trends Cell Biol., vol. 9, no. 10, pp. 409-413. 
 
Maga, J. A., Sherwin, T., Francis, S., Gull, K. & LeBowitz, J. H. 1999, "Genetic 
dissection of the Leishmania paraflagellar rod, a unique flagellar cytoskeleton 
structure", J. Cell. Sci., Pt. 16, pp. 2753-63. 
Manolescu, A. R., Witkowska, K., Kinnaird, A., Cessford, T., & Cheeseman, C. 
2007, "Facilitated hexose transporters: new perspectives on form and function", 
Physiology.(Bethesda.), vol. 22, pp. 234-240. 
Markle, W. H., Makhoul, K. 2004, "Cutaneous Leishmaniasis: Recognition and 
Treatment", Am. Fam. Physician, vol.69, pp. 455-460. 
Marr, J. J. 1983, "Pyrazolopyrimidine metabolism in Leishmania and 
Trypanosomes: Significant differences between host and parasite", Journal of 
Cellular Biochemistry, vol. 22, no. 3, pp. 187-196. 
Martin, E., Simon, M. W., Schaefer, F. W., III, & Mukkada, A. J. 1976, "Enzymes 
of carbohydrate metabolism in four human species of Leishmania: a comparative 
survey", J.Protozool., vol. 23, no. 4, pp. 600-607. 
Mathews, C. K., van Holde, K. E., & Ahern, K. G. 2000, in Biochemistry, 3 edn, 
Addison-Wesley Publishing Company. 
Maugeri, D. A., Cazzulo, J. J., Burchmore, R. J., Barrett, M. P., & Ogbunude, P. 
O. 2003, "Pentose phosphate metabolism in Leishmania mexicana", Mol 
Biochem.Parasitol., vol. 130, no. 2, pp. 117-125. 
McConville, M. J., de Souza, D., Saunders, E., Likic, V. A., & Naderer, T. 2007, 
"Living in a phagolysosome; metabolism of Leishmania amastigotes", Trends 
Parasitol., vol. 23, no. 8, pp. 368-375. 
McConville, M. J. & Ferguson, M. A. 1993, "The structure, biosynthesis and 
function of glycosylated phosphatidylinositols in the parasitic protozoa and 
higher eukaryotes", Biochem.J., vol. 294 ( Pt 2), pp. 305-324. 
McCown, M. & Grzeszak, B. 2010, "Zoonotic and infectious disease surveillance in 
Central America: Honduran feral cats positive for toxoplasma, trypanosoma, 
leishmania, rickettsia, and Lyme disease", J.Spec.Oper.Med., vol. 10, no. 3, pp. 
41-43. 
McDonough, J. & Marban, E. 2005, "Optimization of IPG strip equilibration for 
the basic membrane protein mABC1", Proteomics., vol. 5, no. 11, pp. 2892-2895. 
McNicoll, F., Drummelsmith, J., Muller, M., Madore, E., Boilard, N., Ouellette, 
M., & Papadopoulou, B. 2006, "A combined proteomic and transcriptomic 
approach to the study of stage differentiation in Leishmania infantum", 
Proteomics., vol. 6, no. 12, pp. 3567-3581. 
Miller, M. A., McGowan, S. E., Gantt, K. R., Champion, M., Novick, S. L., 
Andersen, K. A., Bacchi, C. J., Yarlett, N., Britigan, B. E., & Wilson, M. E. 2000, 
  208 
  
"Inducible resistance to oxidant stress in the protozoan Leishmania chagasi", 
J.Biol.Chem., vol. 275, no. 43, pp. 33883-33889. 
Minden, J. 2007, "Comparative proteomics and difference gel electrophoresis", 
Biotechniques, vol. 43, no. 6, pp. 739, 741, 743. 
Mitropoulos, P., Konidas, P., & Durkin-Konidas, M. 2010, "New World cutaneous 
leishmaniasis: updated review of current and future diagnosis and treatment", 
J.Am.Acad.Dermatol., vol. 63, no. 2, pp. 309-322. 
Moreno, S. N. J., Docompo, R., 2009, "The role of acidocalcisomes in parasitic 
protists1", J. Eukaryot Microbiol. , vol. 56, no. 3, pp. 208-213. 
Mottram, J. C., Coombs, G. H. 1985, "Leishmania mexicana: enzyme activities of 
amastigotes and promastigotes and their inhibition by antimonials and 
arsenicals", Exp. Parasitol., vol. 59, no. 2, pp. 151-60. 
Moyersoen, J., Choe, J., Fan, E., Hol, W. G. J. & Michels, P. A. M., 2004, 
"Biogenesis of peroxisomes and glycosomes: trypanosomatid glycosome assembly 
is a promising new drug target", FEMS Microbiol. Rev., vol. 28, pp. 603-643. 
Mukkada, A. J. & Simon, M. W. 1977, "Leishmania tropica: uptake of methionine 
by promastigotes", Exp.Parasitol., vol. 42, no. 1, pp. 87-96. 
Myler, P. J., Beverley, S. M., Cruz, A. K., Dobson, D. E., Ivens, A. C., McDonagh, 
P. D., Madhubala, R., Martinez-Calvillo, S., Ruiz, J. C., Saxena, A., Sisk, E., 
Sunkin, S. M., Worthey, E., Yan, S., & Stuart, K. D. 2001, "The Leishmania 
genome project: new insights into gene organization and function", 
Med.Microbiol.Immunol., vol. 190, no. 1-2, pp. 9-12. 
Myler, P. J. & Stuart, K. D. 2000, "Recent developments from the Leishmania 
genome project", Current Opinion in Microbiology, vol. 3, no. 4, pp. 412-416. 
Naderer, T., Ellis, M. A., Sernee, M. F., DE Souza, D. P., Curtis, J., Handman, E., 
& McConville, M. J. 2006, "Virulence of Leishmania major in macrophages and 
mice requires the gluconeogenic enzyme fructose-1,6-bisphosphatase", 
Proceedings of the National Academy of Sciences of the United States of 
America, vol. 103, no. 14, pp. 5502-5507. 
Naderer, T. & McConville, M. J. 2008, "The Leishmania-macrophage interaction: 
a metabolic perspective", Cell Microbiol., vol. 10, no. 2, pp. 301-308. 
Naula, C. M., Logan, F. M., Wong, P. E., Barrett, M. P., & Burchmore, R. J. 2010, 
"A glucose transporter can mediate ribose uptake: definition of residues that 
confer substrate specificity in a sugar transporter", J.Biol.Chem., vol. 285, no. 
39, pp. 29721-29728. 
Ning, Z. B., Li, Q. R., Dai, J., Li, R. X., Shieh, C. H., & Zeng, R. 2008, 
"Fractionation of complex protein mixture by virtual three-dimensional liquid 
chromatography based on combined pH and salt steps", J.Proteome.Res., vol. 7, 
no. 10, pp. 4525-4537. 
  209 
  
Nogoceke, E., Gommel, D. U., Kiess, M., Kalisz, H. M., & Flohe, L. 1997, "A 
unique cascade of oxidoreductases catalyses trypanothione-mediated peroxide 
metabolism in Crithidia fasciculata", Biol.Chem., vol. 378, no. 8, pp. 827-836. 
Norwicki, M.W,Kuaprasert, B., Mc Nae, I. W., Morgan, H. P., Harding, M. M., 
Michels, P. A., Forthergill-Gilmore, L. A., Walkinshaw, M. D. 2009, " Crystal 
structures of Leishmania mexicana phospho glycerate mutase suggest a one 
metal mechanism and a new enzyme subclass, J. Mol. Biol.,   
Nugent, P. G., Karsani, S. A., Wait, R., Tempero, J., & Smith, D. F. 2004, 
"Proteomic analysis of Leishmania mexicana differentiation", Mol 
Biochem.Parasitol., vol. 136, no. 1, pp. 51-62. 
O'Farrell, P. H. 1975, "High resolution two-dimensional electrophoresis of 
proteins", J. Biol. Chem., vol. 250, no. 10, pp. 4007-21. 
Oliveira, J. S., Melo, M. N., & Gontijo, N. F. 2000, "A sensitive method for 
assaying chemotaxic responses of Leishmania promastigotes", Exp.Parasitol., vol. 
96, no. 3, pp. 187-189. 
Opperdoes, F. R. & Coombs, G. H. 2007, "Metabolism of Leishmania: proven and 
predicted", Trends Parasitol., vol. 23, no. 4, pp. 149-158. 
Ouellette, M., Drummelsmith, J., El Fadili, A., Kundig, C., Richard, D., & Roy, G. 
2002, "Pterin transport and metabolism in Leishmania and related 
trypanosomatid parasites", International Journal for Parasitology, vol. 32, no. 4, 
pp. 385-398. 
Overath, P. & Englster, M., 2004, "Endocytosis, membrane recyclingand sorting 
of GPI-anchored proteins: Trypanososma brucei as model system", Mol. 
Microbiol., vol. 53, pp. 735-744.  
Ozcan, S., Dover, J., & Johnston, M. 1998, "Glucose sensing and signaling by two 
glucose receptors in the yeast Saccharomyces cerevisiae", Embo Journal, vol. 17, 
no. 9, pp. 2566-2573. 
Ozcan, S., Dover, J., Rosenwald, A. G., Wolfl, S., & Johnston, M. 1996, "Two 
glucose transporters in Saccharomyces cerevisiae are glucose sensors that 
generate a signal for induction of gene expression", Proceedings of the National 
Academy of Sciences of the United States of America, vol. 93, no. 22, pp. 12428-
12432. 
Pabon, M. A., Caceres, A. J., Gualdron, M., Quinones, W., Avilan, L., 
concepcion, J. L. 2006, "Purification and characterisation of hexokinase from 
Leishmania mexicana", Mol. Biochem. Parasitol., vol 100, no. 4, pp. 803-10.  
Padmanabhan, P. K., Mukherjee, A., Singh, S., Chattopadhyaya, S., Gowri, V. S., 
Myler, P. J., Srinivasan, N., & Madhubala, R. 2005, "Glyoxalase I from Leishmania 
donovani: a potential target for anti-parasite drug", 
Biochem.Biophys.Res.Commun., vol. 337, no. 4, pp. 1237-1248. 
Paes, L. S., Galvez Rojas, R. L., Daliry, A., Floeter-Winter, L. M., Ramirez, M. I., 
& Silber, A. M. 2008, "Active transport of glutamate in Leishmania (Leishmania) 
amazonensis", J.Eukaryot.Microbiol., vol. 55, no. 5, pp. 382-387. 
  210 
  
Pandey, A. & Mann, M. 2000, "Proteomics to study genes and genomes", Nature, 
vol. 405, no. 6788, pp. 837-846. 
Parsons, M., Furuya, T., Pal., S., & Kessler, P., 2001, "Biogenesis and functions 
of peroxisomes and glycosomes", Mol. Biochem. Parasitol., vol. 115, pp. 19-28. 
Pastakia, K. B. & Dwyer, D. M. 1987, "Identification and characterization of a 
ribose transport system in Leishmania donovani promastigotes", Mol 
Biochem.Parasitol., vol. 26, no. 1-2, pp. 175-181. 
Peacock, C. S., Seeger, K., Harris, D., Murphy, L., Ruiz, J. C., Quail, M. A., 
Peters, N., Adlem, E., Tivey, A., Aslett, M., Kerhornou, A., Ivens, A., Fraser, A., 
Rajandream, M. A., Carver, T., Norbertczak, H., Chillingworth, T., Hance, Z., 
Jagels, K., Moule, S., Ormond, D., Rutter, S., Squares, R., Whitehead, S., 
Rabbinowitsch, E., Arrowsmith, C., White, B., Thurston, S., Bringaud, F., 
Baldauf, S. L., Faulconbridge, A., Jeffares, D., Depledge, D. P., Oyola, S. O., 
Hilley, J. D., Brito, L. O., Tosi, L. R., Barrell, B., Cruz, A. K., Mottram, J. C., 
Smith, D. F., & Berriman, M. 2007, "Comparative genomic analysis of three 
Leishmania species that cause diverse human disease", Nat.Genet., vol. 39, no. 
7, pp. 839-847. 
Pearson, R. D., Harcus, J. L., Symes, P. H., Romito, R., & Donowitz, G. R. 1982, 
"Failure of the phagocytic oxidative response to protect human monocyte-
derived macrophages from infection by Leishmania donovani", J.Immunol., vol. 
129, no. 3, pp. 1282-1286. 
Pedersen, S. K., Harry, J. L., Sebastian, L., Baker, J., Traini, M. D., McCarthy, J. 
T., Manoharan, A., Wilkins, M. R., Gooley, A. A., Righetti, P. G., Packer, N. H., 
Williams, K. L., & Herbert, B. R. 2003, "Unseen proteome: mining below the tip 
of the iceberg to find low abundance and membrane proteins", J.Proteome.Res., 
vol. 2, no. 3, pp. 303-311. 
Piper, R.C., Xu, X., Russell, D.G.,B. M. Landfear, S.M. 1995, "Differential 
targetting of two glucose transporters from Leishmania enrietti is mediated by 
an NH-terminal domain", J.Cell Biol., vol. 128, no. 4, pp. 499-508. 
Portman, N. & Gull, K. 2010, "The paraflagellar rod of kinetoplastid parasites: 
from structure to components and function", Int.J.Parasitol., vol. 40, no. 2, pp. 
135-148. 
Pozzo, L. Y., Fontes, A., de Thomaz, A. A., Santos, B. S., Farias, P. M., Ayres, D. 
C., Giorgio, S., & Cesar, C. L. 2009, "Studying taxis in real time using optical 
tweezers: applications for Leishmania amazonensis parasites", Micron., vol. 40, 
no. 5-6, pp. 617-620. 
Proudfoot, L., O'Donnell, C. A., & Liew, F. Y. 1995, "Glycoinositolphospholipids 
of Leishmania major inhibit nitric oxide synthesis and reduce leishmanicidal 
activity in murine macrophages", Eur.J.Immunol., vol. 25, no. 3, pp. 745-750. 
Quinones, W., Pena, P., Domingo-Sananes, M., Caceres, A., Michels, P. A., 
Avilan, L., Concepcion, J. L. 2007, "Leishmania mexicana: moecular cloning and 
characterisation of enolase", Exp. Parasitol., vol. 116, no. 3, pp. 241-51. 
  211 
  
Rabinovitch, M., Topper, G., Cristello, P., & Rich, A. 1985, "Receptor-mediated 
entry of peroxidases into the parasitophorous vacuoles of macrophages infected 
with Leishmania Mexicana amazonensis", J.Leukoc.Biol., vol. 37, no. 3, pp. 247-
261. 
Rahbar, A. M. & Fenselau, C. 2005, "Unbiased examination of changes in plasma 
membrane proteins in drug resistant cancer cells", J.Proteome.Res., vol. 4, no. 
6, pp. 2148-2153. 
Raina, A. & Janne, J. 1968, "Biosynthesis of putrescine: characterization of 
ornithine decarboxylase from regenerating rat liver", Acta Chem.Scand., vol. 22, 
no. 7, pp. 2375-2378. 
Rainey, P. M. & MacKenzie, N. E. 1991, "A carbon-13 nuclear magnetic resonance 
analysis of the products of glucose metabolism in Leishmania pifanoi amastigotes 
and promastigotes", Mol Biochem.Parasitol., vol. 45, no. 2, pp. 307-315. 
Ready, P. D., Arias, J. R., & Freitas, R. A. 1985, "A pilot study to control 
Lutzomyia umbratilis (Diptera:Psychodidae), the major vector of Leishmania 
braziliensis guyanensis, in a peri-urban rainforest of Manaus, Amazonas State, 
Brazil", Mem.Inst.Oswaldo Cruz, vol. 80, no. 1, pp. 27-36. 
Reid, G. E. & McLuckey, S. A. 2002, "'Top down' protein characterisation via 
tandem masspectrometry", J. Mass Spectrom., no. 37, pp. 663-675. 
Reithinger, R., Dujardin, J. C., Louzir, H., Pirmez, C., Alexander, B., & Brooker, 
S. 2007, "Cutaneous leishmaniasis", Lancet Infect.Dis., vol. 7, no. 9, pp. 581-596. 
Roberts, S. C., Tancer, M. J., Polinsky, M. R., Gibson, K. M., Heby, O., & Ullman, 
B. 2004, "Arginase plays a pivotal role in polyamine precursor metabolism in 
Leishmania - Characterization of gene deletion mutants", Journal of Biological 
Chemistry, vol. 279, no. 22, pp. 23668-23678. 
Rochfort, S. 2005, "Metabolomics reviewed: A new "Omics" platform technology 
for systems biology and implications for natural products research", Journal of 
Natural Products, vol. 68, no. 12, pp. 1813-1820. 
Rodriguez-Contreras, D., Feng, X., Keeney, K. M., Bouwer, H. G., & Landfear, S. 
M. 2007, "Phenotypic characterization of a glucose transporter null mutant in 
Leishmania mexicana", Mol Biochem.Parasitol., vol. 153, no. 1, pp. 9-18. 
Rodriguez-Contreras, D. & Landfear, S. M. 2006, "Metabolic changes in glucose 
transporter-deficient Leishmania mexicana and parasite virulence", 
J.Biol.Chem., vol. 281, no. 29, pp. 20068-20076. 
Rogers, M. E. & Bates, P. A. 2007, "Leishmania manipulation of sand fly feeding 
behavior results in enhanced transmission", PLoS.Pathog., vol. 3, no. 6, p. e91. 
Rojas, R., Valderrama, L., Valderrama, M., Varona, M. X., Ouellette, M., & 
Saravia, N. G. 2006, "Resistance to antimony and treatment failure in human 
Leishmania (Viannia) infection", J.Infect.Dis., vol. 193, no. 10, pp. 1375-1383. 
Romao, P. R., Fonseca, S. G., Hothersall, J. S., Noronha-Dutra, A. A., Ferreira, 
S. H., & Cunha, F. Q. 1999, "Glutathione protects macrophages and Leishmania 
  212 
  
major against nitric oxide-mediated cytotoxicity", Parasitology, vol. 118 ( Pt 6), 
pp. 559-566. 
Rosenzweig, D., Smith, D., Myler, P. J., Olafson, R. W., & Zilberstein, D. 2008, 
"Post-translational modification of cellular proteins during Leishmania donovani 
differentiation", Proteomics., vol. 8, no. 9, pp. 1843-1850. 
Rosypal, A. C., Tripp, S., Lewis, S., Francis, J., Stoskopf, M. K., Larsen, R. S., & 
Lindsay, D. S. 2010, "Survey of antibodies to Trypanosoma cruzi and Leishmania 
spp. in gray and red fox populations from North Carolina and Virginia", 
J.Parasitol., vol. 96, no. 6, pp. 1230-1231. 
Russell, D. G., Xu, S., & Chakraborty, P. 1992, "Intracellular trafficking and the 
parasitophorous vacuole of Leishmania mexicana-infected macrophages", J.Cell 
Sci., vol. 103 ( Pt 4), pp. 1193-1210. 
Sakru, N., Toz, S. O., Korkmaz, M., Ozbel, Y. 2011., "Serological monitoring of 
paediatric visceral leishmaniasis by IFA & ELISA methods",Turkiye Parazitol Derg, 
vol. 35, pp. 125-128. 
Santrich, C., Moore, L., Sherwin, T., Bastin, P., Brokaw, C., Gull, K., & 
LeBowitz, J. H. 1997, "A motility function for the paraflagellar rod of Leishmania 
parasites revealed by PFR-2 gene knockouts", Mol Biochem.Parasitol., vol. 90, 
no. 1, pp. 95-109. 
Saunders, E. C., DE Souza, D. P., Naderer, T., Sernee, M. F., Ralton, J. E., 
Doyle, M. A., Macrae, J. I., Chambers, J. L., Heng, J., Nahid, A., Likic, V. A., & 
McConville, M. J. 2010, "Central carbon metabolism of Leishmania parasites", 
Parasitology, vol. 137, no. 9, pp. 1303-1313. 
Saunders, E. C., Ng, W. W., Chamber, J. M., Ng, M., Naderer, T., Kroemer, J. 
O., Likic, V. A., & McConville, M. J. 2011, "Isoptopomer profiling of Leishmania 
mexicana promastigotes reveals important roles for succinate fermentation and 
aspartate uptake in TCA cycle anaplerosis, glutamate synthesis and growth", 
J.Biol.Chem. 
Sauvage, V., Aubert, D., Escotte-Binet, S., & Villena, I. 2009, "The role of ATP-
binding cassette (ABC) proteins in protozoan parasites", Mol Biochem.Parasitol., 
vol. 167, no. 2, pp. 81-94. 
Scheltema, R. A., Decuypere, S., T'kindt, R., Dujardin, J. C., Coombs, G. H., & 
Breitling, R. 2010, "The potential of metabolomics for Leishmania research in the 
post-genomics era", Parasitology, vol. 137, no. 9, pp. 1291-1302. 
Schlein, Y. 1986, "Sandfly diet and Leishmania", Parasitol.Today, vol. 2, no. 6, 
pp. 175-177. 
Schluesener, D., Fischer, F., Kruip, J., Rogner, M., & Poetsch, A. 2005, "Mapping 
the membrane proteome of Corynebacterium glutamicum", Proteomics, vol. 5, 
no. 5, pp. 1317-1330. 
Seddon, A. M., Curnow, P., & Booth, P. J. 2004, "Membrane proteins, lipids and 
detergents: not just a soap opera", Biochim.Biophys.Acta, vol. 1666, no. 1-2, pp. 
105-117. 
  213 
  
Seifert, K. 2011, "Structures, targets and recent approaches in anti-leishmanial 
drug discovery and development", Open Med. Chem. J., vol. 5, no. 31-9. 
Seyfang, A., Kavanaugh, M. P. & Landfear, S. M. 1997,"Aspartate 19 and 
glutamate 121 are critical for transport function of the myo-inositol/H+ 
symporter from Leishmania donovani", J. Biol. Chem., vol. 272, pp. 24210-
24215. 
Seyfang, A. & Landfear, S. M. 2000,"Four conserved cytoplasmic sequence motifs 
are important for transport function of the Leishmania Inositol/H+ symporter", J. 
Biol. Chem., vol. 275, no. 8, pp. 5687-93. 
Shaked-Mishan, P., Suter-Grotemeyer, M., Yoel-Almagor, T., Holland, N., 
Zilberstein, D., & Rentsch, D. 2006, "A novel high-affinity arginine transporter 
from the human parasitic protozoan Leishmania donovani", Mol Microbiol., vol. 
60, no. 1, pp. 30-38. 
Shapiro, T. A., 1993, "Kinetoplast DNA maxicircles: Networks within networks", 
Proc. Natl. Acad. Sci., vol. 90, pp. 7809-7813. 
Shapiro, T. A. & Englund, P. T. 1995, "The structure and replication of 
kinetoplast DNA", Annu.Rev.Microbiol., vol. 49, pp. 117-143. 
Sharma, S., Singh, G., Chavan, H. D., & Dey, C. S. 2009, "Proteomic analysis of 
wild type and arsenite-resistant Leishmania donovani", Experimental 
Parasitology, vol. 123, no. 4, pp. 369-376. 
Sharma, U. & Singh, S. 2008, "Insect vectors of Leishmania: distribution, 
physiology and their control", J.Vector.Borne.Dis., vol. 45, no. 4, pp. 255-272. 
Simon, M. W. & Mukkada, A. J. 1983,"Intracellular protein degradation in 
Leishmania tropica promastigotes", Mol. Biochem. Parasitol., vol. 7, no.1, pp. 
19-26. 
Simon, M. W., Jayasimhulu, K., & Mukkada, A. J. 1983, "The Free Amino-Acid 
Pool in Leishmania-Tropica Promastigotes", Molecular and Biochemical 
Parasitology, vol. 9, no. 1, pp. 47-57. 
Simon, M. W. & Mukkada, A. J. 1977, "Leishmania tropica: regulation and 
specificity of the methionine transport system in promastigotes", Exp.Parasitol., 
vol. 42, no. 1, pp. 97-105. 
Simpson, A. G., Stevens, J. R., & Lukes, J. 2006, "The evolution and diversity of 
kinetoplastid flagellates", Trends Parasitol., vol. 22, no. 4, pp. 168-174. 
Singer, S. J. 2004, "Some early history of membrane molecular biology", 
Annu.Rev.Physiol, vol. 66, pp. 1-27. 
Singh, G., Chavan, H. D., & Dey, C. S. 2008, "Proteomic analysis of miltefosine-
resistant Leishmania reveals the possible involvement of eukaryotic initiation 
factor 4A (eIF4A)", Int.J.Antimicrob.Agents, vol. 31, no. 6, pp. 584-586. 
Small, G. M., Imanaka, T., & Lazarow, P. B. 1988, "Immunoblotting of 
hydrophobic integral membrane proteins", Anal.Biochem., vol. 169, no. 2, pp. 
405-409. 
  214 
  
Snapp, E. L. & Landfear, S. M. 1997, "Cytoskeletal association is important for 
differential targeting of glucose transporter isoforms in Leishmania", J.Cell Biol., 
vol. 139, no. 7, pp. 1775-1783. 
Spath, G. F., Epstein, L., Leader, B., Singer, S. M., Avila, H. A., Turco, S. J., & 
Beverley, S. M. 2000, "Lipophosphoglycan is a virulence factor distinct from 
related glycoconjugates in the protozoan parasite Leishmania major", 
Proc.Natl.Acad.Sci.U.S.A, vol. 97, no. 16, pp. 9258-9263. 
Speers, A. E. & Wu, C. C. 2007, "Proteomics of integral membrane proteins--
theory and application", Chem.Rev., vol. 107, no. 8, pp. 3687-3714. 
Sprenger, R. R. & Jensen, O. N. 2010, "Proteomics and the dynamic plasma 
membrane: Quo Vadis?", Proteomics., vol. 10, no. 22, pp. 3997-4011. 
Stein, D. A.,Cairns, B. R.,Landfear, S. M.1990,"Developmentally regulated 
transporter in Leishmania is encoded by a family of clustered gene",Nucleic Acid 
Res., vol.18, no.6, pp.1549-1557.  
Stuart, K., Brun, R., Croft, S., Fairlamb, A., Gurtler, R. E., McKerrow, J., Reed, 
S., & Tarleton, R. 2008, "Kinetoplastids: related protozoan pathogens, different 
diseases", J.Clin.Invest, vol. 118, no. 4, pp. 1301-1310. 
Sundar, S., Rai, M, 2002, "Laboratory Diagnosis of Visceral Leishmaniasis", 
Clinical and Diagnostic Laboratory Immunology, vol. 9, pp. 951-958.  
Sundar, S., Sinha, P. K., Rai, M., Verma, D. K., Nawn, K., Alam, S., Chakravarty, 
J., Vaillant, M., Verma, N., Pandey, K., Kumari, P., Shekarlal, C., Arara, R., 
Sharma, B., Strub-Wourgaft, S. E. N., Balasegaran, M., Olliaro, P., Das, P., 
Modabber, F., 2011, "Comparison of short course multidrg treatment with 
standard theraphy for visceral leishmaniasis in India", Lancet, vol. 77, pp. 477-
486.  
Tanford, C. & Reynolds, J. A. 1976, "Characterization of membrane proteins in 
detergent solutions", Biochim.Biophys.Acta, vol. 457, no. 2, pp. 133-170. 
Tang, Y. S. & Ward, R. D. 1998, "Sugar feeding and fluid destination control in 
the phlebotomine sandfly Lutzomyia longipalpis (Diptera : Psychodidae)", 
Medical and Veterinary Entomology, vol. 12, no. 1, pp. 13-19. 
Tatibana, M. & Shigesada, K. 1972, "Two carbamyl phosphate synthetases of 
mammals: specific roles in control of pyrimidine and urea biosynthesis", 
Adv.Enzyme Regul., vol. 10, pp. 249-271. 
ter Kulle, B. H. 1993, "Glucose and proline transport in kinetoplastids", 
Parasitol.Today, vol. 9, no. 6, pp. 206-210. 
Tielens, A. G. & van Hellemond, J. J. 2009, "Surprising variety in energy 
metabolism within Trypanosomatidae", Trends Parasitol., vol. 25, no. 10, pp. 
482-490. 
Trainor, K. E., Porter, B. F., Logan, K. S., Hoffman, R. J., & Snowden, K. F. 
2010, "Eight cases of feline cutaneous leishmaniasis in Texas", Vet.Pathol., vol. 
47, no. 6, pp. 1076-1081. 
  215 
  
Turco, S. J. & Descoteaux, A. 1992, "The lipophosphoglycan of Leishmania 
parasites", Annu.Rev.Microbiol., vol. 46, pp. 65-94. 
Tuon, F. F., Amato, V. S., Graf, M. E., Siqueira, A. M., Nicodemo, A. C., & 
Amato, N., V 2008, "Treatment of New World cutaneous leishmaniasis--a 
systematic review with a meta-analysis", Int.J.Dermatol., vol. 47, no. 2, pp. 
109-124. 
Ubeda, J. M., Legare, D., Raymond, F., Ouameur, A. A., Boisvert, S., Rigault, P., 
Corbeil, J., Tremblay, M. J., Olivier, M., Papadopoulou, B., & Ouellette, M. 
2008, "Modulation of gene expression in drug resistant Leishmania is associated 
with gene amplification, gene deletion and chromosome aneuploidy", Genome 
Biol., vol. 9, no. 7, p. R115. 
Vance, J. E. & Steenbergen, R. 2005, "Metabolism and functions of 
phosphatidylserine", Prog.Lipid Res., vol. 44, no. 4, pp. 207-234. 
Vasudevan, G., Carter, N. S., Drew, M. E., Beverley, S. M, Sanchez, M. A., 
Seyfang, A., Ullman, B & Landfear, S. M.1998, "Cloning of Leishmania nucleoside 
transporter genes by rescue of a transport-deficient mutant", Proc. Natl. Acad. 
Sci. U. S. A., vol. 95, pp. 9873-9878. 
Vega-Lopez, F. 2003, "Diagnosis of cutaneous leishmaniasis", Curr. Opin. Infect. 
Dis., vol. 16, no. 2, pp. 97-101. 
Veland, N., Espinosa, D., Valencia, B. M., Ramos, A. P., Calderon, F., Arevalo, 
J., Low, D. E., Llanos-Cuentas, A. & Boggild, A. 2011,"Polymerase chain reaction 
detection of Leishmania kDNA from the urine of peruvian patients with 
cutaneous and mucocutaneous Leishmaniasis", Am. J. Trop. Med. Hyg., vol. 84, 
no. 4, pp. 556-561. 
Velez, I. D., Colmenares, L. M., & Munoz, C. A. 2009, "Two cases of visceral 
leishmaniasis in Colombia resistant to meglumine antimonial treatment", 
Rev.Inst.Med.Trop.Sao Paulo, vol. 51, no. 4, pp. 231-236. 
Vercesi, A. E., Moreno, S. N. & Docampo, R. 1994, "Ca2+/H+ exchange in acidic 
vacuoles of Trypanosoma brucei, Biochem. J., vol. 304, pp. 227–233. 
Verlinde, C. L., Hannaeart, V., Blonski, C., Wilson, M., Perie, J. J., Fothergill-
Gilmore, L. A., Opperdoes, F. R., Gelb, M. H., Hol, W. G. , Michels, P. A. 2001, 
"Glycolisis as a target for the design of new anti-trypanosome drugs", Drug 
Resist. Updat.vol. 4, no. 1, pp. 50-65. 
Vergnes, B., Gourbal, B., Girard, I., Sundar, S., Drummelsmith, J., & Ouellette, 
M. 2007, "A proteomics screen implicates HSP83 and a small kinetoplastid 
calpain-related protein in drug resistance in Leishmania donovani clinical field 
isolates by modulating drug-induced programmed cell death", Mol Cell 
Proteomics., vol. 6, no. 1, pp. 88-101. 
Vickerman, K. & Tetley, L. 1990, Ciliary and Flagellar Membranes Plenum 
Publishing Corporation. 
  216 
  
Vickers, T. J., Greig, N., & Fairlamb, A. H. 2004, "A trypanothione-dependent 
glyoxalase I with a prokaryotic ancestry in Leishmania major", 
Proc.Natl.Acad.Sci.U.S.A, vol. 101, no. 36, pp. 13186-13191. 
Victoir, K., Dujardin, J. C., De Doncker, S., Barker, D. C., Arevalo, J., Hamers, 
R., & Le Ray, D. 1995, "Plasticity of gp63 gene organization in Leishmania 
(Viannia) braziliensis and Leishmania (Viannia) peruviana", Parasitology, vol. 111 
( Pt 3), pp. 265-273. 
Vincent, I. M., Creek, D,Watson, D. G., Kamleh, M. A., Woods, D. J., Wong, P. 
E., Burchmore, R. J., Barrett, M. P., 2010,"A molecular mechanism for 
eflornithine resistance in African trypanosomes", PLoS Pathog, vol. 6, no. 11. 
Vincent, I. M, Creek, D. J., Burgess, K., Woods, D., Burchmore, R. J. S., Barrett, 
M. P. 2012, "Untargeted metabolomics reveals a lack of synergy between 
nifurtimox and eflornithine agaisnt Trypansoma brucei"PloS Negl. Trop. Dis.,vol. 
6, no.5. 
Viswanathan, S., Unlu, M., & Minden, J. S. 2006, "Two-dimensional difference 
gel electrophoresis", Nat.Protoc., vol. 1, no. 3, pp. 1351-1358. 
Walker, J., Vasquez, J. J., Gomez, M. A., Drummelsmith, J., Burchmore, R., 
Girard, I., & Ouellette, M. 2006, "Identification of developmentally-regulated 
proteins in Leishmania panamensis by proteome profiling of promastigotes and 
axenic amastigotes", Mol Biochem.Parasitol., vol. 147, no. 1, pp. 64-73. 
Waller, R. F. & McConville, M. J. 2002, "Developmental changes in lysosome 
morphology and function Leishmania parasites", Int.J.Parasitol., vol. 32, no. 12, 
pp. 1435-1445. 
Wallin, E. & von Heijne, G. 1998, "Genome-wide analysis of integral membrane 
proteins from eubacterial, archaean, and eukaryotic organisms", Protein Sci., 
vol. 7, no. 4, pp. 1029-1038. 
Wanasen, N. & Soong, L. 2008, "L-arginine metabolism and its impact on host 
immunity against Leishmania infection", Immunologic Research, vol. 41, no. 1, 
pp. 15-25. 
Watson, D. G. 2010, "The potential of mass spectrometry for the global profiling 
of parasite metabolomes", Parasitology, vol. 137, no. 9, pp. 1409-1423. 
Weina, P. J., Neafie, R. C., Wortmann, G., Polhemus, M., & Aronson, N. E. 2004, 
"Old world leishmaniasis: An emerging infection among deployed US military and 
civilian workers", Clinical Infectious Diseases, vol. 39, no. 11, pp. 1674-1680. 
Welinder, C. & Ekblad, L. 2011, "Coomassie Staining as Loading Control in 
Western Blot Analysis", Journal of Proteome Research, vol. 10, no. 3, pp. 1416-
1419. 
Quinones, W, Pena, P., Domingo-Sananes, M., Caceres, A., Michels, P. A., 
Avilan, A., Concepcion, J. L. 2007, Leishmania mexicana: molecular cloning and 
characterisation of enolase", Exp. Parasitol., vol. 116, no. 3. 
  217 
  
Wilson, M. E., Andersen, K. A., & Britigan, B. E. 1994, "Response of Leishmania 
chagasi promastigotes to oxidant stress", Infect.Immun., vol. 62, no. 11, pp. 
5133-5141. 
Wyllie, S., Vickers, T. J., & Fairlamb, A. H. 2008, "Roles of trypanothione S-
transferase and tryparedoxin peroxidase in resistance to antimonials", 
Antimicrob.Agents Chemother., vol. 52, no. 4, pp. 1359-1365. 
Yao, S. Y., Ng, A. M., Muzyka, W. R., Griffifths, M., Cass, C. E., Baldwin, S. A. & 
Young, J. D. 1997,"Molecular cloning and functional characterisation of 
nitrobenzylthioinosine (NBMPR)-sensitive (es) and NBMPR-insensitive (ei) 
equilibrative nucleoside transporter proteins (rENT1 and rENT2) from rat 
tissues." J. Biol. Chem., vol. 272, no. 45, pp. 28423-30. 
Young, C. J., Turner, D. P., Killick-Kendrick, R., Rioux, J. A., & Leaney, A. J. 
1980, "Fructose in wild-caught Phlebotomus ariasi and the possible relevance of 
sugars taken by sandflies to the transmission of leishmaniasis", 
Trans.R.Soc.Trop.Med.Hyg., vol. 74, no. 3, pp. 363-366. 
Yurchenko, V. Y. & Kolesnikov, A. A., 2000, "Minicircular kinetoplast DNA of 
Trypanosomatidae", Mol. Biol., vol. 35, no. 1, pp. 1-10. 
Zeledon, R. A. 1996, "Hemoflagellates". 
Zhang, L. J., Wang, X. E., Peng, X., Wei, Y. J., Cao, R., Liu, Z., Xiong, J. X., Yin, 
X. F., Ping, C., & Liang, S. 2006, "Proteomic analysis of low-abundant integral 
plasma membrane proteins based on gels", Cell Mol Life Sci., vol. 63, no. 15, pp. 
1790-1804. 
Zhang, K., Bangs, J. D., & Beverley, S. M. 2010, "Sphingolipids in parasitic 
protozoa", Adv.Exp.Med.Biol., vol. 688, pp. 238-248. 
Zhang, K., Pompey, J. M., Hsu, F. F., Key, P., Bandhuvula, P., Saba, J. D., Turk, 
J., & Beverley, S. M. 2007, "Redirection of sphingolipid metabolism toward de 
novo synthesis of ethanolamine in Leishmania", EMBO J., vol. 26, no. 4, pp. 
1094-1104. 
Zhang, K., Showalter, M., Revollo, J., Hsu, F. F., Turk, J., & Beverley, S. M. 
2003, "Sphingolipids are essential for differentiation but not growth in 
Leishmania", EMBO J., vol. 22, no. 22, pp. 6016-6026. 
Zhang, L. J., Wang, X. E., Peng, X., Wei, Y. J., Cao, R., Liu, Z., Xiong, J. X., Yin, 
X. F., Ping, C., & Liang, S. 2006, "Proteomic analysis of low-abundant integral 
plasma membrane proteins based on gels", Cell Mol Life Sci., vol. 63, no. 15, pp. 
1790-1804. 
Zhang, L., Xie, J., Wang, X., Liu, X., Tang, X., Cao, R., Hu, W., Nie, S., Fan, C., 
& Liang, S. 2005, "Proteomic analysis of mouse liver plasma membrane: use of 
differential extraction to enrich hydrophobic membrane proteins", Proteomics, 
vol. 5, no. 17, pp. 4510-4524. 
 
Zhou, M. & Veenstra, T. 2008, "Mass spectrometry: m/z 1988-2008", 
BioTechnique., vol. 44,pp. 667-670. 
 
  218 
  
Zilberstein, D. & Dwyer, D. M. 1984, "Glucose transport in Leishmania donovani 
promastigotes", Mol Biochem.Parasitol., vol. 12, no. 3, pp. 327-336. 
Zilberstein, D. & Dwyer, D. M. 1985, "Protonmotive force-driven active transport 
of D-glucose and L-proline in the protozoan parasite Leishmania donovani", 
Proc.Natl.Acad.Sci.U.S.A, vol. 82, no. 6, pp. 1716-1720. 
Zilberstein, D. & Dwyer, D. M. 1988, "Identification of a surface membrane 
proton-translocating ATPase in promastigotes of the parasitic protozoan 
Leishmania donovani", Biochem.J., vol. 256, no. 1, pp. 13-21. 
Zilberstein, D. & Gepstein, A. 1993, "Regulation of L-proline transport in 
Leishmania donovani by extracellular pH", Mol Biochem.Parasitol., vol. 61, no. 
2, pp. 197-205. 
Zucca, M. & Savoia, D. 2011, "Current developments in the therapy of protozoan 
infections", Open.Med.Chem.J., vol. 5, pp. 4-10. 
 
 
 
